New Synthetic Methodologies Directed toward Pharmacologically Active Compounds as well as Silole Based Chromophores for Analytical and Optoelectronic Applications by Moustafa, Mahmoud M. Abd Rabo
Western University 
Scholarship@Western 
Electronic Thesis and Dissertation Repository 
2-25-2011 12:00 AM 
New Synthetic Methodologies Directed toward Pharmacologically 
Active Compounds as well as Silole Based Chromophores for 
Analytical and Optoelectronic Applications 
Mahmoud M. Abd Rabo Moustafa 
The University of Western Ontario 
Supervisor 
Dr. Brian L. Pagenkopf 
The University of Western Ontario 
Graduate Program in Chemistry 
A thesis submitted in partial fulfillment of the requirements for the degree in Doctor of 
Philosophy 
© Mahmoud M. Abd Rabo Moustafa 2011 
Follow this and additional works at: https://ir.lib.uwo.ca/etd 
 Part of the Organic Chemistry Commons 
Recommended Citation 
Moustafa, Mahmoud M. Abd Rabo, "New Synthetic Methodologies Directed toward Pharmacologically 
Active Compounds as well as Silole Based Chromophores for Analytical and Optoelectronic Applications" 
(2011). Electronic Thesis and Dissertation Repository. 93. 
https://ir.lib.uwo.ca/etd/93 
This Dissertation/Thesis is brought to you for free and open access by Scholarship@Western. It has been accepted 
for inclusion in Electronic Thesis and Dissertation Repository by an authorized administrator of 
Scholarship@Western. For more information, please contact wlswadmin@uwo.ca. 
New Synthetic Methodologies Directed toward Pharmacologically Active Compounds as 
well as Silole Based Chromophores for Analytical and Optoelectronic Applications 
 
 
 
(Spine title: Synthesis of Siloles, Azaindoles, Piperidines, and Tetrahydropyrans) 
 
(Thesis format: Monograph) 
 
 
 
 
by 
 
 
Mahmoud Mohamed Abd Rabo Moustafa 
 
 
Graduate Program 
in 
Chemistry 
 
 
 
A thesis submitted in partial fulfillment 
of the requirements for the degree of 
Doctor of Philosophy 
 
 
 
SCHOOL OF GRADUATE AND POSTDOCTORAL STUDIES  
The University of Western Ontario 
London, Ontario, Canada 
 
 
 
 
 Mahmoud M. A. R. Moustafa 2011 
 
 
 
 
 
 
 
 
 
 
  
ii
THE UNIVERSITY OF WESTERN ONTARIO 
      SCHOOL OF GRADUATE AND POSTDOCTORAL STUDIES 
 
 
CERTIFICATE OF EXAMINATION 
 
 
Supervisor 
 
______________________________  
Dr. Brian L. Pagenkopf 
 
 
Supervisory Committee 
 
______________________________  
Dr. Zhifeng Ding 
 
______________________________  
 
Examiners 
 
______________________________  
Dr. Andre M. Beauchemin 
 
______________________________  
Dr. James A. Wisner 
 
______________________________  
Dr. Michael A. Kerr 
 
______________________________  
Dr. Paul A. Charpentier 
 
 
 
 
The thesis by 
 
 
Mahmoud Mohamed Abd Rabo Moustafa 
 
entitled: 
 
New Synthetic Methodologies Directed toward Pharmacologically Active 
Compounds as well as Silole Based Chromophores for Analytical and 
Optoelectronic Applications 
 
 
is accepted in partial fulfillment of the  
requirements for the degree of  
Doctor of Philosophy 
  
 
 
Date February 25th, 2011 _______________________________ 
Chair of the Thesis Examination Board 
  
  
iii
Abstract and Keywords 
 
Abstract - The development of new and efficient synthetic methodologies to prepare 
heterocyclic compounds has received great attention over the years due to their 
importance in the pharmaceuticals and fine chemicals industries. Described herein are 
several novel syntheses of a variety of heterocycles including siloles, azaindoles, 
piperideines, piperidines and tetrahydropyrans.  
A one-pot, two-step methodology involving Tamao’s reductive cyclization 
followed by Negishi cross coupling was utilized to synthesize several new series of 
silole-based chromophores. The property studies revealed new electropolymerized 
poly(thienyl-silole)s with enhanced photoefficiency for all-polymer solar cells. In 
addition, a new procedure is developed for the synthesis of the first dissymmetric silole 
tethered to amine functionality. The synthesized compounds hold great promise in the 
arena of biosensors and solar cell applications.   
Furthermore, a novel and practical two step sequence for the preparation of C2 
substituted 5-azaindoles has been reported. The synthetic sequence features a [3+2] 
dipolar cycloaddition between nitriles and a 3,4-cyclopropanopiperidine followed by 
SeO2 oxidation.  
Finally, the annulation reaction between 2-alkoxy-1,1-cyclobutane diesters and 
imines or aldehydes gave access to highly functionalized piperidines and 
tetrahydropyrans, respectively. Both the synthesis of those donor-acceptor cyclobutanes 
and their subsequent annulations are catalyzed by catalytic Yb(OTf)3. Although known 
for more than two decades, this is the first use of 2-alkoxy-1,1-cyclobutane diesters in 
  
iv
dipolar cycloadditions. 
The new reactions are done under mild conditions providing the target 
compounds in high yields and excellent selectivity. The divergent nature and cost 
effectiveness of these methods make them very suitable for combinatorial applications in 
the pharmaceutical industry. 
 
Keywords: Heterocyclic Compounds, Siloles, Azaindoles, Piperidines, Piperideines, 
Tetrahydropyrans, Cyclopropanes, Cyclobutanes, Electrochemiluminescence, Solar 
Cells, Dipolar Cycloaddition, Lewis Acid Catalysis, New Synthetic Methodologies
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Chapter 1: Structural Tuning of Siloles: Synthesis and Electrochemiluminescence of 
New Silole Based Chromophores for Analytical and Optoelectronic Application 
This chapter describes the work done in our research group towards the development of 
silole-based materials for applications in biological sensors and photoelectronic devices. 
In addition to a short introduction on the fundamentals of electrochemiluminescence 
(ECL), a brief literature review on the chemistry and properties of siloles will be 
discussed. I acknowledge Mrs. Barbora Morra for synthesizing silole 1.16b. Otherwise, 
in addition to proposing a modified synthesis of the dissymmetric siloles 1.36, the whole 
synthetic work presented in this chapter was done by me. Since fully investigating these 
new materials is highly interdisciplinary in nature, the Pagenkopf group has been 
collaborating with several research groups at the University of Western Ontario. The ECL 
and photoluminescence (PL) of the synthesized compounds have been investigated by the 
research group of Prof. Zhifeng Ding. The electro polymerization behavior for solar cell 
applications was studied by Prof. Oleg A. Semenikhin’s research group. While not 
intended to be exhaustive, a section summarizing the results obtained by our collaborators 
will be included. Some of these results have been published in J. Phys. Chem. B.1 
1.1. Introduction 
1.1.1. Basics of Electrochemiluminescence (ECL) 
Electrochemiluminescence (ECL) or electrogenerated chemiluminescence as the word 
implies is the light emission from an exited state molecule that is produced due to a high-
energy electron transfer (ET) reaction between electrogenerated radical anions and 
cations. According to the method involved, ECL could be annihilation or a co-reactant 
2 
 
process.2 A schematic representation of annihilation ECL is given in Figure 1.1. In a 
typical process, the radical anions (R– •) and radical cations (R+ •) of the luminophore (R) 
are  produced during a sequential reduction and oxidation at the surface of an electrode 
by scanning (scanning ECL) or pulsing (pulsing ECL) the potential within a short time 
interval. The annihilation reaction between these ions provides the excited state (R*) as 
well as a ground state molecule. The energy is then released in the form of light when R* 
returns to the ground state (R).2 An alternative way to obtain intense ECL is through a co-
reactant process where another substance is used to produce strong reducing or oxidizing 
intermediates that can interact with the radical ions of the emitter (R– • or R+ •) to generate 
its excited state (R*). Commonly used co-reactants are tri-n-propylamine and benzoyl 
peroxide.2  
 
Figure 1.1 – General mechanism of annihilation ECL 
Over the last decade, ECL has been extensively investigated and has found a 
variety of commercial applications in biomedical diagnostics (e.g. immunoassays), 
pharmaceutical and environmental analyses.3 The development of ECL-based systems 
with high sensitivity, selectivity and quantum efficiency has expanded the research 
interest in designing new luminophores. The new material should be cheap and/or easily 
prepared. In addition, the radical ions should be easily produced under the ECL 
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conditions and are of sufficient stability to allow for the inter diffusion process.2 The first 
attempt to study the ECL properties of siloles was reported by Pagenkopf and Bard in 
2006.4  
1.1.2. Siloles as Novel Materials for Optoelectronic Applications 
The chemistry of siloles has continued to receive much attention with respect to their 
syntheses and properties.5 Of special note is the recent and remarkable progress of siloles 
containing π-conjugated systems due to their potential as conducting materials for novel 
applications such as light-emitting devices,6 nitroaromatic sensors7 and biosensors.8 The 
unique electronic features of the silole ring arise from its low-lying LUMO, which is 
substantially different from cyclopentadiene and other heterocycles (Figure 1.2).9  
 
Figure 1.2 – Relative energy levels of HOMOs (white squares) and LUMOs (black 
squares) for silole vs. other heterocycles (from ref. 9) 
Over the last decade, siloles have set themselves aside as fascinating electronic 
materials. However, in comparison to other related π-conjugated systems such as pyrroles 
and thiophenes, siloles remain relatively unexplored, partly because of their difficult 
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synthesis.10 In addition to the meticulous exploration of silole properties, the pioneering 
efforts by the groups of Tamao and West to construct the silole ring have provided a solid 
foundation for others to build upon leading to the recent advancement of silole 
chemistry.11 
In 1997, Barton’s group utilized a dibromo silole 1.1,11 to synthesize the silole-
acetylene polymers 1.2 (Figure 1.3).12 When compared to the corresponding 
poly(phenyleneethynylene)s (λmax = 425 nm),13 and poly (thiopheneethynylene)s (λmax = 
438 nm,14 the silole-containing polymers significantly showed red-shifted absorptions 
(λmax = 494 nm) implicating the importance of the silole ring in the properties of these 
substances.  
 
Figure 1.3 – Absorption data for polymer 1.2 in THF  
In 1998, Tamao and co-workers reported a series of 2,5-diethynylsilole monomers 
and their polymerized products (e.g. 1.3 and 1.4, Figure 1.4).15 The synthesized polymers 
significantly showed narrow bandgaps (up to 1.8 eV). Moreover, a bathochromic shift in 
the absorption spectrum was observed when a diethynylthiophene moiety was 
incorporated. Despite the unique electronic features of these novel materials, the 
conductivities of the synthesized polymers were found to be moderate. 
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Figure 1.4 – Absorption data for polymers 1.4 in chloroform  
In a subsequent study towards the development of efficient electron-transporting 
(ET) materials for organic devices, the Tamao’s research group has prepared a 
symmetrically substituted series of 2,5-diaryl siloles 1.5-1.7 (Figure 1.5).6d In order to 
optimize the physical properties of the synthesized siloles, different substitution patterns 
have been investigated including; various mono-subtituted phenyl rings, extended π-
conjugated and heteroaryl groups. Whereas compound 1.7 emerged as highly efficient 
fluorophores with potential application as emissive material, compound 1.6 showed high 
performance as a new ET material.  
 
Figure 1.5 – Symmetric siloles 1.5-1.7. 
The ability to fine tune the electronic properties of siloles have been impeded by 
the challenges of synthesizing dissymmetric siloles and hence varying the functional 
groups at the silole termini.16 In addition, the iterative and length-specific synthesis of 
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oligomeric silole requires a dissymmetric silole that can serve either as a starting point or 
an end cap.17 In this regard, the dissymmetric silole 1.8 reported by the Pagenkopf 
research group in 2004 was used to synthesize the first silole-containing extended 
chromophores bearing electronically dissimilar functional groups at C(2) and C(5) 1.9 as 
well as oligomeric siloles of precise composition 1.10 (Figure 1.6).16,17  
 
Figure 1.6 – Donor- acceptor dissymmetric siloles 1.9 and oligomeric siloles 1.10 
The electronic spectra of donor-aceptor (DA) siloles 1.9 showed a stepwise 
bathochromic shift ranging from 429 nm (parent silole; D = A = H) to 496 nm (the most 
polar silole; D = NMe2 & A = NO2) (Figure 1.6).16 This study indicated the important 
role of electron delocalization in these substances which can be fine tuned by 
manipulation of peripheral push-pull substituents at the C(2) and C(5) positions. The 
consequences of varying the nature of the DA groups were also observed in the PL 
spectra. The silole having OCH3 as a donor group and NO2 as an acceptor group 
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displayed the longest wavelength emission, at 649 nm (Figure 1.6). To the best of our 
knowledge, this is the longest wavelength emission for a compound possessing only a 
single silole in the chromophore.16 On the other hand, the relatively low molecular weight 
oligomers 1.10 (Figure 1.6) displayed a similar absorption maximum (492 nm) to the 
analogous high molecular weight silole-containing polymers 1.2 (494 nm). From these 
observations, the effective conjugation length within the corresponding silole polymers 
was established for the first time and it is approximately equal to that of the tetramer 1.10 
(Figure 1.6, n = 3). Unfortunately, the quantum efficiencies were modest with the 
monomer being the most efficient.17 
In order to examine the influence of a single silole ring on the properties of an 
extended chromophore, the Pagenkopf group synthesized silole 1.11 (Figure 1.7) for 
direct comparison the trimer silole 1.10 (Figure 1.6, n = 2). The absorption and emission 
maxima of 1.11 were blue-shifted relative to trimer 1.10, but interestingly the quantum 
efficiency was 20.11×10-2 in the case of 1.11 versus 0.37×10-2 for trimer 1.10.17  
 
Figure 1.7 – Extended chromophore 1.11 
In addition to C2 and C5 functionalization, manipulating the steric requirements 
of the silole ring substituents would increase the energy barriers for non-emissive decay 
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processes and ultimately result in increased PL efficiency. Thus, our group also 
investigated some silole modifications intended to impart “rigidity” or restricted rotation 
compared to the parent chromophore 1.12 (Figure 1.8).18 The outcome of this effort was 
the preparation of the first highly efficient 3,4-diphenylsilole fluorophore 1.13, having a 
quantum efficiency of 63% (determined with reference to fluorescein).18 When compared 
to 1.12 (quantum efficiency is 9%),16 this pioneering discovery welcomed siloles as 
promising structurally tunable fluorophores and unambiguously refuted the notion that all 
3,4-disubstituted siloles will possess intrinsically low quantum efficiencies. Therefore, 
the electrogenerated chemiluminescence (ECL) properties were examined. However, 
moderate ECL quantum yields were obtained.4  This might be attributed to instability of 
their radical cations needed for ECL generation.2  
 
Figure 1.8 – Sterically rigid, highly fluorescent silole 1.13. I acknowledge Dr. Pagenkopf 
for generating graphic 1.12 
Considering that siloles 1.7 are efficient electron transporting materials, we 
expected that replacement of the methyl substituents with larger iPr, tBu and nHex 
groups would increase the energy barriers for non-emissive decay, stabilize the radical 
anions, and thus result in enhanced PL and ECL. Therefore the target chromophores 1.14 
were prepared and the electronic properties (UV-Vis, PL, and ECL) of these new hybrids 
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were investigated (Figure 1.9).19 In general, easier and reversible oxidation was observed 
with extended conjugation (n = 2) and branched substituents on the silicon (R = iPr or 
tBu). In addition, cyclic voltammograms (CVs) showed that the radical cations are more 
stable than the anions. This was translated into enhanced ECL efficiency highlighting the 
potential applications of these siloles.19 
 
Figure 1.9 – Thiophene-silole hybrids  
Finally, a new series of 3,4-diphenylsiloles incorporating arylene ethynylene 
strands at the 2,5-positions (e.g. 1.15, Figure 1.10) have been reported by Ding et al. in 
2007.20 The respective photoluminescence properties were investigated as a function of 
chain length. When compared to our silole 1.13 (quantum efficiency is 20%), double 
incorporation of arylene ethynylene strands in 1.15 (quantum efficiency is 50%) was 
found to be effective for enhancing the photoluminescence.20 
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Figure 1.10 – Arylene ethynylene/ silole hybrid 
1.1.3. Research Objectives 
Development of silole chromophores bearing fine-tuned properties depends on the 
ability to control the electronic nature of the molecule by varying the silole at the 2 and 5-
termini, substitution on the silicon atom as well as the conjugated system. Considering 
the unique features of siloles 1.5 – 1.6,6d including narrow energy gap, high conductivity, 
long emissive life time and high thermal stability, the objective of this study is to fine-
tune the properties of those siloles for ECL-based biomedical applications and 
optoelectronic industries.  
It was anticipated that enhanced PL and ECL could be obtained if the methyl 
substituents on the silicon atom of 1.5 and 1.6 are replaced by n-hexyl groups (1.16 and 
1.17, Figure 1.11). In addition to possible improved solubility, the bulky n-hexyl groups 
might increase the energy barriers for the non-emissive decay and hence stabilize the 
radical anions required for ECL annihilation. Furthermore, the effect of different electron 
donating and withdrawing groups on the one-electron transfer process involved and hence 
the electronic properties of those siloles will be examined.  
In collaboration with Prof. Zhifeng Ding’s research group, we previously 
discovered that bithiophene-silole hybrid (1.14, n = 2) is a more efficient fluorophore 
than thiophene-silole hybrid (1.14, n = 1).19 Therefore, it was envisioned that siloles 1.18 
with a more extended conjugation (terthiophene) will have lower redox potentials and 
hence the radical ions will be easily generated. Ultimately, better ECL efficiency is 
anticipated for 1.18.  
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Figure 1.11 – Target Siloles 1.16, 1.17 and 1.18 
The ultimate objective of this research project is to develop an efficient 
fluorophore for analytical applications in clinical and biomedical diagnostics. An 
essential requirement for ECL-based analytical methods is that these siloles should have 
one binding-site through which the important biological molecules, such as single 
stranded DNA (ss-DNA), antibody and/or oligonucleotide, could be conjugated via 
efficient and practical routes, such as a click reaction (Figure 1.12, A),21 or amide 
formation (Figure 1.12, B).22  
 
Figure 1.12 – Silole-labeled biosensors 
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This study will pursue an efficient methodology to prepare dissymmetric siloles 
by installing NH2 and/or N3 on one side of the ring (Figure 1.13). 
 
Figure 1.13 – Target dissymmetric siloles 
It is believed that these new silole-based materials will find a wide variety of 
applications in biomedical and optoelectronic industries (e.g. biosensors and solar cells). 
The synthetic effort toward these silole targets will be discussed in the following section. 
1.2. Results and Discussions 
1.2.1. Synthesis of Symmetric Siloles 1.16 – 1.18 
The silole ring can be obtained via a zirconocene mediated reductive cyclization 
of acetylenes (Scheme 1.1).23   
 
Scheme 1.1 – Zirconocene mediated reductive cyclization of acetylenes. 
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However direct transmetallation from zirconium to silicon is generally ineffective 
and therefore a series of steps involving iodination, lithiation and electrophilic trapping 
sequences have been developed (Scheme 1.1).23  
Developed by Tamao in 1994, the intramolecular reductive cyclization of 
diethynylsilanes utilizing lithium naphthalene (LiNaph) enables a one pot, practical and 
cost effective synthesis of siloles (Scheme 1.2).11  
  
Scheme 1.2 – Tamao’s reductive cyclization/transmetallation/Negishi coupling one pot 
synthesis of siloles 
The key point to attain high yield is the dropwise addition of the diethynylsilane 
1.24 into an electron-pool consisting of an excess amount (4 equiv) of the reductant 
LiNaph, and thereby both acetylene moieties are reduced simultaneously to form an anion 
radical intermediate 1.25 that undergoes radical coupling to form the 3,4-carbon–carbon 
bond, leaving anions at the 2,5-positions. The resulting 2,5-dilithiosiloles 1.26 can be 
transmetallated using excess ZnCl2. In addition to serving as an oxidizing agent for 
residual LiNaph,16 the use of ZnCl2 at this step allows for in situ generation of the 
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versatile chlorozinc intermediate that can be used directly for a Negishi cross coupling 
reaction with different aryl halides.24 Furthermore, when compared to the dilithio-silole, 
the chlorozinc intermediate 1.27 is considerably less basic and less nucleophilic.16 
Therefore, a one pot, two step methodology involving Tamao’s reductive cyclization 
followed by Negishi cross-coupling strategy was utilized to achieve the target compounds 
1.16 – 1.18. 
Starting from the commercially available phenylacetylene 1.29 and thiophene 
1.30, the synthetic intermediates; bis(phenylethynyl)dialkylsilanes 1.24a-c and 
bromoterthiophene 1.34 were prepared according to the published procedures and 
obtained in good to excellent yields (Scheme 1.3).25 Extra care should be followed during 
the preparation of terthiophene due its high vapour pressure and phototoxicity.25c 
 
Scheme 1.3 – Synthesis of the starting materials. 1.24c was kindly provided by Mr. Xin 
(Kevin) Wang, a previous student in our group. 
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The intramolecular reductive cyclization of bis(phenylethynyl)dialkylsilane 
1.24a-c using an excess amount (4 equiv) of LiNaph, followed by transmetallation with 
ZnCl2 and treatment with different aryl halides in presence of PdCl2(PPh3)2 catalyst 
provided compounds 1.16a-e, 1.17 and 1.18a-c, in moderate to good yields (Scheme 1.4). 
Since all intermediates involved in this methodology are sensitive to moisture, air and 
light, the whole reaction sequence was carried out under an inert atmosphere of dry 
argon, and protected from light using aluminum foil. Single crystals of silole 1.18b were 
grown from a concentrated CH2Cl2 solution by slow diffusion of pentane. The x-ray 
structure was solved and the ORTEP is presented in Figure 1.14. 
 
Scheme 1.4 – Synthesis of the target siloles 1.16 – 1.18. 1.16b was prepared by Mrs. 
Barbora Morra  
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Figure 1.14 – X-ray crystal structure of 1.18b 
1.2.2. Synthesis of Dissymmetric Siloles 1.36 – 1.41 
Considering the attenuated nucleophilicity of the chlorozinc intermediate 1.27 (Scheme 
1.5), our group previously reported an efficient methodology to prepare the first 
dissymmetric silole series.16 The methodology involved a two step halogenation where a 
slow monochlorination using N-chlorophthalimide (NCP) followed by iodination with I2 
afforded the chloroiodosilole 1.9 (Scheme 1.5).16 Although the synthesis of the 
intermediate 1.9 was a milestone step for us, working with this silole is complicated by 
its high light sensitivity and instability. Because it decomposes within minutes from 
isolation, it should be used directly for the successive cross coupling reactions.  
Much of experimental effort has been dedicated over the years by our group to 
synthesize the target silole 1.19 utilizing the synthetic intermediate 1.9 however with no 
success (Scheme 1.5). In fact it was quite a challenging task. 
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Scheme 1.5 – Synthesis of dissymmetric silole 1.36 
To simplify the reaction sequence and to isolate a stable product; instead of 
treating with iodine, the chlorozinc intermediate 1.35 was subjected directly to the cross 
coupling reaction conditions with bromothiophene. By following this modified 
procedure, the versatile monochloro thiophene-silole hybrid 1.36 was isolated in 60% 
yield (Scheme 1.5). When compared to the iodochlorosilole 1.9, the monochlorosilole 
1.36 is very stable and crystalline solid that can be stored for extended periods of time 
without any decomposition. Single crystals of silole 1.36 were grown from a concentrated 
CH2Cl2 solution by slow diffusion of pentane. The x-ray structure was solved and the 
ORTEP is presented in Figure 1.15.           
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Figure 1.15 – X-ray structure of dissymmetric silole 1.36 
Having the chlorosilole 1.36 in hand, it was treated with the chlorozinc 
intermediates generated from bromobenzene 1.37 (Scheme 1.6, equation 1), phenyl 
acetylene 1.29 (Scheme 1.6, equation 2) and 1-(4-bromophenyl)-N-methylmethanamine 
1.40 (Scheme 1.6, equation 3). The expected novel dissymmetric siloles 1.38, 1.39 and 
1.41 were obtained in moderate to excellent yields (Scheme 1.6). To avoid any harsh 
deprotection condition that might destroy the silole ring, a very labile protecting group 
trimethylsilyl (TMS) was selected to protect amine 1.40 during cross coupling reaction.26 
It was easily removed during the aqueous work-up to provide the free amine 1.41 
required for conjugation with biomolecules.      
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Scheme 1.6 – Synthesis of dissymmetric siloles 1.38, 1.39 and 1.41 
In summary, a one pot reaction sequence featuring Tamao’s reductive cyclization, 
transmetallation and Negishi cross coupling reaction has been used to prepare a new 
series of structurally modified siloles with anticipated fine tuned properties. In addition, a 
new synthesis of dissymmetric siloles has been developed and applied efficiently to 
prepare the first dissymmetric silole tethered to amine functionality. Current synthetic 
efforts in our group are directed toward structural modification of the conjugated system, 
the substitution pattern on the silicon atom, the spacer group and the binding 
functionality. Due to the unique electronic properties of the silole ring, the synthesized 
compounds hold great promise in the arena of biosensors and optoelectronic industries. 
While not intended to be comprehensive, the following section summarizes the results 
obtained by our collaborative research groups. 
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1.3. Electronic Properties of Siloles 1.16 – 1.18  
Studying the electronic properties of these synthetic siloles is one of the most important 
components in this project.  It indicates not only the potential of these siloles for future 
applications, but also where the subsequent synthetic effort should go. Our group 
acknowledges the immense effort made by our collaborators. The UV-Vis absorption, 
photoluminescence (PL) and electrochemiluminescence (ECL) properties of siloles 1.16 
– 1.17 were investigated by Prof. Zhifeng Ding’s research group. The electro 
polymerization behavior of siloles 1.18a for solar cell applications was studied by Prof. 
Oleg A. Semenikhin’s research group. Some of these results are summarized in the 
following sections. 
1.3.1.  UV-Vis Absorption, PL and ECL Properties of Siloles 1.16 – 1.17 
The UV-Vis absorption, PL and ECL properties for siloles 1.16 - 1.17 were 
investigated. Table 1.1 summarizes the data obtained from absorption, PL and ECL 
spectra. The absorption and PL spectra are presented in Figure 1.16.  
The conjugative groups e.g. 1.16c and 1.16e showed the lowest energy absorption 
and emission. The observed excimer peaks are due to the enhanced dimerization 
facilitated by the long hexyl chain. Unlike the thiophene-silole hybrids (data is not 
presented here), low quantum yields were observed in the scanning ECL. On the other 
hand, the pulsing technique was able to improve the quantum yields noticeably. The 
remarkable difference in the efficiency between the scanning and pulsing ECL can be 
attributed to the instability of the radical ions produced by these siloles. Because both the 
radical anions and cations are generated simultaneously within a very short time interval 
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in the pulsing ECL, the chance to generate the excited state is higher and hence the 
efficiency. Because the initial data obtained from the cyclic voltamograms (CVs) is not 
conclusive, additional information is required. Detailed computational and experimental 
work is underway to further investigate the redox properties of these siloles  
Table 1.1 – Spectroscopic data of siloles 1.16 – 1.17a 
 
silole Abs. λmax (nm) 
 ECL 
PL λmax (nm) QE (%)c
λmax (nm) QE (%)b monomer/excimer 
scanning/p
ulsling 
1.16a, X = H 355 398/470 1.21 418/615 0.56/54.68 
1.16b, X = CF3 355 401/460 1.98 NAd 0.70/10.46 
1.16c, X = NO2 395 430/520 4.11 463/654 0.22/33.93 
1.16d, X = OCH3 375 493/541 1.60 485/574 0.19/76.99 
1.16e, X = N(CH3)2 425 332/634 48.93 NAd 0.17/20.63 
1.17 355 400/467 0.72 410/630 0.18/214 
adetermined in benzene/acetonitrile solvent mixture at room temperature.bWith respect to 
DPA.cAnnihilation mechanism, relative to DPA.dProduced flat spectra 
22 
 
1.16a, X = H 1.16b, X = CF3 
1.16c, X = NO2 1.16d, X = OCH3 
1.16e, X = N(CH3)2 
 
1.17 
 
 
Figure 1.16 – UV-visible absorption (red) and normalized PL emission (green) spectra of 
the silole series 1.16 – 1.17 in 1.5:1 benzene/acetonitrile solvent. 
 
1.3.2. Poly(thienyl-silole)s for All-polymer Solar Cells 
To examine the utility of these materials for all-polymer solar cells application, the 
electrochemical and photoelectrochemical properties of electropolymerized poly(thienyl-
silole)s were investigated by Prof. Semenikhin’s research group. The materials were 
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prepared by electrochemical anodic polymerization of silole 1.14a (MeTTSTT) and 1.18a 
(MeTTTSTTT, as well as co-polymerization of these monomers with 2,2'-bithiophene 
(BT) (Figure 1.17).1  
 
 
(A) (B) 
Figure 1.17 – Photocurrent-potential dependencies and photocurrent decay against time 
of poly(thienyl-silole)s (A) Photocurrent-potential dependencies for films of 
MeTTTSTTT (1), MeTTSTT (2), PBT (3), 1:1 copolymer of MeTTTSTTT-BT (4) and 
1:1 copolymer of MeTTSTT-BT (5) measured in oxygen-saturated acetonitrile solution. 
(B) Photocurrent decay against time of PBT (1) and 1:1 copolymer of MeTTSTT-BT (2).  
As shown in Figure 1.17A, the photocurrent measurements showed that the 
introduction of siloles gave rise to a remarkable enhancement in the photocurrent of the 
copolymer material (Figure 1.17A, curve 5 and 4) as compared to non-modified parent 
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polybithiophene (PBT) (Figure 1.17A, curve 3). Copolymerization of BT with silole 
1.14a (MeTTSTT) gave the highest photocurrent (Figure 1.17A, curve 5).  
A major drawback of the use of organic materials in solar cells is their tendency to   
rapid photodegradation resulting in photocurrent decay. As shown in (Figure 1.17B, 
curve 1), the photocurrent magnitude of polybithiophene (PBT) rapidly decreased with 
time. In contrast, the magnitude of the photocurrents of Me-TTTSTTT-BT and Me-
TTSTT-BT copolymers grows with time to reach a stable plateau (Figure 1.17B, curve 
2). These results indicate the superior stability of these materials and their great promise 
as electron-acceptor for all-organic solar cells. 
1.4. Conclusion and Future Work 
In summary, several new series of symmetric and dissymmetric silole-based 
chromophores were prepared by a one pot reaction sequence featuring Tamao’s reductive 
cyclization, transmetallation and Negishi cross coupling. In addition, a new methodology 
was developed for the synthesis of the first dissymmetric silole containing a secondary 
amine functionality that can be used for conjugation with various biomolecules. This 
methodology provides a new way for structural modification of siloles and hence novel 
materials for biological sensors and optoelectronic applications. The electronic properties 
(UV-Vis, PL, ECL) and the electropolymerization behavior of these siloles were 
investigated. This has lead to the discovery of new electropolymerized poly(thienyl-
silole)s for all-polymer organic solar cells, displaying enhanced photoefficiency when 
compared to the non-modified polybithiophene. Through extensive collaborations among 
physicists, biologists, synthetic and analytical chemists, future efforts are directed toward 
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structural modification of these siloles. Due to the unique properties of these materials, 
the synthesized compounds hold great promise for biosensors, solar cells and 
optoelectronic applications.  
1.5. Experimental 
1.5.1. General  
All reactions were carried out under an inert atmosphere of dry argon unless 
otherwise indicated. Flasks were oven or flame dried and allowed to cool in a desiccator 
prior to use. All reagents and chemicals were of reagent quality, obtained from common 
commercial sources and used without further purification unless otherwise noted. All 
reactions were protected from light using aluminum foil. All solvents for the reactions 
were obtained from an Innovative Technology SPS-400-5 solvent dispensing system. For 
reactions involving lithium naphthalenide (LiNaph), THF was degassed with argon prior 
to use. LiNaph solutions were titrated using a literature method.27 ZnCl2 was flame-dried 
under vacuum and stored in glovebox. Progress of reactions was monitored by thin layer 
chromatography (TLC) performed on F254 silica gel plates. Column chromatography 
was performed with Silica Flash P60 60 Å silica gel from Silicycle according to the Still 
method.28 
The 1H and 13C nuclear magnetic resonance (NMR) spectra were obtained on a 
Varian Mercury 400 MHz NMR spectrometer. Chemical shifts (δ) were expressed in 
parts per million (ppm) downfield from tetramethylsilane using the residual protonated 
solvent as an internal standard (chloroform-d, 1H 7.25 ppm, 13C 77.0 ppm).When peak 
multiplicities are given, the following abbreviations are used: s, singlet; d, doublet; t, 
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triplet; dd, doublet of a doublet; m, multiplet. Coupling constants for all spectra are 
expressed in Hertz (Hz). HRMS (CI, FAB) were obtained with a Finnigan MAT 8200 
instrument. For known intermediates, only NMR was performed for characterization.  
1.5.2. Detailed Experimental Procedures 
1.5.2.1. General Procedure for the Synthesis of 
Bis(Phenylethynyl)dialkylsilane 
A solution of phenylacetylene (2.5 equiv) in THF (1 mL/ 1 mmol) was cooled to –78 °C 
(internal temperature). nBuLi (2.1 equiv) was added dropwise into the flask such that the 
internal temperature did not exceed –50 °C. It was allowed to warm to 0 ºC, and 
dichlorodialkylsilane (1.0 equiv) was charged into the pale yellow solution dropwise such 
that the internal temperature did not exceed 10 ºC. Then it was allowed to react at rt and 
monitored by TLC. Upon completion (ca 30 min), the reaction mixture was poured into a 
half saturated ammonium chloride aqueous solution, followed by extraction with ethyl 
acetate. The combined organic layers were washed with H2O, brine, dried (MgSO4), and 
concentrated in vacuum.  
 
Dimethylbis(phenylethynyl)silane (1.24a)19 
The reaction was done at 23 mmol scale to yield the product as white powder. 
Recrystallization from hexanes yielded 5.34 g (89%) of the desired product as white 
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crystals. Rf 0.56 (10% EtOAc/hexanes); 1H NMR (400 MHz, CDCl3)  7.53-7.49 (m, 
4H), 7.34-7.28 (m, 6H), 0.48 (s, 6H); 13C NMR (100 MHz, CDCl3)  132.1, 128.8, 128.2, 
122.6, 105.9, 90.6, 0.5. 
 
Dihexylbis(phenylethynyl)silane (1.24c)19 
The reaction was done at 23 mmol scale to yield the product yellow oil (97% yield, 9.00 
g). Rf 0.35 (10% CH2Cl2/hexanes); 1H NMR (400 MHz, CDCl3)  7.51-7.46 (m, 4H), 
7.30-7.24 (m, 6H), 1.64-1.55 (m, 4H), 1.44 (dt, J = 14.1, 7.0 Hz, 4 H), 1.35-1.29 (m, 8H), 
0.92-0.85 (m, 10H); 13C NMR (100 MHz, CDCl3)  132.0, 128.7, 128.1, 122.8, 106.6, 
89.4, 32.7, 31.5, 23.7, 22.6, 14.8, 14.1. 
1.5.2.2. General Procedure for the One-pot Reductive Cyclization/ 
Negishi Cross-coupling Reaction 
A solution of bis(phenylethynyl) dialkylsilane 1.24 (1.5 mmol, 1.0 equiv) was added 
dropwise into a solution of LiNaph (16 mL, 0.38 M, 6.1 mmol, 4.0 equiv) at rt. The 
solution was cooled to –10 °C (internal reaction temperature) and ZnCl2 dissolved in 
THF (25 mL, 0.30 M, 7.5 mmol, 5.0 equiv) was added via syringe in one portion. The 
fine black suspension was allowed to react for 20 min. To this solution was added 
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PdCl2(PPh3)2 (52 mg, 0.075 mmol, 5 mol %) and aryl halide (3.3 mmol, 2.2 equiv). The 
reaction mixture was set to reflux and monitored by TLC. Upon completion (ca 12 h), the 
reaction mixture was allowed to cool to rt, added an aqueous solution of HCl (0.1N, 10 
mL) and extracted with Et2O (3 x 20 mL). The combined organic layers were washed 
with H2O (20 mL), brine (2 x 20 mL), dried (MgSO4), and concentrated in vacuum. The 
product was then purified by flash chromatography on silica gel (hexanes → 30% 
CH2Cl2/hexanes gradient). 
 
2,5-Di(2,2'-terthiophen-5-yl)-1,1-dimethyl-3,4-diphenyl-1H-silole (1.18a) 
The reaction was done at 1.5 mmol scale to yield the product as reddish black solid (90% 
yield, 1.0 g). Rf 0.27 (30% CH2Cl2/hexanes); mp: 350 ºC; 1H NMR (400 MHz, CDCl3)  
7.21-7.17 (m, 8H), 7.12-7.10 (m, 2H), 7.02-6.98 (m, 6H), 6.97(d, J = 3.7 Hz, 2H), 6.94 
(d, J = 3.9 Hz, 2H), 6.81(d, J = 3.7 Hz, 2H), 6.77(d, J = 3.9 Hz, 2H)  0.72 (s, 6H); 13C 
NMR (100 MHz, CDCl3)  153.0, 142.4, 138.7, 137.2, 136.7, 136.5, 136.0, 131.7, 129.4, 
128.6, 128.0, 127.8, 127.4, 124.4, 124.3, 123.9, 123.6, 123.1, -1.7; HRMS m/z 754.0443 
(calcd for C42H30SiS6, 754.0441).  
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2,5-Di(2,2'-terthiophen-5-yl)-1,1-di-tert-butyl-3,4-diphenyl-1H-silole (1.18b) 
The reaction was done at 1 mmol scale to yield the product as a reddish brown solid (86% 
yield, 0.763 g). Rf 0.37 (20% CH2Cl2/hexanes); mp: 58-60 ºC; 1H NMR (400 MHz, 
CDCl3)  7.18 (dd, J = 5.1, 1.0 Hz,  2H), 7.12 - 7.10 (m, 2 H), 7.07-7.04 (m, 6H), 7.0-
6.95 (m, 4H), 6.88-6.84 (m, 8H), 6.65 (d, J = 3.9 Hz, 2H), 1.27 (s, 18H); 13C NMR (100 
MHz, CDCl3)  158.0, 144.0, 139.3, 137.5, 136.8, 136.6, 135.8, 133.3, 130.2, 129.3, 
128.1, 128.0, 127.0, 124.5, 124.5, 123.8, 123.7, 123.0, 77.6, 77.2, 76.9, 29.6, 20.8; 
HRMS m/z 838.1381 (calcd for C48H42SiS6, 838.1380). 
 
2,5-Di(2,2'-terthiophen-5-yl)-1,1-dihexyl-3,4-diphenyl-1H-silole (1.18c) 
The reaction was done at 1 mmol scale to yield the product as a reddish brown solid (65% 
yield, 0.572 g). Rf 0.29 (hexanes); mp: 140-142 ºC; 1H NMR (400 MHz, CDCl3)  7.24-
7.17 (m, 8H), 7.12 (dd, J = 3.7, 1.2 Hz,  2H), 7.01-6.96 (m, 8H), 6.95 (d, J = 3.9 Hz, 2H), 
6.81 (d, J = 3.7 Hz, 2H), 6.76 (d, J = 3.91 Hz, 2H), 1.53-1.45 (m, 4H), 1.36 (dd, J = 7.8, 
6.8 Hz, 4 H), 1.27-1.17 (m, 12H), 0.86-0.80 (m, 6H); 13C NMR (100 MHz, CDCl3)  
154.2, 142.7, 139.0, 137.2, 136.6, 136.6, 135.8, 130.6, 129.5, 128.6, 128.0, 127.8, 127.4, 
124.3, 124.3, 123.8, 123.5, 123.1, 32.5, 31.5, 23.6, 22.6, 14.1; HRMS m/z 894.2004 
(calcd for C51H48SiS6, 894.2006).  
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1,1-Dihexyl-2,3,4,5-tetraphenyl-1H-silole (1.16a) 
The reaction was done at 1 mmol scale to yield the product as yellow oil (86% yield, 
0.476 g). Rf 0.27 (hexanes); 1H NMR (400 MHz, CDCl3)  7.15 - 7.09 (m, 4 H), 7.05 (d, 
J = 7.2 Hz, 2 H), 7.03 - 6.97 (m, 6 H), 6.92 (d, J = 7.0 Hz, 4 H), 6.82 - 6.77  (m, 4 H), 
1.44 -1.36  (m, 4 H), 1.30 (dt, J = 14.3, 6.9 Hz, 4 H), 1.24 - 1.16  (m, 8 H), 1.04 - 0.98  
(m, 4 H), 0.84 (t, J = 6.8 Hz, 6 H); 13C NMR (100 MHz, CDCl3)  155.1, 140.7, 140.4, 
139.0, 130.0, 128.9, 127.8, 127.3, 126.1, 125.3, 32.7, 31.4, 23.5, 22.5, 14.1, 12.0; HRMS 
m/z 554.3373 (calcd for C40H46Si, 554.3369).  
 
1,1-Dihexyl-3,4-diphenyl-2,5-bis(4-(trifluoromethyl)phenyl)-1H-silole (1.16b) 
The reaction was done at 1 mmol scale to yield the product as yellow oil (65% yield, 
0.448 g). Rf 0.22 (hexanes); 1H NMR (400 MHz, CDCl3)  7.38 (d, J = 8.0 Hz, 4H), 7.01 
(t, J = 8.3 Hz, 10 H), 6.75 (d, J = 6.4Hz,  4H), 1.38-1.26 (m, 8H), 1.21-1.12 (m, 8H), 
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1.04-0.98 (m,4H), 0.83 (t, J = 6.3 Hz,  6H); 13C NMR (100 MHz, CDCl3)  156.6, 144.1, 
140.3, 138.0, 129.8, 128.8, 127.6, 126.7, 125.7, 124.9, 124.9, 32.7, 31.4, 23.4, 22.4, 14.0, 
11.8; HRMS m/z 690.3123 (calcd for C42H44SiF6, 690.3116).  
 
1,1-Dihexyl-2,5-bis(4-methoxyphenyl)-3,4-diphenyl-1H-silole (1.16d) 
The reaction was done at 1 mmol scale to yield the product as yellow oil (78% yield, 
0.480 g). Rf 0.13 (hexanes); 1H NMR (400 MHz, CDCl3)  7.02-6.97(m, 6H), 6.82 (d, J = 
8.6 Hz, 4 H), 6.78 (dt, J = 3.7, 2.8 Hz, 4 H), 6.65 (d, J = 8.8 Hz, 4 H), 3.73 (s, 6 H), 1.40 - 
1.32 (m, 4 H), 1.29 - 1.25 (m, 4 H), 1.21 - 1.14 (m, 8 H), 1.0 - 0.95 (m, 4 H), 0.82 (t, J = 
6.8 Hz, 6 H); 13C NMR (100 MHz, CDCl3)  157.3, 154.2, 139.5, 139.0, 132.7, 130.1, 
130.0, 127.4, 125.9, 113.3, 55.0, 32.7, 31.5, 23.5, 22.5, 14.1, 12.3; HRMS m/z 614.3565 
(calcd for C42H44SiF6, 614.3580).  
 
4,4'-(1,1-Dihexyl-3,4-diphenyl-1H-silole-2,5-diyl)bis(N,N-dimethylaniline) (1.16e) 
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The reaction was done at 1 mmol scale to yield the product as yellow oil (57% yield, 0.36 
g). Rf 0.16 (5% ethylacetate-hexanes); 1H NMR (400 MHz, CDCl3)  7.04 – 6.99 (m, 6 
H), 6.85 - 6.80 (m, 6 H), 6.79 (s, 2 H), 6.48 (d, J = 8.8 Hz, 4 H), 2.87 (s, 12 H), 1.42 - 
1.36 (m, 4 H), 1.30 - 1.25 (m, 6 H), 1.20 - 1.16 (m, 6 H), 1.02 – 0.98 (m, 4 H), 0.82 (t, J = 
6.7 Hz, 6 H); 13C NMR (100 MHz, CDCl3)  152.9, 148.1, 140.6, 138.0, 130.1, 130.1, 
128.5, 127.5, 125.6, 111.9, 40.4, 32.7, 31.6, 23.6, 22.6, 14.2, 13.0; HRMS m/z 640.4240 
(calcd for C44H56N2Si, 640.4213).  
 
2,2'-(1,1-Dihexyl-3,4-diphenyl-1H-silole-2,5-diyl)dipyridine (1.17)  
The reaction was done at 1 mmol scale to yield the product as yellow oil (70% yield, 
0.389 g). Rf 0.6 (5% ethylacetate-hexanes); 1H NMR (400 MHz, CDCl3)  8.52 (dt, J = 
4.9, 0.8 Hz, 2 H), 7.22 - 7.16 (m, 2 H), 7.12- 7.07 (m, 6 H), 6.92 - 6.86 (m, 6 H), 6.50 
(dd, J = 8.1, 0.5 Hz, 2 H), 1.44 - 1.39 (m, 4 H), 1.29 - 1.25 (m, 4 H), 1.23 - 1.15 (m, 12 
H), 0.81 (t, J = 6.8 Hz, 6 H); 13C NMR (100 MHz, CDCl3)  159.0, 155.8, 149.1, 144.0, 
139.6, 134.8, 129.3, 127.9, 126.5, 122.5, 120.0, 32.7, 31.5, 23.8, 22.6, 14.1, 12.6; HRMS 
m/z 556.3250 (calcd for C38H44N2Si, 556.3274).  
1.5.2.3. General Procedure for the Synthesis of Dissymmetric Siloles 
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A solution of bis(phenylethynyl) dialkylsilane 1.24a (1.0 equiv) was added dropwise into 
a solution of LiNaph in THF (4.0 equiv) at rt. The solution was cooled to –10 °C (internal 
reaction temperature) and ZnCl2 dissolved in THF (5.0 equiv) was added via syringe in 
one portion. The fine black suspension was allowed to react for 20 min. After cooling the 
reaction then cooled to –78 °C, N-chlorophthalimide solution in THF (1.0 equiv) was 
added dropwise. The reaction then allowed to stir at –78 °C for 30 min. To this solution 
was added PdCl2(PPh3)2 (5 mol %) and aryl halide (1.3 equiv). Then the reaction mixture 
was set to reflux and monitored by TLC. Upon completion (ca 12 h), the reaction mixture 
was allowed to cool to rt and concentrated. The crude product dissolved in minimum 
amount of CH2Cl2 was applied on silica gel and purified by flash chromatography 
(hexanes → 30% CH2Cl2/hexanes gradient). 
 
2-Chloro-1,1-dimethyl-3,4-diphenyl-5-(thiophen-2-yl)-1H-silole (1.36) 
The reaction was done at 5 mmol scale to yield the product as yellow powder. 
Recrystallization from CH2Cl2/hexanes yielded 1.1 g (60%) of the desired product as 
yellow crystals. Rf  0.3 (hexanes); 1H NMR (400 MHz, CDCl3)  7.23 - 7.19 (m, 3 H), 
7.18 - 7.13 (m, 3 H), 7.05 - 6.99 (m, 5 H), 6.90 - 6.87 (m, 1 H), 6.84 - 6.81  (m, 1 H), 0.60 
(s, 6 H); 13C NMR (100 MHz, CDCl3)  155.0, 150.1, 142.4, 138.3, 135.9, 133.1, 131.0, 
129.6, 129.1, 128.5, 127.5, 127.4, 127.1, 127.0, 126.2, 125.7, -4.3; HRMS m/z 378.0657 
(calcd for C22H19ClSSi, 378.0665).  
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1,1-Dimethyl-2,3,4-triphenyl-5-(thiophen-2-yl)-1H-silole (1.38) 
To a solution of bromobenzene (1.5 equiv) in ether cooled to 0 °C, nBuLi (1.5 equiv) was 
added dropwise. The reaction then allowed to stir at 0 °C. After completion (ca 1 h), the 
reaction mixture was carefully transferred via cannula to a solution of ZnCl2 (1.8 equiv) 
in THF at 0 °C. The reaction then allowed to stir at rt. After completion (ca 30 min), 
MeTSiCl 1.36 (1.0 equiv) and Pd(PPh3)4 (5 mol %) were added. The reaction then was 
set to reflux. After completion (ca 16 h), the reaction was cooled to rt, diluted with 
hexanes, filtered through silica plug and concentrated. The product was purified by flash 
chromatography (hexanes → 10% CH2Cl2/hexanes gradient). 
The reaction was done at 0.2 mmol scale to yield the product as yellow powder (83% 
yield, 0.07 g). Rf  0.16 (hexanes); 1H NMR (400 MHz, CDCl3)  7.21 - 7.16 (m, 3 H), 
7.11 (br. s., 2 H), 7.04 - 6.94 (m, 10 H), 6.88 - 6.84 (m, 3 H), 0.59 (s, 6 H); 13C NMR 
(100 MHz, CDCl3)  154.7, 152.2, 142.9, 139.9, 139.5, 139.2, 138.9, 133.0, 129.8, 128.8, 
128.8, 128.4, 127.9, 127.4, 127.1, 126.2, 126.1, 125.6, 125.6, -2.8; HRMS m/z 420.1367 
(calcd for C28H24SSi, 420.1368).  
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1,1-Dimethyl-3,4-diphenyl-2-(phenylethynyl)-5-(thiophen-2-yl)-1H-silole (1.39) 
To a solution of ZnCl2 (1.5 equiv) in THF, Et3N (3 equiv) and phenylacetylene (1.2 
equiv) were added. After stirring the reaction mixture at rt for 30 min, silole 1.36 (1.0 
equiv) and Pd(PPh3)4 (5 mol %) were added. The reaction then was set to reflux. After 
completion (ca 16 h), the reaction was cooled to rt, diluted with hexanes, filtered through 
silica plug and concentrated. The product was purified by flash chromatography (hexanes 
→ 10% CH2Cl2/hexanes gradient. 
The reaction was done at 0.2 mmol scale to yield the product as yellow powder (75% 
yield, 0.07 g). Rf  0.33 (10% CH2Cl2/hexanes); 1H NMR (400 MHz, CDCl3)  7.250 - 
7.20 (m, 8 H), 7.15 - 7.11 (m, 5 H), 7.06 - 7.02 (m, 3 H), 6.89 - 6.84 (m, 2 H), 0.61 (s, 6 
H); 13C NMR (100 MHz, CDCl3)  163.5, 151.0, 142.7, 138.6, 138.0, 134.1, 131.4, 
129.8, 129.2, 128.6, 128.1, 127.8, 127.5, 127.0, 126.2, 126.1, 124.6, 121.1, 98.8, 89.8, -
3.7; HRMS m/z 444.1365 (calcd for C30H24SSi, 444.1368).  
 
1-(4-(1,1-Dimethyl-3,4-diphenyl-5-(thiophen-2-yl)-1H-silol-2-yl)phenyl)-N-
methylmethanamine (1.41) 
To a solution of 1-(4-bromophenyl)-N-methylmethanamine (3.0 equiv) in ether cooled to 
0 °C, TMSCl (3.3 equiv) and Et3N (3.5 equiv) were added. The reaction then allowed to 
stirr at rt. After completion (ca 16 h), the heterogeneous reaction mixture was allowed to 
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separate and the ether layer was carefully decanted via a syringe into another flask. Then 
the solution was cooled to 0 °C and nBuLi (3.0 equiv) was added dropwise. The reaction 
then allowed to stirr at 0 °C. After completion (ca 2 h), the reaction mixture was carefully 
transferred via cannula to a solution of ZnCl2 (3.3 equiv) in THF at 0 °C. The reaction 
then allowed to stir at rt. After completion (ca 30 min), silole 1.36 (1.0 equiv) and 
Pd(PPh3)4 (5 mol %) were added. The reaction then was set to reflux. After completion 
(ca 16 h), the reaction was cooled to rt, diluted with hexanes, filtered through silica plug 
and concentrated. The crude product was then dissolved in ethyl acetate and poured into 
water, followed by extraction with ethyl acetate. The combined organic layers were 
washed with brine, dried (MgSO4), and concentrated in vacuum. The product was 
purified by flash chromatography (ethyl acetate → 5% MeOH/CH2Cl2 gradient). 
The reaction was done at 0.2 mmol scale to yield the product as yellow oil (40% yield, 
0.04 g). Rf  0.16 (ethyl acetate); 1H NMR (400 MHz, CDCl3)  7.20 - 7.16 (m, 3 H), 7.05 
- 7.02 (m, 2 H), 7.02 - 6.96 (m, 6 H), 6.90 (d, J = 8.4 Hz, 2 H), 6.88 - 6.81 (m, 4 H), 3.62 
(s, 2 H), 2.41 (s, 3 H), 0.87 (br. s., 1 H), 0.58 (s, 6 H); 13C NMR (100 MHz, CDCl3)  
154.5, 152.3, 142.9, 139.5, 139.2, 139.1, 138.1, 137.5, 132.8, 129.8, 128.8, 128.4, 127.8, 
127.5, 127.1, 126.2, 126.1, 125.5, 55.8, 36.1, -2.7; HRMS m/z 463.1796 (calcd for 
C30H29NSSi, 463.1790). 
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Chapter 2: Cyclopropane Activation for Dipolar Cycloaddition: Synthesis of 5-
Azaindoles via a Cycloaddition Reaction between Nitriles and Donor−Acceptor 
Cyclopropanes 
This chapter describes the expansion of current group methodology, namely 
nitriles/donor−acceptor (DA) cyclopropanes formal [3+2] cycloaddition, to include a 
highly efficient synthesis of 5-azaindoles. In addition to a brief introduction on the 
bonding and general reactivity of small membered cycloalkanes (cyclopropane and 
cyclobutane), the utility of cyclopropane rings in dipolar cycloaddition will be discussed. 
The whole synthetic work presented in this chapter was done by me and the results have 
been published in Organic Letters.1 Some portions of the text and schemes have been 
reproduced in part with permission from Moustafa, M. M. A. R.; Pagenkopf, B. L. Org. 
Lett. 2010, 12, 3168. Copyright 2010 American Chemical Society. 
2.1. Introduction 
2.1.1. Bonding and General Reactivity of Small Membered Cycloalkanes 
Due to their biological activity, high chemical reactivity, and their relative stability at 
room temperature, cyclopropane2 and cyclobutane3 derivatives have been emerged as 
important pharmacophores in many drugs and as versatile building blocks in modern 
organic synthesis. Because of the inherent ring strain, both cyclopropanes and 
cyclobutanes can undergo a facile C−C bond cleavage. In contrast, it is difficult to cleave 
this bond of cyclopentanes and the higher cycloalkanes.4 On the other hand, cyclopropane 
shows a reactivity profile similar to olefins by reacting readily with bromine,5 and 
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sulfuric acid.6 However cyclobutanes donot react with either of these reagents. This can 
be explained by differences of structures and energies of these compounds.4 
Despite the large difference in C−C−C bond angles, cyclobutane has a ring strain 
(26.3 kcal/mol) similar to that of cyclopropane (27.5 kcal/mol).4 This may be explained 
by invoking a 1,3 (nonbonded) carbon/carbon interactions.7 Cyclobutane has two 
interactions with a relative small distance between the carbons. Because all of the carbons 
are bonded to each other, cyclopropane does not have such interaction. This cross-ring 
repulsion can also explain why cyclobutanes have markedly longer C−C bond lengths. 
The C−C bond lengths of cyclobutanes cover a range of 1.521–1.606 Å depending on the 
substitution pattern, with an average value of 1.554 Å. In contrast, cyclopropane has 
shorter C−C bond lengths and cyclopentane is only 0.013 Å greater.4  
The C−C−C bond angle of cyclobutane is 88°, with a puckered conformation, to 
minimize the torsional interaction between the two adjacent methylene groups (Figure 
2.1).4 However this leads to increased bond angle strain. The balance between these two 
strains controls the equilibrium geometry. The properties of the C−H bonds in 
cyclobutane are much closer to those of the other cycloalkanes.4 In contrast, The C−C−C 
bond angle of cyclopropane is 60° which is a large deviation from the 109.5° expected for 
sp3−hybridized carbons. As explained by Förster-Coulson-Moffitt model, the high p 
character in the C−C bonds of cyclopropane (ring bonds) must lead to high s character in 
its C−H bonds (peripheral bonds). Therefore the C−H bonds of cyclopropane are shorter 
and stronger.4 In addition, the electron density is thought to lie on the outside of the ring 
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because of the geometric constraints of the cyclopropane ring.8 As a result, reactivity of 
cyclopropane is closer to that of alkenes rather than alkanes.9  
               
Figure 2.1 – Puckered conformation of cyclobutane and Förster-Coulson-Moffitt model 
of cyclopropane bonding 
The inherent reactivity of cyclopropanes and cyclobutanes can be further 
enhanced through the use of activating substituents. In general, there are three classes of 
activated cyclopropanes. The first class is activated with electron-withdrawing groups 
and those cyclopropanes can react as homo Michael acceptors with a variety of 
nucleophiles (Figure 2.2, Equation i). In the second class, the cyclopropane ring is 
substituted with electron-donating groups and those cyclopropanes can be cleaved by 
different electrophiles (Figure 2.2, Equation ii). In each case an ionic intermediate will 
be generated that can be used in the subsequent transformations. The third class is 
donor−acceptor (DA) cyclopropane where both donor and acceptor groups are utilized in 
a synergistic fashion (Figure 2.2, Equation iii). Under mild conditions, usually LA 
catalysis, those cyclopropanes undergo ring opening to form 1,3-zwitterionic 
intermediates that can be used as dipole equivalents in many useful transformations. 
Dipolar cycloaddition involving activated cyclopropanes (DA cyclopropanes) is 
extensively studied and has been demonstrated by the preparation of highly substituted 
carbo- and heterocyclic natural and unnatural targets.10  In contrast, reports that extend 
these methodologies to cyclobutanes are rare. This was surprising because both rings 
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have very similar ring strain suggesting a facile heterolytic ring opening of the 
cyclobutanes and potential homologous applications (Figure 2.2, Equation iv). The utility 
of doubly activated cyclopropanes will be discussed in this chapter while the use of 
cyclobutanes in dipolar cycloaddition will be covered in chapter 3. 
 
Figure 2.2 – Activated cyclopropane and cyclobutane  
2.1.2. Formal [3+2] Cycloaddition of DA Cyclopropanes  
While there are a wide variety of annulation reactions involving DA cyclopropanes, this 
section will deal only with the formal intermolecular [3+2] cycloaddition reactions of 
1,1-cyclopropanediesters 2.1 (Figure 2.3, Equation i) and/or 2-alkoxy cyclopropane 
carboxylic ester 2.3 (Figure 2.3, Equation ii). A particular emphasis will be placed on 
aldehydes, imines and nitriles. Other dipolarophiles for example; isocyanates,11 
isothiocyanates,12 azodicarbonyl derivatives,13 acetylenes,14 alkenes,15 silyl enol ethers,16 
silyl ketene acetals,17 allenylsilanes,18 nitrones,19 and diazenes20 will not be covered. 
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Figure 2.3 – The formal [3+2] cycloaddition of 1,2-dipoles with DA cyclopropane 
Among different dipolarophiles examined, aldehydes and ketones have been 
studied extensively. For instance, Saigo and co-workers have reported a highly 
diastereoselective synthesis of γ-lactones 2.7 and 2.10 by a LA catalyzed reaction of 
carbonyl compounds with cyclopropane 2.5 and 2.8, respectively (Scheme 2.1).21  
 
Scheme 2.1 – Cycloaddition between 2,2-dialkoxycyclopropane carboxylic ester and 
aldehydes or ketones 
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The diastereoselectivity of the reaction varies according to LA utilized and the 
substitution pattern of the substrates. In general, a high cis-selectivity was obtained with 
TiBr4, SnBr4 and TiCl4 whereas ZrCl4 was moderately trans-selective (Scheme 2.1).  
In 2000, Sugita et al reported a related reaction with a chromatene-derived 
1,1-cyclopropanediesters 2.11 where the trans-fused tetrahydrofuro[2,3-
b][1]benzopyranones 2.13 were obtained in good yields and high diastereoselectivities 
(Scheme 2.2).22  
 
Scheme 2.2 – Cycloaddition reactions with chromatene derived cyclopropanes 
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In absence of the diester functionality, an endo ring cleavage occurs giving rise to 
a different zwitterion intermediate 2.18, that can be trapped with silyl enol ethers 2.17 to 
afford the oxepanone derivatives 2.17 in 40-95% yield (Scheme 2.2).22    
A few years later the same annulation was extended to other 1,1-
cyclopropanediesters activated with different types of donating groups. For example, a 
cobalt-complexed 2-ethynyl group (2.19) reported by Christie and co-workers,23  and 
aromatic substituents (2.22) reported by the Johnson group (Scheme 2.3).24 The reaction 
conditions, scope and product diastereoselectivity vary according to cyclopropane nature.  
 
Scheme 2.3 – The reaction of aldehydes and 1,1-cyclopropanediester 
In Christie’s work, three equivalents of BF3•OEt2 was optimal for the 
cycloaddition to occur where aliphatic, electron-deficient or neutral aryl aldehydes 
undergo the reaction to provide the target tetrahydrofurans 2.21 however in moderate 
yield and diastereoselectivity. Unfortunately, electron-rich aromatic aldehydes were 
incompatible to the reaction conditions.23 In contrast, the Johnson’s Sn(OTf)2-catalyzed 
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approach provided the desired tetrahydrofurans 2.23 in excellent diastereoselectivities 
and yields.24 While Sn(OTf)2 promoted the reaction with aromatic, alkenyl, and alkynyl 
aldehydes, SnCl4 effectively catalyzed the reaction with aliphatic ones (Scheme 2.3).25 
More recently, Johnson reported an asymmetric variant where enantioenriched 
tetrahydrofurans were obtained via a dynamic kinetic resolution of racemic 
cyclopropanes and aldehydes.26  
The cycloaddition reaction between DA cyclopropanes and aldehydes has been 
applied in the synthesis of many natural products including (+)-virgatusin 2.24,27 (+)-
polyanthellin A 2.25,28 (+)-isatisine A 2.26,29 and (±)-bruguierol 2.27 (intramolecular 
annulation) (Scheme 2.4).30 
 
Scheme 2.4 – Applications of DA cyclopropane-aldehyde cycloaddition 
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DA cyclopropanes have also been reported to undergo cyclization with imines to 
furnish pyrrolidine derivatives in a stereoselective manner.31 The Pagenkopf group has 
shown that TMSOTf can mediate the cycloaddition of imine 2.29 with glucal–derived 
DA cyclopropane 2.28. The reaction displayed excellent stereoselectivity and furnished 
the aminal product 2.30 in 82% yield (Scheme 2.5).10e  
 
Scheme 2.5 – Annulation reactions of glucal–derived DA and iminies 
In addition, the annulation reaction between 1,1-cyclopropanediesters  and imines 
has been examined by several research groups including the Kerr,32 the Tang,33 the 
Christie34 and the Johnson groups.35   When the reaction of cyclopropane 2.22 and in situ 
generated aromatic imines 2.31 is catalyzed by Yb(OTf)3, refluxing toluene was required 
to give 2,5-cis-pyrrolidines 2.32 (Scheme 2.6) as the major product.32 Interestingly, when 
the more reactive Sc(OTf)3 was used, better diastereocontrol can be achieved and the 
reaction can be done at milder conditions.33 On the other hand, the annulation of cobalt-
complexed 2-ethynyl-1,1-cyclopropanediester 2.19 with imines 2.31 is catalyzed by 
BF3•OEt2 to produce pyrrolidines 2.33 in moderate diastereoselectivity and yield 
(Scheme 2.6).34 More recently, the Johnson group has reported an asymmetric variant 
where enantioenriched pyrrolidines were obtained via a dynamic kinetic resolution of 
racemic cyclopropanes and imines.35 
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Scheme 2.6 – The reaction of imines and 1,1-cyclopropanediesters  
The cycloaddition reaction between 1,1-cyclopropanediesters and imines has been 
applied in the synthesis of (-)-allosecurinine 2.34,36  and FR901483 2.35 (Scheme 2.7).37 
 
Scheme 2.7 – Applications of DA cyclopropane-imine cycloaddition 
The annulation reaction between nitriles and DA cyclopropanes was first reported 
by the Pagenkopf group in 2003,38 where a highly stereoselective formal [3+2] 
cycloaddition reaction between glycal-derived cyclopropane 2.28 and nitriles 2.36 
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afforded 3,4-dihydro-2H-pyrroles 2.37 (Scheme 2.8). The reaction is mediated efficiently 
with TMSOTf at room temperature affording only one diastereomeric product 2.37. The 
cycloaddition demonstrated a broad scope where ,-unsaturated, aliphatic and aromatic 
nitriles participated in the reaction. In addition, the di-tert-butylsilylene protective group 
is not a necessary structural feature. Unfortunately, electron deficient nitriles failed to 
participate.  
 
Scheme 2.8 – Nitriles/glycal-derived DA cyclopropane cycloaddition 
Under these conditions the internal lactone linkage in 2.28 is important for the 
cycloaddition to occur. Therefore, attempted reaction between nitriles and cyclopropane 
2.38 gave multiple products.38 Interestingly, when the cycloaddition was done at lower 
temperature, the pyrrole derivatives 2.39 were obtained in excellent yields.39 This 
observation prompted extending the reaction to general non-carbohydrate-derived DA 
cyclopropane substrates 2.40 and a highly efficient pyrrole synthesis was reported.39 The 
reaction is highly regiospecific permitting the synthesis of multi substituted pyrroles 2.42 
in moderate to excellent yields with a precise control on the substitution pattern (Scheme 
2.9). 
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Scheme 2.9 – Pyrrole synthesis through nitrile/DA cyclopropane cycloaddition 
Shortly afterward, this reaction was applied to the synthesis of many natural and 
unnatural targets including bipyrroles 2.43a and thienylpyrroles 2.43b,40 (±)-goniomitine 
2.44,41 and (±)-quebrachamin 2.45 (Scheme 2.10).42 The effectiveness, cost efficiency 
and regioselectivity of this powerful annulation encouraged our group to apply it for the 
synthesis of 5-azaindoles. This work will be covered in the following section. 
 
Scheme 2.10 – Applications of DA cyclopropane/nitrile cycloaddition 
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2.2. Synthesis of 5-Azaindoles via a Cycloaddition Reaction between Nitriles and 
DA Cyclopropanes 
2.2.1. Research Objectives 
Due to enhanced solubility and perhaps superior bioavailability and activity, the 
development of azaindoles as indole isosteres has received considerable attention over the 
past decade.43 These efforts have resulted in the discovery of many active drug candidates 
(see Figure 2.4 for representative examples).44 Despite the promising potential of these 
heterocycles, they remain largely underexplored, in part due to the limited synthetic 
methods to prepare and functionalize the azaindole nucleus.  
 
Figure 2.4 – Examples of pharmacologically active azaindoles 
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While there are many synthetic methods available for the preparation of 
substituted indoles,45 only a few have been developed for the preparation of azaindoles.  
Some of the classic methods either do not work or are inefficient. The alternative 
methods generally rely on highly functionalized pyridine substrates, which are expensive 
or require multistep syntheses to prepare.46 Some recent examples are summarized in 
Scheme 2.11.46, 47 Additionally, C2 and C3 substituted 5-azaindoles are notoriously 
difficult to access as they often depend on multistep approaches involving highly 
functionalized pyridines, or strong bases to lithiate the 5-azaindole itself followed by 
electrophile trapping.47  
 
Scheme 2.11 – Synthetic approaches to azaindoles 
The goal of my research was to expand the formal [3+2] cycloaddition reaction 
between DA cyclopropanes and nitriles developed by our group in order to gain a 
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versatile access to azaindole heterocycles. The new approach envisioned a two step 
sequence for the synthesis of 5-azaindoles 2.66 by oxidation of a tetrahydro-1H-
pyrrolo[3,2-c]pyridine intermediate 2.67 obtained through a cycloaddition reaction 
between nitriles 2.36 and a 3,4-cyclopropanopiperidine 2.68 (Scheme 2.12). This strategy 
allows for an easy access to a wide variety of C2 functionalized azaindoles simply by 
varying the starting nitrile.  
 
Scheme 2.12 – Retrosynthetic analysis of azaindoles 
2.2.2. Results and Discussions 
The synthesis of the cyclopropanopiperidine began with benzyl protection of 4-
piperidone 2.69 followed by acetalization in acidic methanol (Scheme 2.13).48  Then the 
resulting acetal 2.71 was converted to enol ether 2.72 under Gassman’s conditions;49  
however, when 2.72 was subjected to cyclopropanation with ethyl diazoacetate in 
presence of Cu(TBS)2,50  the ethyl cinnamate 2.73 was obtained in 60% yield and none of 
the desired cyclopropane 2.74 was observed. The cinnamate is likely formed by 
nucleophilic attack of the piperidine nitrogen at the carbene followed by nucleophilic 
attack of the formed carbanion at the benzylic position followed by elimination. 
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Scheme 2.13 – Attempted synthesis of the cyclopropanopiperidine 
To avoid this undesired reaction a tosyl protecting group was employed (Scheme 
2.14),51 and cyclopropanation under the same conditions afforded the desired 
cyclopropane 2.75 in 90% yield as an inconsequential 8 : 1 mixture of endo to exo 
diastereomers (Scheme 2.14).  
 
Scheme 2.14 – Access to cyclopropanopiperidines 
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With cyclopropane 2.75 in hand it was allowed to react with acetonitrile under the 
standard annulation conditions (1.0 equiv. Me3SiOTf, –40 °C).39 Both diastereomers 
worked equally well to give the tetrahydropyrrolopyridine 2.76a as a white solid in 95% 
isolated yield (Scheme 2.15). This material was easily and economically prepared on 
gram scale, and was selected as a model substrate for screening oxidation conditions to 
provide the desired azaindole nucleus. 
 
Scheme 2.15 – Nitrile annulation 
It was thought that either a two step sequence involving elimination or 
deprotection of the tosylate followed by oxidation would be acceptable, as well as a one 
step process to give the azaindole directly. Various strategies were explored, including 
strong bases,52 Na-naphthalenide,53 DDQ,54 Pd/C, and MnO2.55  In each case, either 
decomposition or no reaction was observed (Table 2.1, entries 1– 6). Ultimately it was 
found that SeO2 executed the desired oxidation extraordinarily well and afforded the 
azaindole in 92% isolated yield (Table 2.1, entry 7).56 A control experiment was done 
where the product after SeO2 was isolated directly without basic work up. In this case the 
fully oxidized product was obtained as sulfonyl salt with the pyridine nitrogen. Therefore 
a basic workup is only necessary to neutralize this salt. It is noteworthy that both 
oxidation and deprotection of the tosylate group was done in a single step utilizing SeO2. 
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Table 2.1 – Deprotection and oxidation 
 
entry conditions yield (%) 
1 MeONa/MeOH decomposition 
2 tBuOK/tBuOH decomposition 
3 Na-naphthalenide/THF decomposition 
4 DDQ/toluene decomposition 
5 5% Pd/C, mesitylene no reaction 
6 MnO2,CH2Cl2 no reaction 
7 SeO2, dioxane 92% azaindole (2.79a) 
With reaction conditions established for both the nitrile annulation and subsequent 
oxidation the reaction scope was explored, and the results are summarized in Table 2.2. 
The reaction works well with other aliphatic nitriles (Table 2.2, entry b) as well as 
aromatic and electron rich aromatic nitriles (Table 2.2, entries c and d). Unsaturated 
nitriles are effective (Table 2.2, entry e) as are those containing heteroatoms, such as 2-
thiophenecarbonitrile (Table 2.2, entry f). The annulation reaction is conveniently run 
with a large excess of nitrile as solvent, but where this is impractical, nitromethane was 
employed. Unfortunately, sterically hindered (e.g., pivalonitrile and isobutyronitrile) or 
electron deficient nitriles (e.g., 4-bromobenzonitrile) did not engage in the reaction. 
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Table 2.2 – Scope of azaindole synthesisa 
 
entry nitrile azaindole (2.79) ann. yield ox. yield 
a MeCN R = Me 95% 92% 
b EtCN R = Et 62% 94% 
c PhCN R = Ph 92% 97% 
d 86% 81% 
e 
  
69% 61% 
f 
 
 
87% 61% 
aCycloaddition reactions were run at –40 °C using 1.0 equiv of 
cyclopropane, 2.0 equiv nitrile, 1.0 equiv Me3SiOTf in nitromethane 
solvent. In the case of acetonitrile (entry a), excess nitrile was used as 
solvent. Oxidation conditions: 5 equiv of SeO2 in refluxing dioxane. 
The Pagenkopf group had shown previously that other functional groups can react 
in formal dipolar cycloadditions with DA cyclopropanes, including electron deficient 
pyridines57 and indoles.58  While not intended to be exhaustive, Table 2.3 shows that the 
3,4-cyclopropanopiperidine 2.75 reacts analogously to afford fused azaindoles very 
efficiently. The reactions with both 4-cyanopyridine and 2-cyanopyridine gave their 
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respective tetrahydro-pyridoindolizines (Table 2.3), and both underwent oxidation with 
SeO2 to the pyridoindolizine. The single crystal x-ray structure of 2.81b was solved and 
the ORTEP is presented in (Figure 2.5). The cycloaddition with indole provided the 
cycloadduct 2.80c in 57% yield, but the standard SeO2 oxidation conditions were 
ineffective in this case. 
Table 2.3 – [3+2] Cycloannulation between pyridines and indole with cyclopropane 2.59 
 
entry dipolarophile 
annulation 
product (2.80) 
yield 
oxidation 
product (2.81) 
yield 
a 
  
2.80a 
(71%) 
 
2.81a 
(99%) 
b 
   
2.80b 
(53%) 
 
2.81b 
(64%) 
ca 
  
2.80c 
(57%) 
decomposition N/A 
a Relative stereochemistry was not determined but was assigned by analogy only.  For a 
relevant discussion with similar systems, see reference 58.  
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Figure 2.5 – X-ray crystal structure of 2.81b 
2.2.3. Summary 
A novel and practical two step sequence for the preparation of C2 substituted 5-
azaindoles and fused azaindoles has been reported. The target compounds were obtained 
in 34-87% overall yield. The synthetic sequence starts with an easily prepared and 
inexpensive piperidine based DA cyclopropane, which is then allowed to react with 
nitriles, pyridines and indoles.  A subsequent SeO2 mediated oxidation cleaves the tosyl 
protecting group and oxidizes the substrates to provide the aromatic azaindoles. 
2.3. Experimental 
2.3.1. General  
All reactions were run under an argon atmosphere unless otherwise indicated. Flasks 
were oven dried and cooled in a dessicator prior to use. Solvents and reagents were 
purified by standard methods.59 Dichloromethane, dioxane were purified by passing the 
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solvents through activated alumina columns. MeNO2 was dried by refluxing under CaH2 
for one hour prior to distillation. Synthetic intermediates including enol ethers,51 bis(N-
tertbutylsalicylamidinato)copper(II) (Cu(TBS)2),50 and ethyl diazoacetate were prepared 
according to the published procedures.  All other chemicals were of reagent quality and 
used as obtained from commercial sources unless otherwise noted. The progress of 
reactions were monitored by thin layer chromatography (TLC) performed on F254 silica 
gel plates. The plates were visualized by staining with ceric ammonium molybdate,60 or 
p-anisaldehyde. Column chromatography was performed with Silica Flash P60 60 Å 
silica gel from Silicycle according to the Still method.61 
The 1H and 13C NMR data were obtained on 400 or 600 MHz spectrometers. All 
spectra were obtained in deuterated chloroform and/or DMSO-d6. The spectra were 
referenced to residual chloroform (at δ 7.25 ppm for 1H spectra and the center peak of the 
triplet at δ 77.0 (t) for 13C spectra) and  DMSO-d6 (at δ 2.49 ppm for 1H spectra and the 
center peak of the multiplet at δ 39.50 (m) for 13C spectra). When peak multiplicities are 
given, the following abbreviations are used: s, singlet; d, doublet; dd, doublet of doublets; 
td, triplet of doublets; t, triplet; q, quartet; m, multiplet; br, broad; EI mass spectra were 
obtained spectrometer at an ionizing voltage of 70 eV. Melting points are uncorrected.  
2.3.2. Detailed Experimental Procedures 
2.3.2.1. Cyclopropane Synthesis 
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endo - Ethyl 6-methoxy-3-tosyl-3-azabicyclo[4.1.0]heptane-7-carboxylate (endo-2.75) 
and exo- ethyl 6-methoxy-3-tosyl-3-azabicyclo[4.1.0]heptane-7-carboxylate (exo-
2.75) 
 To a refluxing solution of the corresponding enol ether,51 (1.33g, 5 mmol) and 
Cu(TBS)2,50 (0.014 g, 0.25 mmol)  in 15 mL CH2Cl2, diazoacetate (1.09 mL, 10.4 mmol) 
was added drop wise over 3 hrs. After refluxing for 8 h at room temperature, the solvent 
evaporated and the crude reaction mixture was flashed on silica gel using EtOAc/hexanes 
(10–30%) for elution to provide the endo diastereomer as yellow oil (80% yield, 1.4 g). 
Rf 0.16 (30% EtOAc/hexanes); 1H NMR (400 MHz, CDCl3) 7.49 (d, J = 8.4, 2H), 7.22 
(d, J = 8.01, 2H), 4.07–3.99 (m, 2H), 3.28 (d, J = 11.72, 1H), 3.09 (s, 3H), 3.06-2.97(m, 
2H), 2.58-2.55 (m, 1H), 2.32 (s, 3H), 2.18-2.10 (m, 3H), 1.67 (d, J = 6.25, 1H), 1.15 (t, J 
= 7.13, 3H); 13C NMR (100 MHz, CDCl3)  168.8, 143.5, 132.8, 129.5, 127.1, 64.6, 60.4, 
54.1, 43.6, 42.4, 30.6, 27.9, 25.3, 21.1, 13.9; HRMS m/z 353.12970 (calcd for 
C17H23NO5S, 353.1297).  
The exo diastereomer was obtained as yellow oil (10% yield, 0.17 g). Rf 0.2 (30% 
EtOAc/hexanes); 1H NMR (400 MHz, CDCl3) 7.54 (d, J = 8.4, 2H), 7.23 (d, J = 8.01, 
2H), 4.11-4.03 (m, 3H), 3.40-3.33 (m, 1H), 3.20 (dd, J = 12.31, 7.03 Hz, 1H), 3.16 (s, 
3H), 2.78-2.71(m, 1H), 2.48-2.42 (m, 1H), 2.34 (s, 3H), 2.10-2.03 (m, 1H), 1.84 (d, J = 
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10.75, 1H), 1.72-1.67(m, 1H), 1.18 (t, J = 7.23, 3H); 13C NMR (100 MHz, CDCl3)  
168.3, 143.3, 133.3, 129.4, 127.3, 61.5, 60.5, 53.7, 42.1, 40.6, 28.5, 23.9, 23.5, 21.3, 
13.8; HRMS m/z 353.1293 (calcd for C17H23NO5S, 353.1297). 
2.3.2.2. General Procedure for the Cycloaddition Reaction 
To a solution of cyclopropane  275 (0.17 g, 0.5 mmol) and nitrile (1.0 mmol, 2 eq) in 
MeNO2 (3.0 mL) at –40 °C, TMSOTf (0.1 ml, 0.5 mmol) was added dropwise. After 
completion (14-18 h, TLC), 5.0 mL of EtOAc was added and the mixture was poured into 
a saturated solution of NaHCO3 (15 mL). The heterogeneous mixture was separated and 
the aqueous layer was extracted with EtOAc (3 x 10 mL). The combined organic layers 
were washed with brine, dried (MgSO4), filtered through Celite and concentrated under 
reduced pressure. Purification by flash chromatography on silica gel using EtOAc-
hexanes for elution provided the title compounds. 
 
Ethyl 2-methyl-5-tosyl-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridine-3-carboxylate 
(2.76a) 
White powder (95% yield, 0.17 g). Rf 0.5 (50% EtOAc/hexanes); mp 158–160 °C;   1H 
NMR (400 MHz, CDCl3) 8.10 (s, 1H), 7.67 (d, J = 8.21, 2H), 7.27 (d, J = 8.01, 2H), 
4.25 (s, 2H), 4.21(q, J = 7.52, 2H), 3.37 (t, J = 5.67, 2H), 2.63 (t, J = 5.37, 2H), 2.43 (s, 
3H), 2.40 (s, 3H), 1.33 (t, J = 7.03, 3H); 13C NMR (100 MHz, CDCl3)  165.3, 143.3, 
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135.0, 134.2, 129.5, 127.4, 122.3, 114.6, 108.4, 59.2, 44.7, 43.2, 22.9, 21.4, 14.45, 13.2; 
HRMS m/z 362.1310 (calcd for C18H22N2O4S, 362.1300). 
 
Ethyl 2-ethyl-5-tosyl-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridine-3-carboxylate 
(2.76b) 
White powder (62% yield, 0.10 g). Rf 0.18 (30% EtOAc/hexanes); mp 50–52 °C; 1H 
NMR (400 MHz, CDCl3) 8.47 (s, 1H), 7.64 (d, J = 8.21, 2H), 7.25 (d, J = 8.01, 1H), 
4.23–4.17 (m, 4H), 3.34 (t, J = 5.47, 2H), 2.85 (q, J = 7.42, 2H), 2.62 (s, 2H), 2.37 (s, 
3H), 1.31 (t, J = 7.03, 3H), 1.14 (t, J = 7.52, 3H); 13C NMR (100 MHz, CDCl3)  165.2, 
143.3, 141.1, 133.9, 129.54, 127.3, 122.3, 114.4, 107.3, 59.1, 44.7, 43.3, 22.8, 21.4, 20.5, 
14.3, 13.6; HRMS m/z 376.1467 (calcd for C19H24N2O4S, 376.1457). 
 
Ethyl 2-phenyl-5-tosyl-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridine-3-carboxylate 
(2.76c) 
White powder (92% yield, 0.15 g). Rf 0.16 (30% EtOAc/hexanes); mp 54-56 °C; 1H 
NMR (400 MHz, CDCl3) 8.10 (s, 1H), 7.71 (d, J = 8.21, 2H), 7.47 (d, J = 7.82, 2H), 
7.38–7.29 (m, 5H),  4.34 (s, 2H), 4.15(q, J = 7.23, 2H), 3.34 (t, J = 5.67, 2H), 2.73 (t, J = 
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5.57, 2H), 2.41 (s, 3H), 1.23 (t, J = 7.13, 3H); 13C NMR (100 MHz, CDCl3)  164.6, 
143.4, 136.8, 134.2, 132.0, 129.6, 128.9, 128.2, 128.0, 127.5, 124.6, 116.2, 108.7, 59.5, 
44.8, 43.1, 23.0, 21.4, 14.1; HRMS m/z 424.1462 (calcd for C23H24N2O4S, 424.1457). 
 
Ethyl 2-(4-methoxyphenyl)-5-tosyl-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridine-3-
carboxylate (2.76d) 
Yellow oil (86% yield, 0.39 g). Rf 0.16 (30% EtOAc/hexanes); 1H NMR (400 MHz, 
CDCl3) 8.54 (s, 1H), 7.66 (d, J = 8.21, 2H), 7.38 (d, J = 8.79, 2H), 7.27 (d, J = 8.01, 
2H), 6.82 (d, J = 8.79, 2H), 4.29 (s, 2H), 4.09 (q, J = 7.03, 2H), 3.76 (s, 3H), 3.37 (t, J = 
7.03, 2H), 2.66 (t, J = 5.47, 2H), 2.39 (s, 3H), 1.22 (t, J = 7.13, 3H); 13C NMR (100 MHz, 
CDCl3)  164.8, 159.4, 143.4, 137.0, 133.9, 130.2,  129.5, 127.4, 124.3, 124.2, 115.6, 
113.3, 107.9, 59.4, 55.2, 44.8, 43.1, 22.9, 21.4,14.2; HRMS m/z 454.1572 (calcd for 
C24H26N2O5S, 454.1562). 
 
(E)-Ethyl 2-styryl-5-tosyl-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridine-3-
carboxylate (2.76e) 
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White powder (69% yield, 0.12 g). Rf 0.15 (30% EtOAc/hexanes); mp 63-65 °C;   1H 
NMR (400 MHz, CDCl3) 8.73 (s, 1H), 7.75 (d, J = 16.80, 1H), 7.68 (d, J = 7.21, 2H), 
7.40 (d, J = 7.62, 2H), 7.30-7.27 (m, 4H), 7.20 (t, J = 7.33, 1H), 6.72 (d, J = 17.00, 1H), 
4.29-4.24 (m, 4H), 3.39 (t, J = 5.67, 2H), 2.71 (t, J = 5.67, 2H), 2.40 (s, 3H), 1.36 (t, J = 
7.13, 3H); 13C NMR (100 MHz, CDCl3)  164.9, 143.5, 136.7, 134.5, 134.0, 129.6, 
128.6, 127.7, 127.4, 126.8, 126.3, 125.7, 117.6, 116.6, 110.2, 59.7, 44.7, 43.1, 23.1, 21.4, 
14.4; HRMS m/z 450.1602 (calcd for C25H26N2O4S, 450.1613). 
 
Ethyl 2-(thiophen-2-yl)-5-tosyl-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridine-3-
carboxylate (2.76f) 
 White powder (87% yield, 0.37 g). Rf 0.14 (40% EtOAc/hexanes); mp 45-48 °C; 1H 
NMR (400 MHz, CDCl3)  8.40 (s, 1H), 7.68 (d, J = 8.21, 2H), 7.40 (dd, J = 3.66, 1.17 
Hz, 1H), 7.30–7.28 (m, 3H), 7.01 (dd, J = 5.13, 3.66 Hz, 1H), 4.31 (s, 2H), 4.21 (q, J = 
7.18, 2H), 3.41 (t, J = 5.72, 2H), 2.70 (t, J = 5.72, 2H), 2.40 (s, 3H), 1.30 (t, J = 7.11, 
3H); 13C NMR (100 MHz, CDCl3)  164.4, 143.4, 134.1, 132.9, 129.8, 129.6, 127.4, 
127.3, 127.0, 125.9, 124.9, 116.3, 109.1, 59.8, 44.8, 43.0, 22.9, 21.4, 14.2; HRMS m/z 
430.1010 (calcd for C21H22N2O4S2, 430.1021). 
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Ethyl 8-cyano-2-tosyl-1,2,3,4-tetrahydropyrido[3,4-b]indolizine-10-carboxylate 
(2.80a) 
Light brown powder (71%, 0.15 g). Rf 0.8 (10% MeOH/DCM); mp 183–185 °C; 1H 
NMR (400 MHz, CDCl3)  8.51 (s, 1H), 7.75 (s, 1H), 7.71 (d, J = 8.06, 2H), 7.30 (d, J = 
8.06, 2H), 6.83 (dd, J = 7.11, 1.69 Hz, 1H), 4.56 (s, 2H), 4.36 (q, J = 7.08, 2H), 3.57 (t, J 
= 5.72, 2H), 2.91 (t, J = 5.64, 2H), 2.40 (s, 3H), 1.42 (t, J = 7.18, 3H);  13C NMR (100 
MHz, CDCl3)  163.7, 143.8, 133.9, 132.5, 129.7, 127.4, 126.1, 124.8, 122.2, 121.8, 
118.2, 112.1, 104.1, 103.6, 60.2, 44.6, 42.6, 21.9, 21.5, 14.5; HRMS m/z 423.1253 (calcd 
for C22H21N3O4S, 423.1253). 
 
Ethyl 6-cyano-2-tosyl-1,2,3,4-tetrahydropyrido[3,4-b]indolizine-10-carboxylate 
(2.80b) 
Yellow crystals (53% yield, 0.22 g). Rf 0.28 (40% EtOAc/hexanes); mp 158–160 °C; 1H 
NMR (400 MHz, CDCl3)  8.41 (d, J = 9.04, 1H), 7.72 (d, J =  8.06, 2H), 7.30 (d, J =  
8.06, 2H), 7.26 (d, J = 6.84, 1H), 6.97 (dd, J = 8.07, 7.45 Hz, 1H), 4.53 (s, 2H), 4.34 (q, J 
= 7.08, 2H), 3.50 (t, J = 5.62, 2H), 3.43 (t, J = 5.62, 2H), 2.40 (s, 3H), 1.42 (t, J = 6.96, 
3H);  13C NMR (100 MHz, CDCl3)  163.8, 143.7, 135.3, 133.8, 129.7, 127.5, 124.9, 
124.3, 121.8, 119.3, 114.7, 107.3, 103.2, 60.0, 44.8, 42.9, 24.0, 21.4, 14.4; HRMS m/z 
423.1261 (calcd for C22H21N3O4S, 423.1253). 
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10a-Methoxy-5,5a,6,6a,7,8,9,10,10a,10b decahydrocyclopentadiene[c]pyridine[5,6-
b]indole-6-carboxylic acid ethyl ester (2.80c) 
White powder (57% yield, 0.8 g). Rf 0.17 (30% EtOAc/hexanes); mp 45–47 °C; 1H NMR 
(400 MHz, CDCl3)  7.62 (d, J = 8.21, 2H), 7.27 (d, J = 8.01, 2H), 7.09 (d, J = 7.42, 1H), 
7.01 (t, J = 7.33, 1H), 6.61 (t, J = 7.33, 1H), 6.54 (d, J = 7.82, 1H), 4.59 (dd, J = 10.36, 
5.28 Hz, 1H), 4.32 (brs, 1H), 4.18 (q, J = 7.23, 2H), 3.82 (dd, J = 10.94, 3.91 Hz, 1H), 
3.71 (d, J = 11.72, 1H), 3.41 (d, J = 10.55, 1H), 3.09 (s, 1H), 2.95 (dd, J = 12.70, 5.28 
Hz, 1H), 2.69 (t, J = 11.14, 1H), 2.52 (s, 3H), 2.38 (s, 3H), 2.08 (td, J = 4.10, 1H), 1.69 
(td, J = 4.49, 1H), 1.28 (t, J = 7.13, 3H);  13C NMR (100 MHz, CDCl3)  173.9, 152.5, 
143.1, 134.0, 129.5, 128.5, 127.2, 125.3, 118.0, 109.9, 81.1, 66.7, 60.6, 56.8, 52.7, 50.7, 
50.6, 50.5, 44.3, 41.48, 29.5, 21.3, 14.1.; HRMS m/z 470.1889 (calcd for C25H30N2O5S, 
470.1875). 
2.3.2.3. General Procedure for SeO2 Oxidation 
To a solution of pyrrole (1.0 mmol) in dioxane (5.0 mL), SeO2 (5.0 mmol, 5 eq) was 
added. The heterogeneous reaction mixture was heated at reflux for 24-40 h. After 
completion, the reaction was allowed to cool to rt and NaHCO3 (2 g) and anhydrous 
MgSO4 (1 g) were added.  After stirring for 30 min the heterogeneous mixture was 
filtered and the solids were washed with EtOAc (3 x 5 mL). The collected filtrate was 
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washed with 10% NaOH (3 x 10 mL) and the organic layer was separated. The organic 
layer was extracted with HCl 10% (3 x 10 mL). The combined acidic extracts were 
collected and neutralized with 10% NaOH and back extracted with EtOAc (3 x 10 mL). 
The organic layer then washed with brine, dried (MgSO4), filtered through celite and 
concentrated under reduced pressure to provide the title compounds. 
 
Ethyl 2-methyl-1H-pyrrolo[3,2-c]pyridine-3-carboxylate (2.79a) 
 White powder (92% yield, 0.18 g). Rf 0.24 (10% MeOH/DCM); mp 145–150 °C; 1H 
NMR (600 MHz, DMSO-d6)  9.10 (s, 1H), 8.21 (d, J = 5.27, 1H), 7.34 (d, J = 5.27, 1H), 
4.29 (q, J = 6.83, 2H), 2.66 (s, 3H), 1.35 (t, J = 7.03, 3H); 13C NMR (600 MHz, DMSO-
d6)  164.3, 145.8, 142.7, 140.9, 138.6, 123.3, 106.4, 102.2, 59.1, 14.3, 13.3; HRMS m/z 
204.0892 (calcd for C16H14N2O2,  C11H12N2O2, 204.0899). 
 
Ethyl 2-ethyl-1H-pyrrolo[3,2-c]pyridine-3-carboxylate (2.79b) 
White powder (94% yield, 0.20 g). Rf 0.14 (10% MeOH/DCM); mp 135–137 °C; 1H 
NMR (400 MHz, DMSO-d6)  9.12 (brs, 1H), 8.24 (brs, 1H), 7.39 (s, 1H), 4.29 (q, J = 
6.94, 2H), 3.10 (q, J = 7.48, 2H), 1.35 (t, J = 7.04, 3H), 1.26 (t, J = 7.55, 3H); 13C NMR 
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(100 MHz, DMSO-d6)  172.0, 164.2, 151.4, 142.9, 140.9, 138.7, 106.7, 101.4, 59.2, 
20.3, 14.36, 13.4; HRMS m/z 218.1058 (calcd for C12H14N2O2, 218.1055). 
 
Ethyl 2-phenyl-1H-pyrrolo[3,2-c]pyridine-3-carboxylate (2.79c) 
Off-white powder (97% yield, 0.25 g). Rf 0.17 (10% MeOH/DCM); mp 210-213 °C; 1H 
NMR (600 MHz, DMSO-d6)  9.25 (s, 1H), 8.29 (d, J = 5.28, 1H), 7.73–7.71 (m, 2H), 
7.51–7.49 (m, 3H), 7.42 (d, J = 5.42, 1H), 4.22 (q, J = 7.04, 2H), 1.25 (t, J = 7.11, 3H);  
13C NMR (100 MHz, DMSO-d6)  163.7, 145.5, 143.9, 141.4, 139.2, 130.9, 130.02, 
129.3, 127.8, 123.9, 106.9, 102.4, 59.4, 14.1; HRMS m/z 266.1047 (calcd for 
C16H14N2O2,  266.1055). 
 
Ethyl 2-(4-methoxyphenyl)-1H-pyrrolo[3,2-c]pyridine-3-carboxylate (2.79d) 
White powder (81% yield, 0.23 g). Rf 0.11 (10% MeOH/DCM); mp 198-200 °C; 1H 
NMR (400 MHz, DMSO-d6)  9.25 (brs, 1H), 8.29 (brs, 1H), 7.68 (d, J = 8.50, 2H), 
7.42(s, 1H),  7.05 (d, J = 8.50, 2H), 3.23 (q, J = 7.04, 2H), 3.83 (s, 3H), 1.27 (t, J = 7.04, 
3H); 13C NMR (100 MHz, DMSO-d6)  163.8,160.2, 145.7, 143.7, 141.2, 139.2, 131.5, 
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122.9, 113.4, 101.8, 100.2, 94.3, 59.4, 55.3, 14.2; HRMS m/z 296.1156 (calcd for 
C17H16N2O3, 296.1161). 
N
N
H
CO2Et
Ph
 
(E)-Ethyl 2-styryl-1H-pyrrolo[3,2-c]pyridine-3-carboxylate (2.79e) 
Yellow powder (61% yield, 0.18 g). Rf 0.20 (10% MeOH/DCM); mp 258-260 °C; 1H 
NMR (600 MHz, DMSO-d6)  9.17 (brs, 1H), 9.30 (brs, 1H), 8.00 (d, J = 16.40, 1H), 
7.60–7.56 (m, 3H), 7.46 (t, J = 7.61, 2H), 7.42 (d, J = 5.72, 1H), 7.38 (t, J = 7.32, 1H), 
4.37 (q, J = 7.03, 2H), 1.41 (t, J = 7.03, 3H); 13C NMR (100 MHz, DMSO-d6)  164.0, 
143.4, 142.9, 141.8, 140.0, 135.8, 134.0, 129.0, 128.9, 126.8, 116.7, 106.6, 103.6, 59.6, 
14.2.; HRMS m/z 292.1205 (calcd for C18H16N2O2,  292.1212). 
 
Ethyl 2-(thiophen-2-yl)-1H-pyrrolo[3,2-c]pyridine-3-carboxylate (2.79f) 
Yellow powder (61% yield, 0.8 g). Rf 0.2 (10% MeOH/DCM); mp 170-175 °C; 1H NMR 
(400 MHz, DMSO-d6)  9.20 (brs, 1H), 8.29 (brs, 1H), 7.94 (s, 1H), 7.81 (d, J = 4.69, 
1H), 7.42 (d, J = 5.27, 1H), 7.24–7.23(m, 1H), 4.34 (q, J = 7.03, 2H), 1.37 (t, J = 7.32, 
3H); 13C NMR (100 MHz, DMSO-d6)  163.7, 143.30, 141.1,139.8, 139.1, 131.8, 130.3, 
129.8, 127.1, 124.1, 106.9, 101.9, 59.6, 14.2; HRMS m/z 272.0612 (calcd for 
C14H12N2O2S, 272.0619). 
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Ethyl 8-cyanopyrido[3,4-b]indolizine-10-carboxylate (2.81a) 
Yellow powder (73% yield, 0.19 g). Rf 0.17 (10% MeOH/DCM); mp 168–171 °C; 1H 
NMR (400 MHz, DMSO-d6)  9.42 (brs, 1H), 9.17 (d, J = 7.23, 1H), 8.52 (brs, 1H), 8.50 
(s, 1H), 8.26 (d, J = 5.47, 1H), 7.23 (d, J  = 6.84, 1H), 4.36 (q, J = 7.03, 2H), 1.42 (t, J = 
7.03, 3H); 13C NMR (100 MHz, DMSO-d6)  163.1, 144.9, 141.09, 136.6, 134.0, 128.4, 
126.1, 122.9, 117.4, 111.2, 110.6, 106.9, 96.8, 59.9, 14.3; HRMS m/z 265.0856 (calcd for 
C15H11N3O2, 265.0851). 
 
Ethyl 6-cyanopyrido[3,4-b]indolizine-10-carboxylate (2.81b) 
Yellow crystals (64% yield, 0.16 g). Rf 0.30 (10% MeOH/DCM); mp 183-186 °C; 1H 
NMR (400 MHz, DMSO-d6)  9.61 (s, 1H), 8.61 (dd, J = 9.38, 1.17 Hz, 1H), 8.58 (d, J = 
6.06, 1H), 8.46 (dd, J = 6.15, 1.07 Hz, 1H), 7.90 (dd, J = 7.03, 1.17 Hz, 1H), 7.60 (dd, J = 
9.38, 6.84 Hz, 1H),4.41 (q, J = 7.10, 2H), 1.43 (t, J = 7.13, 3H); 13C NMR (100 MHz, 
DMSO-d6)  163.4, 145.4, 139.5, 133.8, 127.5, 125.0, 124.8, 123.2, 114.5, 111.1, 107.4, 
107.2, 96.2, 59.9, 14.4; HRMS m/z 265.0846 (calcd for C15H11N3O2, 265.0851). 
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Chapter 3: Cyclobutane Activation for Dipolar Cycloaddition: New Synthesis of 
Alkoxy Substituted Donor−Acceptor (DA) Cyclobutanes and their First Use in 
Dipolar Cycloaddition with 1,2-Dipoles  
This chapter describes the development of a new synthesis of alkoxy substituted 1,1-
cyclobutane diesters (DA cyclobutanes) and their utility for the first time in dipolar 
cycloaddition to prepare highly substituted piperidines, piperideines and 
tetrahydropyrans. A brief summary of the reactivity and utility of cyclobutane rings in 
dipolar cycloaddition will be covered. The cyclobutane chemistry presented in this 
chapter was proposed, proofed and optimized by me. Part of the synthetic work was 
carried out in collaboration with colleagues Mr. Andrew C. Stevens and Mr. Benjamin P. 
Machin; namely the tetrahydropyran methodology; and the results have been published in 
Organic Letters.1 The individual contributions for the tetrahydropyran methodology are 
as follows: the reaction concept was designed, proofed and firstly optimized by me. I 
made the cyclobutane starting materials and cycloadducts derived from 1-
methoxycyclohex-1-ene. The rest of substrate scope and examining different reaction 
conditions was carried by Mr. Andrew C. Stevens and Mr. Benjamin P. Machin. Some 
portions of the text and schemes have been reproduced in part with permission from 
Moustafa, M. M. A. R.; Pagenkopf, B. L. Org. Lett. DOI: 10.1021/ol102062t and 
Moustafa, M. M. A. R.; Stevens, A. C.; Machin, B. P.; Pagenkopf, B. L. Org. Lett. DOI: 
10.1021/ol102063f. Copyright 2010 American Chemical Society.  
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3.1. Introduction 
3.1.1. Formal [4+2] Cycloaddition of DA Cyclobutanes  
The introduction of cyclobutane derivatives, as molecular building blocks in the synthesis 
of highly complex compounds has gained increasing importance in the last decades. This 
is mainly because cyclobutane derivatives are easily obtained by many reliable methods. 
In addition, activated cyclobutanes can undergo a facile and selective bond cleavage 
under a variety of conditions due to an inherent ring strain. The cleavage point and rate 
are dependent on the reaction mechanism, conditions, reagents and the ring substituents.2 
While there are numerous reactions involving C−C bond cleavage of cyclobutanes, this 
section will include an extensive review of the cycloaddition examples where 
cyclobutane ring is being used as 1,4–dipole equivalent (Scheme 3.1).   
 
Scheme 3.1 – Dipolar cycloadditions with cyclobutanes 
Saigo and coworkers at the University of Tokyo were the first to utilize activated 
cyclobutanes in cycloaddition reactions in a similar fashion to cyclopropanes.3  In the 
presence of titanium(IV) chloride, a novel [4+2] annulation reaction between 2-
(dimethylamino)cyclobutanecarboxylic esters 3.1 and carbonyl compounds 3.2 proceeds 
easily to give the pyran derivatives 3.4 in moderate to good yields (Scheme 3.2). When a 
basic work up was involved a mixture of unhydrolyzed dimethylamino derivative 3.3 and 
δ-lactol 3.4 were obtained. In order to hydrolyze 3.3 into 3.4, acidic treatment was 
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required. Although Saigo obtained a mixture of stereoisomers with his amine activated 
cyclobutanes, moderate to excellent diastereoselectivities were obtained when other 
activating groups were utilized (vide infra).     
 
Scheme 3.2 – The reaction of dimethylamino cyclobutanecarboxylic esters and carbonyl 
compounds 
Since Saigo’s first communication in 1991, surprisingly no other reports appeared 
until very recently where the Matsuo group has extended the previous reaction to alkoxy-
activated cyclobutanones rings.4 They have shown that aldehydes or ketones undergo a 
BF3•OEt2-catalyzed [4+2] annulation reaction with 3-alkoxycyclobutanones 3.5 and 3.9 
to give substituted δ-pyrones 3.7 and 3.11 respectively (Scheme 3.3). Compared to 
Saigo’s cycloaddition, a single diastereomer was obtained in case of aldehydes 
cycloadducts. On the other hand cycloadducts of ketones were obtained in moderate 
diastereoselectivity when the reaction done in CH2Cl2. Interestingly, the diastereomeric 
ratio of these cycloadducts dramatically increased when diisopropyl ether was employed 
as a solvent. In addition to this marked diastereoselectivity, a regioselective ring opening 
was also observed. While the bicyclic cyclobutanone 3.5 gave rise to less substituted 
enolate intermediates 3.8, more substituted enolates 3.12 were generated from the 
monocyclic cyclobutanone 3.9 (Scheme 3.3). The new methodology was utilized 
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efficiently to prepare various multisubstituted dihydro-δ-pyrones, which might be 
difficult to be accessed by hetero Diels-Alder chemistry.5 Shortly thereafter, Matsuo has 
extended the annulation reactions of these 3-alkoxycyclobutanones to include silyl enol 
ethers,6 allyl silanes,7 and imines.8     
 
Scheme 3.3 – The reaction of 3-alkoxycyclobutanones with carbonyl compounds. 
From various Lewis acids screened, EtAlCl2 catalyzed the desired annulation of 
silyl enol ether 3.14 with different 3-alkoxycyclobutanone (e.g. 3.9) to yield highly 
oxygenated cyclohexanone derivatives 3.15 in moderate yield and good selectivity 
(Scheme 3.4).6 
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Scheme 3.4 – The reaction of silyl enol ether and 3-alkoxycyclobutanone 
On the other hand, tin(IV) chloride was the best catalyst for the formal [4+2] 
cycloaddition between allysilanes 3.17 and 3-alkoxycyclobutanones 3.16 (Scheme 3.5).7 
The cyclohexanone cycloadducts 3.18 were obtained in good yield however in moderate 
diastereoselectivity. Furthermore, when these cycloadducts were treated with Me3SiOTf, 
the versatile cyclohexenone derivatives 3.19 were synthesized in good to excellent yields 
over two steps. Interestingly, when a sterically none demanding silyl group was 
employed (e.g. allyl trimethylsilane), the desired cycloaddition occurred rather than 
elimination of the silyl group. These results are in contrast to the usual tendency of LA 
catalyzed reactions of allyltrimethylsilane with carbonyl compound to give the allylation 
products. When the bulky SiPh2tBu group was employed, the unexpected pyrones 3.20 
were obtained in moderate yields (Scheme 3.5).  This pyrone product is believed to arise 
from the more stable zwitterionic intermediate 3.22 generated through a 1,5-hydride 
transfer of the β–silyl cation 3.21. The tendency toward the hydride shift and hence the 
pyrone formation improved by increasing the steric demand of the R substituent of the 
cyclobutane 3.16. 
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Scheme 3.5 – The reaction of allysilane and 3-alkoxycyclobutanone 
Finally, the Matsuo group has very recently extended the cycloaddition reactions   
of the alkoxycyclobutanones to include imine based dipolarophiles.8 A formal [4+2] 
cycloaddition reaction was achieved when 3.9 was treated with different N-p-
toluenesulfomyl imines 3.22 in the presence of catalytic TiCl4 to yield different 
dihydropyridone derivatives 3.24 after elimination of ethanol from the expected 
cycloadducts (Scheme 3.6).  Cleverly, this cycloaddition has been applied to the 
synthesis of bremazocine 3.25 in six steps starting from the cycloadduct 3.24a. When 
compared to the many natural products that have been prepared through DA 
cyclopropane based methodologies, the synthesis of bremazocine 3.25, published in 
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2010,8 is the first natural product to be synthesized based on DA cyclobutane 
cycloadditions.   
 
Scheme 3.6 – The reaction of imines and 3-alkoxycyclobutanone 
 In the previous examples either the cyclobutane or the cyclobutanone is activated 
by dimethylamino, or alkoxy substituents, respectively. However the first reports 
regarding the annulation of 1,1-cyclobutanediesters 3.26 and 3.29, activated by carbon-
based activating groups were published in 2009 simultaneously by Christie and 
Pritchard,9 and the Johnson groups (Scheme 3.7).10 In Johnson’s work, the reaction with 
different electron deficient and/or electron rich aromatic aldehydes was efficiently 
catalyzed by Sc(OTf)3. However, a more bulky LA 3.28 was required to activate the 
cyclobutane ring toward aliphatic aldehydes. In both cases, the cis-2,6-disubstituted 
tetrahydropyrans 3.27 were obtained in excellent yields and diastereoselectivities 
(Scheme 3.7).10 When compared to Johnson’s work, the cycloaddition reported by 
Christie and Pritchard is limited to cyclobutanes activated by a dicobalt-alkyne complex. 
In addition, shorter reaction time, high diastereoselectivity and yield were observed only 
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with electron rich aromatic aldehydes. When aliphatic and/or electron deficient aldehydes 
were utilized, either a poor yield, diastereoselectivity or a limited scope was observed 
(Scheme 3.7).9 This is in contrast to the homologues reaction with DA cyclopropanes 
where the electron deficient aldehydes react faster.              
  
Scheme 3.7 – The reaction of aldehydes and 1,1-cyclobutane diesters 
3.1.2. Research Objectives 
Doubly activated 2-alkoxy-1,1-cyclobutane diesters 3.33 are interesting 1,4-dipole 
equivalents because they can be prepared in a single step from the corresponding enol 
ether and methylidene malonate by LA catalysis (Scheme 3.8). Although they are known 
compounds, the use of these DA cyclobutanes in dipolar cycloadditions had not been 
realized prior to the work presented in this thesis. 
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Scheme 3.8 – Lewis acid catalyzed synthesis of 2-alkoxy-1,1-cyclobutane diesters 
The objective of my research was to synthesize these cyclobutanes and to utilize 
them in dipolar cycloadditions. Under LA catalysis these cyclobutanes are expected to 
undergo a facile heterolytic bond cleavage to form 1,4-zwitterion intermediates 3.34 that 
can be trapped with different 1,2- and 1,3-dipoles including aldehydes, nitriles,  imines, 
diazines, acetylenes, nitrones, etc (Scheme 3.9).    
 
Scheme 3.9 – Targeted formal [4+2] cycloadditon with 1,2 and 1,3 dipoles e.g. 
aldehydes, nitriles,  imines, diazines, acetylenes, nitrones, etc. 
The expected six and/or seven membered carbo and heterocycles are important 
cores of many natural and unnatural products. The introduction of the formal [4+2] 
cycloaddition of 2-alkoxy-1,1-cyclobutane diesters as a new way to achieve these rings is 
expected to have a great impact on the scope, versatility and utility of DA cyclobutane 
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based methodologies. The following sections will discuss the synthesis of these DA 
cyclobutanes and their use for the first time to prepare piperidine, piperideines and 
tetrahydropyrans.  
3.2. Results and Discussions 
3.2.1. Synthesis of 2-Alkoxy-1,1-Cyclobutane Diesters 
Although there are many recent highly efficient and stereoselective syntheses of 
cyclobutanes activated by silyl ether groups,11 the syntheses of cyclobutanes activated by 
alkyl ethers are very limited.12 Two methods have been reported that allow access to 
alkoxy substituted DA cyclobutanes with geminal electron withdrawing groups in good 
yields (Scheme 3.10).  
 
Scheme 3.10 – Synthesis of 2-alkoxy-1,1-cyclobutane diesters  
The use of a Michael induced ring closure of acyclic substrates (e.g 3.36) was not 
selected as a preparative route as it offers limited control over the stereochemistry and 
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required multiple steps. On the other hand, the ZnBr2 mediated [2+2] annulation reaction 
reported by Roberts in 1986 appeared much more promising since the same LA (ZnBr2) 
can be used in the subsequent [4+2] reaction allowing for a one-pot tandem process 
(Scheme 3.10). 
Based on this earlier precedence, ZnBr2 was taken as the Lewis acid for the 
cycloaddition of dihydropyran 3.31a and di-t-butyl methylidene malonate 3.32a. 
Unfortunately, duplication of the conditions reported by Roberts, in our hands, gave a 
poor yield (39% Table 3.1, entry 1), and isolation of the cyclobutane was complicated by 
both considerable byproducts and the stoichiometric ZnBr2. More problematic, however, 
was our inability to extend this methodology to the more readily available and cheaper 
diethyl methylidene malonate 3.32b (depending on their synthesis from the 
corresponding malonates, they cost approximately 150$/5g for 3.32a and 120$/kg for 
3.32b). Only trace amounts of the desired cyclobutane 2.39b was isolated along with a 
complex mixture of polymerization and ring opened byproducts (Table 3.1, entry 2). This 
may be attributed to the higher reactivity of diethyl methylidene malonate 3.32b and its 
tendency to rapid polymerization when compared to 3.32a. To improve the outcome of 
the reaction, other Lewis acids were screened, including TMSOTf, ZnCl2, Sc(OTf)3, and 
Yb(OTf3 (Table 3.1). Although TMSOTf and ZnCl2 were completely ineffective, 
Sc(OTf)3, and Yb(OTf3) emerged as highly effective catalysts, with Yb(OTf)3 being the 
catalyst of choice due to slightly higher yields and lower catalyst cost (Table 3.1, entries 
5 and 6). The use of catalytic Yb(OTf)3 rather than stoichiometric ZnBr2 made the 
reactions operationally much simpler to perform, requiring only a simple filtration 
through silica plug to provide the cyclobutane in high purity and yield. In addition, 
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comparable yields were obtained with catalyst loadings as low as 2 mol % however 
longer reaction times are required. 
Table 3.1 – Optimization of the 2-alkoxy-1,1-cyclobutane diesters synthesis 
 
entry R catalyst temperature yield (%)a 
1 tBu 1 equiv ZnBr2 –130 °C to –78 °C 39b 
2 Et 1 equiv ZnBr2 –130 °C to –78 °C 17b 
3 Et 1 equiv ZnCl2 –130 °C to –78 °C 0c 
4 Et 1 equiv TMSOTf –78 °C 0c 
5 Et 10 mol % Sc(OTf)3 –78 °C 78 
6 Et 10 mol % Yb(OTf)3 –78 °C 84 
a Isolated yield. b Product contaminated by ring opened and 
polymeric substance. c Polymeric substances observed. 
The crude cyclobutane obtained from the reaction catalyzed by Yb(OTf)3 (Figure  
3.1, C) is sufficiently pure and even cleaner than the purified material obtained when 
ZnBr2 is used (Figure  3.1, A).  
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Figure  3.1 – 1H NMR spectra of 3.39b isolated from ZnBr2 and Yb(OTf)3 (with and 
without pyridine additive) catalyzed reactions as well as the TLC images. 
On the other hand, it was observed that the cyclobutane ring is very sensitive to 
Yb(OTf)3 and it decomposes within minutes after isolation if there are any traces of the 
catalyst left (Figure  3.1, b). Therefore, the cyclobutane should be purified once collected 
to avoid any decomposition. For large scale applications, few drops of pyridine 
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(B) 1H NMR spectrum of the crude product from Yb(OTf)3 catalyzed reaction  
(without pyridine additives, data collected after 5 minutes) 
(C) 1H NMR spectrum of the crude product from Yb(OTf)3 catalyzed reaction  
(with pyridine additives, data collected after 16 h) 
(A)  1H NMR spectrum of the  purified product from ZnBr2 catalyzed reaction
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(equivalent amount to LA) can be added to the reaction at –78 °C before filtration. The 
pyridine additive chelates Yb(OTf)3 and prevents cyclobutane ring opening  (Figure  3.1, 
c).  
With a promising catalyst identified for the desired [2+2] annulation, the reaction 
scope was explored, and the results are summarized in Table 3.2.  
Table 3.2 – Scope of the cyclobutane synthesis  
 
Entry Enol Ether Cyclobutane yieldsa 
1 
 
3.39c, R3= H, R = Et (93%) 
3.39d, R3= H, R = tBu (72%) 
3.39e, R3= R = Me (NR)b 
2 
  
3.39f, R = Me (56%) 
3.39g, R = Et (80%) 
3 
  
3.39h, (70%) 
a Isolated yield. When possible, only one diastereomer was 
isolated. b No reaction was observed. When the reaction warmed up 
to rt, polymerization takes place. 
The range of compatible methylidene malonates has been expanded from the most 
stable t-butyl, to now encompass ethyl and the very reactive methyl derivatives. All 
methylidene malonates gave the target DA cyclobutanes in good to excellent yields 
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(entries 1-3). Unfortunately, the more substituted and stable 2-ethylidenemalonate was an 
ineffective reactant partner under these conditions (entry 1, 3.39e).  The range of enol 
ethers that participated in the cycloaddition was quite broad with cyclic, acyclic and 
higher-substitution patterns being tolerated (entries 1-3). All cyclobutanes were obtained 
in good to excellent yields and as single diastereomers. Some of the cyclobutanes were 
prepared on large scale in a single pot, with reactions providing the cyclobutane in up to 
12 grams. The relative stereochemistry of the cis-products was assigned on the basis of 
NOE interactions. A representative spectrum (for cyclobutane 3.39b) is presented in 
Figure 3.2.  
 
Figure 3.2 – 1D NOESY of cyclobutane 3.39b 
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The 1D NOESY spectrum showed a strong interaction in the positive direction of 
the spectrum (highlighted in a blue circle) between the ring junction protons when either 
of them is irradiated (the irradiated proton colored red appears in the negative direction of 
the spectrum) (Figure 3.2). 
Next, the ability of Yb(OTf)3 to catalyze the same annulation reaction between 
methylidene malonates 3.32 and other electron rich alkenes was explored (Table 3.3).  
Table 3.3 – Annulation reaction between styrene derivatives and methylidene malonates 
 
entry styrene derivatives cyclobutane yieldsa 
1 
 
3.41a, R3 = H, R = Et (81%) 
3.41b, R3 = Ph, R = Me (NR)b
2 
  
3.41c, R = Me (51%) 
3.41d, R = Et (71%) 
3.41e, R= tBu (59%) 
 
3 
  
3.41f, (NR)b 
aIsolated yield. When possible, only one diastereomer was isolated. bNo reaction 
was observed. When the reaction warmed up to rt, polymerization takes place. 
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The [2+2] reaction of methylidene malonates 3.32 with p-vinyl anisole (Table 
3.3, entry 1) and anethole (Table 3.3, entry 2) gave cyclobutanes 3.41a-e as a single 
diastereomeric product. Similarly to 2-ethylidenemalonate, no reaction was observed with 
the more substituted 2-benzylidenemalonate (Table 3.3, entry 1, 3.41b). Unfortunately, 
no reaction was observed with styrene and only polymerization products were observed 
(Table 3.3, entry 3, 3.41f).  
In summary, ytterbium triflate has been shown to be an excellent catalyst for the 
[2+2] annulation reaction between a wide variety of electron rich alkenes and 
methylidene malonates. The use of ytterbium triflate makes the reactions operationally 
much simpler to perform, and gives single diastereomeric products that are obtained 
cleaner and in higher yield. The use of these synthetically useful cyclobutanes in dipolar 
cycloaddition reactions will be covered in the following sections. 
3.2.2. Formal [4+2] Cycloaddition of Alkoxy-substituted DA Cyclobutanes 
and Imines: Stereoselective Synthesis of Piperidines  
Functionalized piperidine rings are among the most common heterocyclic cores in 
many natural compounds and unnatural synthetic analogues. Figure 3.3 shows several 
representative examples.13,14Due to their broad pharmacological effects, the development 
of new synthetic methodologies to prepare piperidine heterocycles has received enormous 
attention over the years.14 While a comprehensive review is beyond the scope of this 
thesis, some of the commonly used methods to prepare piperidines are summarized in 
Figure 3.4. In general, piperidines can be easily accessed by nucleophilic substitution, 
reductive amination, hydroamination, Michael addition, ring-closing metathesis, ene 
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reaction, radical cyclization, reduction of pyridine (Figure 3.4) and/or cycloaddition 
reactions (Scheme 3.11).14 
 
Figure 3.3 – Biologically active piperidines 
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Figure 3.4 – Synthetic approaches toward piperidines 
Although, many of these methods have been applied successfully in the synthesis 
of different piperidine derivatives, the stereoselective synthesis of multisubsituted 
piperidines and those containing quaternary carbons remains a known synthetic 
challenge.14e Cycloaddition reactions and related syntheses are among the most important 
methods that have been developed to solve this problem. Scheme 3.11 shows some recent 
examples including Diels-Alder approach (equation 1&2),15 dipolar cycloaddition with 
azides (equation 3)16 and/or nitrones (equation 4),17 palladium-trimethylenemethane 
mediated annulation (equation 5)14f,18 and cyclopropane ring-opening/Conia-Ene 
cyclization (equation 6).19  
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Scheme 3.11– Cycloaddition routes and related syntheses toward multisubsituted 
piperidines 
Indeed, these methods provide a reliable and efficient solution however with a 
variety of limitations..14e As such, the development of concise, versatile, efficient and 
stereocontrolled routes to multisubstituted piperidines stands to be of great importance to 
synthetic and medicinal chemists. 
Imines have been utilized by us20 and others21 as dipolarophiles in Lewis acid-
catalyzed [3+2] cycloadditions with DA cyclopropanes to furnish pyrrolidine derivatives 
in a stereoselective manner. At the onset of this project, analogous reactions with DA 
cyclobutanes were not known,22 thus we sought to access the piperidine nucleus 3.65 
through a Lewis acid-catalyzed formal [4+2] cycloaddition of appropriately substituted 
DA cyclobutanes 3.39 and imines 3.64 (Scheme 3.12). Given our ongoing interest in 
alkoxy substituted DA cyclopropanes,23 the analogous cyclobutanes were chosen as 
substrates for the exploration of this chemistry. 
 
Scheme 3.12 – Formal [4+2] cycloaddition of DA cyclobutanes and imines 
Since Yb(OTf)3 has been identified as a superior catalyst for the synthesis of 
alkoxy substituted DA cyclobutanes (Table 3.1), the feasibility of using it to catalyze the 
[4+2] cycloaddition of these cyclobutanes with imines was explored to allow for a 
101 
 
possible  one-pot synthesis of piperidine.24  To our delight, upon exposure of cyclobutane 
3.39b and imine 3.66a (prepared in situ) to catalytic Yb(OTf)3 at –50 °C, the trans fused 
bicyclic piperidine trans-3.67a as a single diastereomer and piperideine 3.68a were 
observed (Scheme 3.13). On the other hand, reaction of imine 3.66b gave cycloadduct 
3.67b as a 2:1 mixture of diastereomers as well as the piperideine 3.68b. The relative 
stereochemistry of trans-3.67b and cis-3.67b was assigned on the basis of NOE 
interactions, and ultimately confirmed by single-crystal X-ray analysis (Figure 3.5 and 
Figure 3.6). It is likely that the piperideine 3.68 is produced from cycloadduct 3.67 by 
tetrahydropyran ring opening followed by a proton transfer. In order to isolate a single 
product, the reaction was warmed to room temperature for an hour after consumption of 
the cyclobutane to drive the product from the piperidine 3.67a to the piperideine 3.68a.  
 
Scheme 3.13 – Formal [4+2] cycloaddition of 2-alkoxy-1,1-cyclobutane diesters and 
imines 
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Figure 3.5 – Single crystal X-ray structure of trans-3.67b 
 
Figure 3.6 – Single crystal X-ray structure of cis-3.67b 
Having demonstrated that the piperdeine synthesis was successful, the scope for 
the reaction was explored and the results are summarized in Table 3.4. Unfortunately, the 
scope for the formal [4+2] reaction is quite limited. While aniline-derived imines were 
effective substrates, no reaction was observed with imines bearing aliphatic substituents 
on the nitrogen. The reaction tolerated various substituents at C2 including cinnamyl, 
naphthyl, electron rich or deficient aromatic and heteroaromatic (Table 3.4, 3.68a- 
3.68g). On the other hand, the more reactive cyclobutanes 3.39g and 3.39h gave complex 
mixtures when subjected to the same reaction conditions. 
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Table 3.4 – Ytterbium triflate catalyzed synthesis of piperdeines 
 
entry cyclobutane 3.39 piperideine 3.68 yielda 
1 
  
3.68a, Ar = C6H5 (83%) 
3.68b, Ar = 3-NO2C6H4 (73%) 
3.68c, Ar = 4-MeOC6H4 (77%)
3.68d, Ar = 2-thienyl (42%) 
3.68e, Ar = 1-naphthyl (84%) 
2 
 
3.68f, Ar = Ph (86%) 
3.68g, Ar = 3-NO2C6H4 (81%) 
3 
  
3.68h, Ar = C6H5 (NR)b 
3.68i, Ar = 3-NO2C6H4 (NR)b 
3.68j, Ar = 4-MeOC6H4 (NR)b 
4 
  
3.68k, Ar = C6H5 (NR)b 
aIsolated yield. bComplex reaction mixture was observed.  
In regard to the nitrogen functionalization, extensive optimization has been done 
to install a variety of aliphatic groups including methyl, iso propyl and/or benzyl however 
with no success and the results are summarized in Table 3.5 (entries 1-11). A wide 
variety of reaction conditions have been examined including different LAs (Et2ALCl2, 
MgCl2, MgBr2, SnCl2, ZnCl2, ZnBr2, Zn(OTf)2, Yb(OTf)3, Sc(OTf)3, TiCl4), different 
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solvents (sulfolane, CH2Cl2, toluene) and/or different reaction temperatures (–50 °C, 0 °C 
or ambient).  
Table 3.5 – Optimizing the reaction conditions with aliphatic iminesa 
 
 
LA (10 
mol %) 
CH2Cl2 toluene,
rt 
CH3NO2 
–50 °C-
rt 
sulfol-
ane, 
rt entry 
–50 °C, 
12 h 
0 °C, 
12 h 
rt, 
12 h 
1 Et2ALCl2  NRb 3.70 -- -- -- -- 
2 MgCl2 NR NR 3.70 -- -- -- 
3 MgBr2 NR 3.70 -- -- -- -- 
4 SnCl2 NR decomp. -- -- -- -- 
5 ZnCl2 NR decomp. -- -- -- -- 
6 ZnBr2 NR NR+decomp. -- -- -- -- 
7 Zn(OTf)2 NR NR 3.68lc -- -- -- 
8 Yb(OTf)3 NR NR 3.68lc 3.68lc 3.71 3.72 
9 Sc(OTf)3 3.68lc -- -- -- -- -- 
10 TiCl4 decomp.d -- -- -- -- -- 
11 TMSOTf 3.70 -- -- -- -- -- 
a reaction monitored by NMR.bNR= no reaction and only cyclobutane observed. c traces 
of the product and decomposition.ddecomp.= decomposition.  
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In general, either cyclobutane ring opening product 3.70 and/or decomposition 
were obtained. Traces of the expected cycloadduct 3.68l as well as decomposition 
products were observed when the reaction catalyzed by Zn(OTf)2, or Sc(OTf)3 or 
Yb(OTf)3 (Table 3.5, entries 7-9). In order to stabilize the oxocarbenium ion intermediate 
and hence to avoid cyclobutane decomposition, more polar solvents were examined 
including CH3NO2 and sulfolane.23a,25 When CH3NO2 was used, it underwent enolization 
under the reaction condition following by addition to the imine and elimination providing 
the nitro alkene 3.71 (Scheme 3.14). Therefore sulfolane as a polar and inert solvent was 
examined.25 However, lactol 3.72 was isolated due to addition of water to the zwitterion 
intermediate 3.73. Since sulfolane is a very hygroscopic solvent, the attempts to make it 
dry were met with failure.25 
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Scheme 3.14 – Plausible mechanism for 3.71 and 3.72 formation 
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Despite the limited scope of the new methodology, the substitution pattern of the 
piperideines 3.68a-g on the N1, C2 and C3 positions as well as the C5-C6 alkene 
functionality and the aliphatic alcohol side chain on C5 can provide a valuable handle for 
further synthetic manipulation. In addition, the milder reaction condition and cost 
effectiveness associated with this one pot approach compete to other related reaction for 
example Diels-Alder cycloaddition. In fact, targeting those piperideines using aza-diene 
Diels-Alder reaction could be a difficult task to realise since the aza-dienes can suffer 
from competitive imine addition and/or tautomerisation.14e         
Since only aldehydes have been reported to undergo dipolar cycloaddition with 
cyclobutanes activated with carbon based donating groups, the ability of Yb(OTf)3 to 
catalyze the same annulation with cyclobutanes 3.41 was then explored (Table 3.6). In 
contrast to the cyclobutanes activated by alkoxy group, the cycloaddition of imines with 
cyclobutane 3.41a required higher temperatures and longer reaction times (0 °C for 10 h 
vs. –50 °C for 1 h). Nonetheless, the cycloaddition proceeded smoothly to provide 
pentasubstituted piperidines 3.74. All the cycloadducts 3.74a-f were obtained in moderate 
to good yields and exclusively as the trans-diastereomer. Similar to cyclobutanes 
activated by alkoxy group 3.39, electron-rich or deficient aromatic, conjugated aromatic, 
and heteroaromatic imines participated in the reaction providing the piperidines 3.74a-
3.74f. Unfortunately, cyclobutane 3.41d failed to react productively with imines, and 
only decomposition was observed along with traces of the piperidine 3.74g. 
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Table 3.6 – Synthesis of pentasubstituted piperidines 
 
entry cyclobutane 3.41 piperidine 3.74 yielda 
1 
 
3.74a, Ar = Ph (62%) 
3.74b, Ar = 3-NO2 C6H4 (86%) 
3.74c, Ar = 4-MeO C6H4 (73%) 
3.74d, Ar = 2-thienyl (59%) 
3.74e, Ar = 1-naphthyl (68%) 
3.74f, Ar = CHCPh2 (61%) 
2 
 
 
3.74g, Ar = Ph (traces) 
a Isolated yield 
Again this cycloaddition does not tolerate aliphatic substituent on the imine 
nitrogen (Scheme 3.15). When the reaction was heated in CH2Cl2, interestingly a retro 
[2+2] followed by [4+2] annulation between styrene and the cyclobutane starting material 
3.41a was observed and the cyclohexane derivative 3.75 was isolated. This observation 
suggests that these DA cyclobutanes can undergo formal [4+2] cycloaddition reaction 
with other electron rich olefin to form multi substituted cyclohexanes.  
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3.41a
Yb(OTf)3 (10 mol%),
CH2Cl2, MS 4 Å, reflux, 3 h
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Scheme 3.15 – Annulation of cyclobutane 3.41a and aliphatic imines 
Finally, the possibility of carrying out the cyclobutane formation/imine annulation 
sequence in one pot was examined. When a CH2Cl2 solution of imine was added to a 
concentrated solution of the in situ formed cyclobutane, the expected cycloadducts were 
obtained in yields ranging from (59 – 84%). The variation in yield is attributed to the 
purity of methylidene malonate, as higher yields were observed with freshly prepared 
methylidene malonate.  
 
Scheme 3.16 – One pot, multi-step synthesis of piperideines 
In summary, the use of 2-alkoxy-1,1-cyclobutane diesters for the first time in 
dipolar cycloadditions have been reported. They undergo a formal [4+2] cycloaddition 
with imines to afford highly substituted piperidines and piperideines. Although there are 
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some limitations, this new piperidine synthesis has some advantages when compared to 
other related [4+2] cycloaddition for example aza-diene Diels-Alder reaction. It starts 
with readily available and cheap DA cyclobutanes. In addition, the reaction can be done 
under milder conditions and with a broader scope. Finally, a one pot procedure for 
cyclobutane synthesis and subsequent imine cycloaddition can be achieved easily. Future 
efforts include applying this methodology in the total synthesis of piperidine natural 
products and developing an asymmetric variant.  
3.2.3. Formal [4+2] Cycloaddition of Alkoxy-substituted DA Cyclobutanes 
and Aldehydes Catalyzed by Yb(OTf)3 
Six-membered oxygenated heterocycles are a common structural feature in a 
plethora of bioactive compounds including naturally occurring carbohydrates and non 
carbohydrates products as well as synthetic analogues. Figure 3.7 shows some 
representative examples. These compounds can vary from simple tetrahydropyrans, 
spiroketals, chromanes and flavanones to more elaborate architectures present in marine 
natural products such as palytoxin and maitotoxin.26  
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Figure 3.7 – Biologically active tetrahydropyrans 
Due to their wide range of functionalities and biological activities, the 
development of new syntheses of these heterocycles has continued to be of major 
importance. In general, the tetrahydropyran ring can be prepared by numerous 
intramolecular cyclizations of an oxygenated precursor for example nucleophilic 
substitution, ring-closing metathesis, Michael additions as well as alkyne, alkene, allene 
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and/or epoxide mediated cyclization.26 These methods are widely used and provide the 
target structures in a highly efficient and simple way. On the other hand, a variety of 
intermolecular syntheses of tetrahydropyrans have also been reported (Scheme 3.17). 
Classical and extensively used examples are the [4+2] Hetero Diels-Alder (Scheme 3.17, 
equation 1),27 the Prins cyclization (Scheme 3.17, equation 2),28 the Petasis-Ferrier 
rearrangement (Scheme 3.17, equation 3).29   
 
Scheme 3.17 – Intermolecular syntheses of tetrahydropyrans 
Having demonstrated the utility of 2-alkoxy-1,1-cyclobutane diesters in the 
synthesis of piperidines and piperideines, it was envisioned that the tetrahydropyran rings 
could also be formed by the formal [4+2] dipolar cycloaddition of these DA cyclobutanes 
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with aldehydes (Scheme 3.18). When compared to the related [4+2] annulation reaction 
(Scheme 3.7),9,10 the unique feature of this approach is that the expected cycloadduct will 
have an anomeric carbon bearing an alkoxy substituent that can be easily modified (e.g., 
C-glycosidation reactions and elimination)30 providing important pyran derivatives 3.87 – 
3.89 that can be further elaborated into many natural products (Scheme 3.18). 
 
Scheme 3.18 – Formal [4+2] approach to tetrahydropyrans and the potential utility of the 
expected cycloadduct. 
Therefore cyclobutane 3.39c was allowed to react with benzaldehyde 3.90 (Table 
3.7). As expected, Yb(OTf)3 catalyzed the annulation reaction very efficiently to afford 
the fused acetal 3.91 which was obtained in moderate to excellent yield and  as a single 
diastereomer under a variety of reaction conditions. The optimization studies revealed 
that temperature had little effect on the yield or diastereoselectivity (Table 3.7, entries 1 
– 3). In addition, the reaction could be effected with catalyst loadings as low as 0.5 mol 
% (Table 3.7, entry 8). Furthermore, the reactions were complete in 2 min when done in 
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the microwave reactor (Table 3.7, entry 9). Finally, we noticed that the aldehyde 
equivalency had very little effect on the yield (Table 3.7, entries 5 and 6). It is important 
to note that only a single diastereomer was observed by NMR. The relative 
stereochemistry of the cis-product was assigned on the basis of NOE interactions.  
Table 3.7 – Optimization of the [4+2] cycloaddition between DA cyclobutanes and 
benzaldehydea 
 
entry 
conditionsb
yieldb (%)
Yb(OTf)3 (mol %) PhCHO (equiv) temp (°C)
time 
(min) 
1 10 3.0 -40 120 70 
2 10 3.0 0 15 84 
3 10 3.0 20 15 78 
5 10 1.1 0 15 78 
6 10 0.9 0 15 68 
7 2 1.1 0 45 74 
8d 0.5 1.1 25 18 h 79 
9e 2 1.1 60 2 76 
aThe proof of concept reaction was done by me. The extensive optimization 
presented in this table was done by Mr. Andrew C. Stevens and Mr. Benjamin 
P. Machin. bReactions were conducted on 0.4 mmol scale.c Isolated yield.dNo 
reaction was observed at 0 °C. eReaction was conducted in a microwave 
reactor. 
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After the reaction conditions were optimized, the scope was explored and the 
results are summarized in Table 3.8.  
Table 3.8 – Scope of the formal [4+2] cycloaddition of DA cyclobutanes and aldehydesa 
 
 
tetrahydropyrans 3.91/ yieldb 
 
3.91a, X = H, 84% 
3.91b, X = OMe, 80% 
3.91c, X = Cl, 89% 
3.91d, X = CN, 88% 
3.91e, X = NO2, 75% 
 
3.91f, 80% 
3.91g, 80% 
 
3.91h, 69% 
 
3.91i, 71% 
3.91j, 62% 
3.91k, 87% 
 
3.91l, 51% 
 
3.91m, R = (CH2)2Ph, 
68% 
3.91n, R = (CH2)4CH3, 
56% 
3.91o, R = CH3, 51% 
3.91p, R = iPr, 58% 
3.91q, R= cyclopropyl, 
72% 
 
3.91r, R = Ph, 60% 
3.91s, R = (CH2)2Ph, 
62% 
 
3.91t, R = Ph, 72% 
3.91u, R = (CH2)2Ph, 70% 
 
3.91v, R = p-C6H4OMe, 76% 
3.91w, R = p-C6H4Cl, 69% 
3.91x, R = m-C6H4NO2, 60% 
3.91y, R = trans-C2H2Ph,71% 
3.91z, R = 2- thienyl, 56% 
acyclobutane starting materials and cycloadducts 3.91v – 3.91z were prepared by me. The 
rest of the scope was done by Mr. Andrew C. Stevens and Mr. Benjamin P. Machin. 
bIsolated yield. For cycloadducts 3.91v – 3.91z, reagents were added –50 °C then the 
reactions warmed gradually to 0 °C.  
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Aromatic aldehydes were found to be excellent reaction partners regardless of 
whether they were electron rich (3.91b), halogenated (3.91c), or electron poor (3.91d, 
3.91e). In addition, heteroaromatic (2-furfural, 2-thiofurfural, and indole-2-
carboxaldehyde, entries 3.91g–3.91i) as well as conjugated aldehydes (3.91j–3.91l) 
underwent the cycloaddition. All tetrahydropyrans 3.91a-3.91l were obtained as a single 
diastereomer in moderate to excellent yields ranging from 51% to 89% (Table 3.8).  
In Johnson’s previous work, a stronger Lewis acid was required for aliphatic 
aldehydes to react with aryl-substituted cyclobutanes.10 Interestingly, we discovered that 
the same mild Lewis acid, Yb(OTf)3, effectively catalyzed the [4+2] cycloaddition 
between the alkoxy-substituted cyclobutanes and aliphatic aldehydes (Table 3.8). 
Examining the reaction scope revealed that linear (dihydrocinnamaldehyde, 3.91m, and 
hexanal, 3.91n), acetaldehyde (3.91o), branched (isobutyraldehyde, 3.91p), and 
cyclopropyl aldehydes (3.91q) all underwent the cycloaddition to provide exclusively the 
cis bicyclic acetals (Table 3.8, 3.91m-3.91q).   
Several additional DA cyclobutanes were investigated (Table 3.8). 
Tetrahydropyran-fused cyclobutane 3.39b underwent successful cycloaddition with both 
aromatic and aliphatic aldehydes to afford the all cis-products (3.91r, 3.91s). The 
unsubstituted cyclobutane 3.39c also participated in the cycloaddition with aliphatic and 
aromatic aldehydes (3.91t, 3.91u). Furthermore, the cyclohexyl-fused cyclobutane 3.39d 
underwent cycloaddition with aromatic aldehydes to afford the fused ring systems 3.91v–
3.91z, each as a single diastereomer. Unfortunately, when aliphatic aldehydes were 
allowed to react with 3.39d, decomposition was observed.   
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Next, the possibility of carrying out the cyclobutane formation/aldehyde 
annulation sequence in a one pot was examined (Scheme 3.19). When benzaldehyde was 
added to a solution of the in situ formed cyclobutane 3.39g at –78 °C and the reaction 
then was allowed to warm to 0 °C, the tetrahydropyran 3.91t was obtained in 54% yield. 
Although, it provides a lower yield than the two-step sequence, the one-pot reaction 
allowed for the efficient synthesis of this tetrahydropyrans 3.91t in eight gram scale for 
further synthetic manipulations.30   
 
Scheme 3.19 – One pot, multi-step synthesis of tetrahydropyan 
When compared to imines, aldehydes are more efficient dipolarophiles in the 
annulation reaction with 2-alkoxy 1,1-cyclobutane diesters. In addition to the broader 
scope and the shorter reaction times, the tetrahydropyran cyloadducts were obtained in 
moderate to excellent yields and as single diastereomers.  
In summary, by utilizing the formal [4+2] annulation between aldehydes and DA 
cyclobutanes, a novel synthesis of tetrahydropyran derivatives is reported. The reaction 
was efficiently catalyzed by Yb(OTf)3 with a wide variety of aldehydes. The new method 
highly selective for the cis-diastereomer and provide the product in moderate to excellent 
yields. Developing an asymmetric variant of this methodogly and further applying it in 
the total synthesis of pyran-based natural products are future projects in our group.  
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3.3. Chapter Summary 
Although known for more than two decades, the first use of 2-alkoxy-1,1-
cyclobutane diesters in dipolar cycloaddition was reported. Both the synthesis of those 
donor-acceptor cyclobutanes and their subsequent annulation with imines (in situ formed) 
as well as aldehydes are catalyzed by catalytic Yb(OTf)3. In addition, novel syntheses of 
several bilogicaly important heterocycles including piperidine, piperideine and 
tetrahydropyrans were also reported. The reactions are done under very mild conditions 
providing the products in high yields and excellent selectivity. Future efforts are to target 
different heterocycles by identify new dipolarophile partners, to develop an asymmetric 
variant of the current methodologies and to apply them in the total synthesis of 
biologically active natural compounds as well as synthetic analogues.  
3.4. Experimental 
3.4.1. General  
1H and 13C NMR spectra were recorded using a Varian Mercury 400 or 600 MHz 
spectrometers. Chemical shifts (δ) were expressed in parts per million (ppm) downfield 
from tetramethylsilane using the residual protonated solvent as an internal standard 
(chloroform-d, 1H 7.25 ppm and 13C 77.00 ppm). Coupling constants were expressed in 
Hertz (Hz). When peak multiplicities are given, the following abbreviations are used: s, 
singlet; d, doublet; dd, doublet of doublets; td, triplet of doublets; t, triplet; q, quartet; m, 
multiplet; br, broad. HRMS (CI, FAB) were obtained with a Finnigan MAT 8200 
instrument. Melting points are uncorrected. X-ray analysis were carried out at low 
temperature (–123 °C) on a Nonius Kappa-CCD diffractometer. The progress of reactions 
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were monitored by thin layer chromatography (TLC) performed on F254 silica gel plates. 
The plates were visualized by staining with ceric ammonium molybdate (CAM),31 or 
potassium permanganate. Column chromatography was performed with Silica Flash P60 
60 Å silica gel from Silicycle according to the Still method. 32 All solvents were obtained 
from an Innovative Technology SPS-400-5 solvent purification system. All chemicals 
were of reagent quality and used as obtained from commercial sources unless otherwise 
noted. Flasks were oven dried and cooled in a desiccator prior to use. Reactions were 
carried out under an inert atmosphere (dry argon) unless otherwise indicated. 
3.4.2. General Procedure A for the [2+2] Synthesis of Cyclobutanes 3.39b-h 
and 3.41a-e   
To a solution of Yb(OTf)3 (0.01 eq) in CH2Cl2 (0.5 mmol/ 10.0 mL) maintained at –78 
°C was added simultaneously by syringe pump over 45 minutes a solution of enol ether 
(1.2 equiv) in CH2Cl2 (5 mmol/ 10.0 mL) and a second solution of methylidene 
malonate33 (1.0 equiv) in CH2Cl2 (5 mmol/ 10.0 mL) (both at rt). To avoid any 
polymerizations and side reactions, methylidene malonate solution should be dilute and 
have roughly the same molar concentration of the enol ether. Alternatively, alkenes (6 
mmol of enol ether and 5 mmol of methylidene malonate) can be dissolved in CH2Cl2 
(20.0 mL), cooled down to approximately –78 °C, then this solution was added through a 
cannula to CH2Cl2 solution of Yb(OTf)3 maintained at –78 °C. After the reaction 
appeared complete (tlc, 1-3 h), pyridine (0.01 eq) was added at –78 °C and the reaction 
was filtered while still cold through a silica gel (2 cm) and celite (1 cm) bilayer pad open 
to the atmosphere. The filtrate was concentrated under reduced pressure. Purification of 
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the residue by flash column chromatography on silica gel using EtOAc-hexanes for 
elution (buffered with 1% Et3N) provided the title compounds. The procedure was 
effectively run at up to 50 mmol scale for some cyclobutanes. 
 
Diethyl 2-oxabicyclo[4.2.0]octane-8,8-dicarboxylate (3.39b):34 
The synthesis was done at 50 mmol scale to yield cyclobutane as colorless oil (87% yield, 
11.14 g). Rf 0.40 (30% EtOAc/hexanes); 1H NMR (400 MHz, CDCl3)  4.62 (t, J = 4.1 
Hz, 1H), 4.32-4.27 (m, 1H), 4.25-4.20 (m, 1H), 4.18-4.11 (m, 2H), 3.78 (d, J = 11.7 Hz, 
1H), 3.23 (t, J = 10.5 Hz, 1H), 2.95 (t, J = 11.1 Hz, 1H), 2.56 (apparent s, 1H), 2.14 (ddd, 
J = 11.4, 8.4, 3.5,  1H), 1.81-1.73 (m, 1H), 1.64-1.55 (m, 2H), 1.39 (d, J = 14.0, 1H), 1.24 
(t, J = 7.0, 6H); 13C NMR (100 MHz, CDCl3)  170.4, 168.0, 75.4, 64.5, 61.3, 61.2, 55.9, 
29.6, 28.2, 22.7, 20.8, 14.1, 14.0; HRMS m/z 256.1315 (calcd for C13H20O5, 256.1311). 
 
Diethyl 2-oxabicyclo[3.2.0]heptane-7,7-dicarboxylate (3.39c): 
The synthesis was done at 40 mmol scale to yield cyclobutane as colorless oil (93% yield, 
9.00 g). Rf 0.48 (30% EtOAc/hexanes); 1H NMR (400MHz , CDCl3)  4.96 (dd, J = 5.5, 
2.7 Hz, 1 H), 4.29- 4.12 (m, 4 H), 4.11- 4.04 (m, 1 H), 3.99- 3.92 (m, 1 H), 3.14- 3.06 (m, 
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1 H), 2.48 (dd, J = 13.5, 6.8 Hz, 1 H), 2.28 (ddd, J = 13.3, 9.0, 2.7 Hz, 1 H), 1.79- 1.73 
(m, 2 H), 1.23 (td, J = 7.0, 3.5 Hz, 6 H);  13C NMR (100 MHz, CDCl3)  170.7, 168.0, 
81.7, 69.5, 61.3, 56.3, 35.9, 31.1, 29.3, 14.09, 13.98; HRMS m/z 242.1150 (calcd for 
C12H18O5, 242.1154).  
 
Di-tert-butyl 2-oxabicyclo[3.2.0]heptane-7,7-dicarboxylate (3.39d): 
The synthesis was done at 5 mmol scale to yield cyclobutane as colorless oil (72% yield, 
1.00 g). Rf 0.50 (30% EtOAc/hexanes); 1H NMR (400 MHz, CDCl3)  4.91 (dd, J =  5.5, 
2.0 Hz, 1H), 4.05 (t, J = 7.6 Hz, 1H), 3.95 (td, J = 9.5, 6.1 Hz, 1H), 3.06-3.02 (m, 1H), 
2.39 (dd, J =  13.1, 6.7 Hz, 1H), 2.16 (ddd, J = 12.8, 9.3, 2.3 Hz,  1H),1.80-1.71 (m, 2H), 
1.46 (s, 9H), 1.45 (s, 9H); 13C NMR (100 MHz, CDCl3)  170.3, 167.4, 81.5, 81.2, 81.1, 
69.3, 57.6, 35.5, 31.2, 29.1, 27.9, 27.8; HRMS m/z 299.1857 (calcd for C16H26O5, 
298.1780). 
 
Dimethyl 2-ethoxycyclobutane-1,1-dicarboxylate (3.39f): 
The synthesis was done at 35 mmol scale to yield cyclobutane as colorless oil (56% yield, 
4.2 g). Rf 0.33 (20% EtOAc/hexanes); 1H NMR (400 MHz, CDCl3)  4.45 (t, J = 8.3 Hz, 
1H), 3.76 (s, 3H), 3.71 (s, 3H), 3.54-3.46(m, 1H), 2.49 (quin, J = 5.8 Hz, 1H), 2.16 (td, J 
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= 9.0, 6.8 Hz, 2H), 1.70 (apparent q, J = 9.0 Hz, 1H), 1.12 (t, J =  7.0 Hz, 3H); 13C NMR 
(100 MHz, CDCl3)  171.42 , 169.5, 75.5, 65.1, 61.0, 52.5, 52.4, 26.0, 21.0, 15.0; HRMS 
m/z 216.0992 (calcd for C10H16O5, 216.0998). 
 
Diethyl 2-ethoxycyclobutane-1,1-dicarboxylate (3.39g): 
The synthesis was done at 1 mmol scale to yield cyclobutane as colorless oil (80% yield, 
0.19 g). Rf 0.40 (20% EtOAc/hexanes); 1H NMR (400 MHz, CDCl3)  4.45 (t, J = 8.5 Hz, 
1H), 4.30-4.10 (m, 4H), 3.74-3.66 (m, 1H), 3.54-3.47 (m, 1H), 2.49 (quin, J = 6.2 Hz, 
1H), 2.16 (td, J = 8.8, 6.4 Hz, 2H), 1.68 (apparent q, J = 9.3, 1H), 1.25 (dt, J = 10.2, 7.1 
Hz, 6H), 1.13 (t, J =  7.0 Hz, 3H); 13C NMR (100 MHz, CDCl3)  171.0, 168.6, 75.4, 
65.1, 61.3, 61.2, 61.1, 25.9, 20.9, 14.9, 14.1, 14.0; HRMS m/z 244.1310 (calcd for 
C12H20O5, 244.1311). 
 
 Diethyl 6-methoxybicyclo[4.2.0]octane-7,7-dicarboxylate (3.39h): 
The synthesis was done at 85 mmol scale to yield cyclobutane as colorless oil (70% yield, 
16 g). Rf 0.33 (30% EtOAc/hexanes); 1H NMR (400 MHz, CDCl3)  4.23-4.18 (m, 4H), 
3.35 (s, 3H), 2.79-2.75 (m, 1H), 2.42 (d, J = 13.1 Hz, 1H), 2.31 (t, J = 10.2 Hz, 1H), 1.78 
(t, J = 11.3 Hz, 1H), 1.58-1.53 (m, 2H), 1.50-1.48 (m, 1H), 1.41 (d, J = 14.6 Hz, 1H), 
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1.30 (t, J = 7.5 Hz, 1H), 1.26 (t, J = 6.9 Hz, 6H), 1.20 (d, J = 12.0 Hz, 2H); 13C NMR 
(100 MHz, CDCl3)  169.7, 168.8, 81.3, 62.8, 61.3, 60.8, 51.6, 36.5, 27.4, 25.0, 23.2, 
21.1, 20.1, 14.0,13.9; HRMS m/z 284.1631 (calcd for C15H24O5, 284.1624). 
 
Diethyl 2-(4-methoxyphenyl)cyclobutane-1,1-dicarboxylate (3.41a): 
The synthesis was done at 15 mmol scale to yield cyclobutane as colorless oil (81% yield, 
3.7 g). Rf 0.35 (30% EtOAc/hexanes); 1H NMR (400 MHz, CDCl3)  7.21 (d, J = 8.7 Hz, 
2H), 6.80 (d, J = 8.7 Hz, 2H), 4.30 (t, J = 9.6 Hz, 1H), 4.27-4.23 (m, 1H), 4.21-4.16(m, 
1H), 3.81-3.78 (m, 1H), 3.76 (s, 3H), 3.70-3.65 (m, 1H), 2.66 (dt, J = 9.3 Hz, 2.34 Hz, 
1H), 2.55 (quin, J = 9.8 Hz, 1H), 2.20 (apparent q, J = 9.3 Hz, 1H), 2.13 (dq, J = 8.7, 2.93 
Hz, 1H), 1.26 (t, J = 7.0 Hz, 3H), 0.80 (t, J = 7.3 Hz, 3H); 13C NMR (100 MHz, CDCl3)  
171.7, 169.4, 158.5, 131.3, 128.8, 113.3, 61.1, 60.8, 59.6, 55.2, 44.3, 25.4, 20.8, 14.0, 
13.6; HRMS m/z 306.1474 (calcd for C17H22O5, 306.1467). 
 
Dimethyl 2-(4-methoxyphenyl)-3-methylcyclobutane-1,1-dicarboxylate (3.41c): 
The synthesis was done at 35 mmol scale to yield cyclobutane as colorless oil (51% yield, 
5.20 g). Rf 0.45 (30% EtOAc/hexanes); 1H NMR (400 MHz, CDCl3)  7.17 (d, J = 8.5 
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Hz, 2H), 6.80 (d, J = 8.5 Hz, 2H), 3.78 (d, J = 7.0 Hz, 1H), 3.76 (s, 3H), 3.74 (s, 3H), 
3.27 (s, 3H), 2.96-2.86 (m, 1H), 2.80 (dd, J = 11.3, 8.3 Hz, 1H), 1.77 (dd, J = 11.1, 9.1 
Hz, 1H), 1.11 (d, J = 6.6 Hz, 3H); 13C NMR (100 MHz, CDCl3)  172.15, 169.9, 158.5, 
130.3, 128.6, 113.4, 57.0, 55.1, 52.3, 51.9, 33.6, 29.1, 20.3; HRMS m/z 292.1311 (calcd 
for C16H20O5, 292.1311). 
 
Diethyl 2-(4-methoxyphenyl)-3-methylcyclobutane-1,1-dicarboxylate (3.41d): 
The synthesis was done at 1 mmole scale to yield cyclobutane as colorless syrup (71% 
yield, 0.22 g). Rf 0.28 (30% EtOAc/hexanes); 1H NMR (400 MHz, CDCl3)  7.19 (d, J = 
8.5 Hz, 2H), 6.79 (d, J = 8.5 Hz, 2H), 4.29-4.13 (m, 2H), 3.84-3.8 (m, 1H), 3.78 (d, J = 
3.9 Hz, 1H), 3.76 (s, 3H), 3.72-3.64 (m, 1H), 2.97-2.86 (m, 1H), 2.97 (dd, J = 11.3, 8.5 
Hz, 1H), 1.76 (dd, J = 10.9, 8.9 Hz, 1H), 1.25 (t, J = 7.0 Hz, 3H), 1.12 (d, J = 6.6 Hz, 
3H), 0.79 (t, J = 7.2 Hz, 3H); 13C NMR (100 MHz, CDCl3)  171.8, 169.6, 158.5, 130.5, 
128.8, 113.4, 61.1, 60.8, 56.9, 55.2, 52.0, 33.6, 28.9, 20.4, 14.0, 13.6; HRMS m/z 
320.1633 (calcd for C18H24O5, 320.1624).  
 
Di-tert-butyl 2-(4-methoxyphenyl)-3-methylcyclobutane-1,1-dicarboxylate (3.41e): 
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The synthesis was done at 5 mmol scale to yield cyclobutane as white solid (59% yield, 
1.00 g). Rf 0.32(30% EtOAc/hexanes); 1H NMR (400 MHz, CDCl3)  7.23 (d, J = 8.6 Hz, 
2H), 6.82 (d, J = 8.9 Hz, 2H), 3.76 (s, 3H), 3.74 (d, J = 10.1 Hz, 1H), 2.88-2.78 (m, 1H), 
2.70 (dd, J = 10.9, 8.2 Hz, 1H), 1.64 (dd, J = 10.9, 8.9 Hz, 1H), 1.46 (s, 9H), 1.11 (d, J = 
6.6 Hz, 3H), 1.02 (s, 9H); 13C NMR (100 MHz, CDCl3)  171.2, 168.8, 158.4, 130.8, 
129.2, 113.3, 80.89, 80.73, 68.1, 57.9, 55.3, 51.3, 33.6, 28.2, 27.9, 27.4, 20.3; HRMS m/z 
376.2291 (calcd for C22H32O5, 376.2250).  
3.4.3. General Procedure B for the Formal [4+2] Cycloaddition of Imine and 
Cyclobutanes 3.39b and 3.39c: Synthesis of Piperideine 3.68a-g  
A solution of aldehyde (1 eq, 3 mmol) and amine (1 eq, 3 mmol) dissolved in dry CH2Cl2 
(2 mL) was stirred at rt over activated 4 Å MS (ca. 2 g) under Ar for 1 h. Without 
isolation the in situ generated imine was added via cannula to a solution of Yb(OTf)3 
(0.01 eq) in CH2Cl2 (0.5 mL) over activated 4 Å MS (ca. 1 g) in a –50 °C cold bath, 
followed immediately by neat cyclobutane (1.0 eq, 1 mmol). The reaction was maintained 
at –50 °C until complete (tlc, 30 – 60 min), and then allowed to warm to rt.  After an hour 
the reaction mixture was treated with solid NaHCO3 (ca. 0.5 g) and filtered through a 
silica gel (2 cm) and celite (1 cm) bilayer pad open to the atmosphere. The filtrate was 
concentrated under reduced pressure. Purification of the residue by flash column 
chromatography on silica gel using EtOAc-hexanes for elution (buffered with 1% Et3N) 
provided the title compounds.  
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Diethyl 7,8-diphenylhexahydro-2H-pyrano[2,3-b]pyridine-6,6(7H)-dicarboxylate 
(3.67a): 
This piperidine was obtianed as a minor product when the reaction (according to general 
procedure A) was stoped at –50 °C after ca. 30 min.  Colorless syrup (17% yield, 0.02 g) 
as a single diasteriomer. Rf 0.26 (20% EtOAc/hexanes); 1H NMR (400 MHz, CDCl3)  
7.11-7.06 (m, 5H), 7.02 (d, J = 6.4, 2H), 6.91 (d, J = 8.2, 2H), 6.83 (t, J = 7.3, 1H), 5.61 
(s, 1H), 4.68 (d, J = 8.2, 1H), 4.40-4.34 (m, 2H), 3.93 (dd, J = 11.7, 4.7, 1H), 3.79-3.75 
(m, 1H), 3.72-3.67 (m, 1H), 3.56-3.52 (m, 1H), 2.5-2.44 (m, 2H), 1.91 (d, J = 12.9, 1H), 
1.76-1.74 (m, 1H), 1.68-1.65(m, 1H), 1.61-1.57 (m, 2H), 1.36 (t, J = 7.0, 3H), 0.86 (t, J = 
7.0, 3H); 13C NMR (100 MHz, CDCl3)  169.8, 168.4, 146.6, 136.7, 129.9, 127.9, 
127.6,127.5, 124.2, 122.6, 87.4, 68.7, 67.1, 62.1, 61.4, 58.7, 38.0, 30.4, 29.3, 26.0, 14.1, 
13.4; HRMS m/z 437.2206 (calcd for C26H31NO5, 437.2202).  
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Diethyl 7-(3-nitrophenyl)-8 phenylhexahydro-2H-pyrano[2,3-b]pyridine-6,6(7H)-
dicarboxylate (3.67b): 
This piperidine was obtianed as a minor product when the reaction (according to general 
procedure A) was stoped at –50 °C after ca. 30 min. Yellow powder (22% yield, 0.03 g) 
as two diasteriomers (2:1 trans:cis); trans-3.67b: recrystallization from CH2Cl2/hexanes 
yielded yellow crystals. Rf 0.25 (20% EtOAc/hexanes); 1H NMR (400 MHz, CDCl3)  
7.99 (d, J = 8.2, 1H), 7.95 (s, 1H), 7.36 (d, J = 7.6, 1H), 7.29 (t, J = 7.6, 1H), 7.08 (t, J = 
7.6, 2H), 6.9 (d, J = 7.6, 2H), 6.85 (t, J = 7.0, 1H), 5.78 (s, 1H), 4.64 (d, J = 8.2, 1H), 
4.42-4.35 (m, 2H), 3.94 (dd, J = 11.7, 4.7, 1H), 3.84-3.80 (m, 1H), 3.75-3.71 (m, 1H), 
3.57 (t, J = 11.1, 1H), 2.52 (dd, J = 14.6, 3.5, 1H), 2.37 (t, J = 14.0, 1H), 1.94 (d, J = 
11.7, 1H), 1.78-1.74 (m, 1H), 1.64-1.59 (m, 3H), 1.37 (t, J = 7.0, 3H), 0.91 (t, J = 7.0, 
3H); 13C NMR (100 MHz, CDCl3)  169.2, 168.0, 147.4, 145.9, 139.2, 135.6, 128.6, 
128.3, 124.2, 123.8, 123.1, 122.5, 87.4, 67.9, 67.2, 62.4, 61.8, 58.5, 37.8, 30.3, 29.2, 25.9, 
14.1, 13.5; HRMS m/z 482.2043 (calcd for C26H30N2O7, 482.2053).  
cis-3.67b: recrystallization from CH2Cl2/hexanes yielded yellow crystals. Rf  0.31 (20% 
EtOAc/hexanes); 1H NMR (400 MHz, CDCl3)  8.72 (t, J = 2.0, 1H), 8.04 (d, J = 7.6, 
1H), 7.97 (d, J = 9.3, 1H), 7.32 (t, J = 7.9, 1H), 7.21-7.19 (m, 2H), 7.17-7.14 (m, 2H), 
6.81-6.79 (m, 1H), 6.04 (s, 1H), 4.77 (d, J = 2.3, 1H), 4.34-4.30 (m, 1H), 4.28-4.24 (m, 
1H), 4.18 (d, J = 11.1, 1H), 3.89-3.86 (m, 1H), 3.73-3.70 (m, 1H), 3.62-3.58 (m, 1H), 
2.82 (t, J = 14.0, 1H), 2.08 (dd, J = 14.0, 2.9, 1H), 1.95-1.91 (m, 1H), 1.75 (d, J = 13.5, 
1H), 1.45 (d, J = 12.3, 1H), 1.29 (t, J = 7.0, 3H), 1.04 (t, J = 7.0, 3H); 13C NMR (100 
MHz, CDCl3)  170.3, 168.3, 148.1, 147.7, 140.5, 136.4, 129.0, 128.5, 125.6, 122.5, 
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120.8, 118.0, 85.3, 66.3, 62.2, 61.7, 59.9, 59.7, 31.8, 29.0, 24.1, 20.8, 14.0, 13.64; HRMS 
m/z 482.2043 (calcd for C26H30N2O7, 482.2053).   
 
Diethyl-(3-hydroxypropyl)-1,2-diphenyl-1,2-dihydropyridine-3,3(4H)-dicarboxylate 
(3.68a): 
The synthesis was done at 0.3 mmole scale to yield the tiltled compound as colorless oil 
(81% yield, 0.10 g). Rf 0.13 (20% EtOAc/hexanes); 1H NMR (400 MHz, CDCl3)  7.28-
7.26 (m, 5H), 7.19-7.15 (m, 2H), 6.84-6.80 (m, 3H), 6.59 (s, 1H), 5.51 (s, 1H), 4.16-4.04 
(m, 4H), 3.69 (t, J = 6.4, 2H), 2.58 (d, J = 17.2, 1H), 2.50 (d, J = 17.2, 1H), 2.71 (t, J = 
7.4, 2H), 1.78-1.71 (m, 2H), 1.60 (brs, 1H), 1.19 (t, J = 7.2, 3H), 1.06 (t, J = 7.2, 3H); 13C 
NMR (100 MHz, CDCl3)  169.2, 168.6, 147.0, 139.8, 129.0, 128.5, 127.9, 127.1, 124.4, 
120.3, 115.9, 107.9, 62.5, 61.9, 61.7, 57.6, 31.1, 26.5, 13.9, 13.8; HRMS m/z 437.2194 
(calcd for C26H31NO5, 437.2202).  
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 Diethyl 5-(3-hydroxypropyl)-2-(3-nitrophenyl)-1-phenyl-1,2-dihydropyridine-
3,3(4H)-dicarboxylate (3.68b): 
The synthesis was done at 0.3 mmole scale to yield the tiltled compound as colorless oil 
(73% yield, 0.10 g). Rf 0.12 (20% EtOAc/hexanes); 1H NMR (400 MHz, CDCl3)  8.19 
(t, J = 1.76, 1H), 8.13 (d, J = 8.2, 1H), 7.63 (d, J = 7.8, 1H), 7.48 (t, J = 7.2, 1H), 7.20 (t, 
J = 8.0, 2H), 6.87 (t, J = 7.4, 1H), 6.80 (d, J = 7.8, 2H), 6.61 (s, 1H), 5.65 (s, 1H), 4.20-
4.02 (m, 4H), 3.70 (t, J = 6.4, 2H), 2.64 (d, J = 17.5, 1H), 2.45 (d, J = 17.5, 1H), 2.24 (t, J 
= 7.8, 2H), 1.75 (quin, J = 6.9, 2H), 1.53 (brs, 1H), 1.24 (t, J = 7.0, 3H), 1.06 (t, J = 7.2, 
3H); 13C NMR (100 MHz, CDCl3)  168.5, 168.2, 148.3, 146.5, 142.0, 133.4, 129.6, 
129.2, 124.3, 123.0, 122.2, 120.9, 116.1, 108.5, 62.26, 62.20, 62.0, 61.3, 57.3, 31.0, 30.9, 
26.4, 13.9, 13.7; HRMS m/z 482.2026 (calcd for C26H30N2O7, 482.2053).  
 
Diethyl 5-(3-hydroxypropyl)-2-(4-methoxyphenyl)-1-phenyl-1,2-dihydropyridine-
3,3(4H)-dicarboxylate (3.68c): 
The synthesis was done at 0.3 mmole scale to yield the tiltled compound as colorless oil 
(77% yield, 0.10 g). Rf 0.14 (20% EtOAc/hexanes); 1H NMR (400 MHz, CDCl3)  7.18 
(d, J = 8.6, 2H), 7.15 (d, J = 7.4, 2H), 6.83 (d, J = 8.2, 2H), 6.79 (d, J = 8.6, 3H), 6.57 (s, 
1H), 5.47 (s, 1H), 4.17-4.03 (m, 4H), 3.76 (s, 3H), 3.69 (t, J = 6.2, 2H), 2.58 (d, J = 17.8, 
1H), 2.50 (d, J = 17.9, 1H), 2.21 (t, J = 7.4, 2H), 1.75 (quin, J = 6.6, 2H), 1.35 (brs, 1H), 
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1.20 (t, J = 7.0, 3H), 1.05 (t, J = 7.2, 3H); 13C NMR (100 MHz, CDCl3)  169.3, 168.7, 
159.1, 147.0, 131.8, 129.0, 128.3, 124.3, 120.2, 115.8, 113.8, 107.7, 77.3, 62.5, 61.67, 
61.65, 61.3, 57.7, 55.1, 31.1, 26.5, 13.9, 13.80; HRMS m/z 467.2297 (calcd for 
C27H33NO6, 467.2308).  
 
 Diethyl 5-(3-hydroxypropyl)-1-phenyl-2-(thiophen-2-yl)-1,2-dihydropyridine-
3,3(4H)-dicarboxylate (3.68d): 
The synthesis was done at 0.3 mmole scale to yield the tiltled compound as colorless oil 
(42% yield, 0.05 g). Rf 0.16 (20% EtOAc/hexanes); 1H NMR (400 MHz, CDCl3)  7.22-
7.17 (m, 3H), 6.95 (d, J = 3.5, 1H), 6.91-6.83(m, 4H), 6.39 (s, 1H), 5.89 (s, 1H), 4.26-
4.09 (m, 2H), 4.02 (q, J = 7.0, 2H), 3.69 (t, J = 6.4, 2H), 2.69 (d, J = 17.6, 1H), 2.58 (d, J 
= 17.6, 1H), 2.21 (t, J = 7.4, 2H), 1.77 (quin, J = 7.0, 2H), 1.59 (brs, 1H), 1.24 (t, J = 7.2, 
3H), 0.98 (t, J = 7.0, 3H); 13C NMR (100 MHz, CDCl3) 168.5, 168.3, 146.6, 141.5, 
129.1, 126.3, 126.0, 125.2, 123.2, 120.4, 115.8, 109.5, 62.5, 61.95, 61.87, 58.22, 58.1, 
31.1, 30.9, 27.0, 13.9, 13.6; HRMS m/z 443.1753 (calcd for C24H29NO5S, 443.1766).  
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 Diethyl 5-(3-hydroxypropyl)-2-(naphthalen-1-yl)-1-phenyl-1,2-dihydropyridine-
3,3(4H)-dicarboxylate (3.68e): 
The synthesis was done at 0.3 mmole scale to yield the tiltled compound as colorless oil 
(84% yield, 0.12 g). Rf 0.12 (20% EtOAc/hexanes); 1H NMR (400 MHz, CDCl3)  8.27 
(d, J = 8.8, 1H), 7.87 (d, J = 8.2, 1H), 7.97 (d, J = 8.2, 1H), 7.65 (d, J = 7.6, 1H), 7.53 (t, 
J = 7.6, 1H), 7.48 (t, J = 7.0, 1H), 7.42 (t, J = 7.9, 1H), 7.12 (t, J = 7.0, 2H), 6.81-6.78 
(m, 3H), 6.72 (s, 1H), 6.43 (s, 1H), 4.21-4.11 (m, 2H), 3.73 (t, J = 6.4, 2H), 3.51-3.43 (m, 
2H), 2.75 (d, J = 16.7, 1H), 2.64 (d, J = 16.7, 1H), 2.28 (t, J = 7.3, 2H), 1.80 (quin, J = 
6.8, 2H), 1.58 (brs, 1H), 1.13 (t, J = 7.0, 3H), 0.83 (t, J = 7.0, 3H); 13C NMR (100 MHz, 
CDCl3) 169.6, 168.8, 147.0, 136.3, 133.3, 130.2, 129.18, 129.07, 128.52, 125.97, 
125.84, 125.75, 125.4, 124.7, 122.2, 120.3, 115.9, 107.5, 62.4, 61.66, 61.51, 57.1, 56.4, 
31.0, 27.1, 13.8, 13.17; HRMS m/z 487.2343 (calcd for C30H33NO5, 487.2359).  
 
Diethyl 5-(2-hydroxyethyl)-1,2-diphenyl-1,2-dihydropyridine-3,3(4H)-dicarboxylate 
(3.68f): 
The synthesis was done at 0.3 mmole scale to yield the tiltled compound as colorless oil 
(86% yield, 0.10 g). Rf 0.15 (20% EtOAc/hexanes); 1H NMR (400 MHz, CDCl3)  7.32-
7.25 (m, 5H), 7.20-7.16 (m, 2H), 6.86-6.82 (m, 3H), 6.65 (s, 1H), 5.59 (s, 1H), 4.16-4.04 
(m, 4H), 3.81-3.75 (m, 1H), 3.71-3.65 (m, 1H), 2.66 (d, J = 17.2, 1H), 2.45 (d, J = 17.6, 
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1H), 2.39-2.35 (m, 2H), 1.89 (brs, 1H), 1.18 (t, J = 7.2, 3H), 1.02 (t, J = 7.0, 3H); 13C 
NMR (100 MHz, CDCl3)  169.6, 168.3, 146.7, 139.5, 129.0, 128.5, 128.0, 127.2, 126.6, 
120.6, 116.1, 104.7, 62.3, 62.0, 61.8, 60.2, 58.0, 37.7, 25.7, 13.8, 13.70; HRMS m/z 
423.2045 (calcd for C25H29NO5, 423.2046).   
 
Diethyl 5-(2-hydroxyethyl)-2-(3-nitrophenyl)-1-phenyl-1,2-dihydropyridine-3,3(4H)-
dicarboxylate (3.68g): 
The synthesis was done at 0.3 mmole scale to yield the tiltled compound as colorless oil 
(81% yield, 0.11 g). Rf 0.14 (20% EtOAc/hexanes); 1H NMR (400 MHz, CDCl3)  8.23 
(t, J = 1.9, 1H), 8.13 (dd, J = 8.2, 1.5, 1H), 7.69 (d, J = 7.8, 1H), 7.49 (t, J = 8.2, 1H), 
7.20 (t, J = 7.4, 2H), 6.89 (t, J = 7.0, 1H), 6.81 (d, J = 7.8, 2H), 6.66 (s, 1H), 5.71 (s, 1H), 
4.20-4.06 (m, 4H), 3.84-3.78 (m, 1H), 3.75-3.69 (m, 1H),  2.72 (d, J = 17.5, 1H), 2.41-
2.36 (m, 3H), 1.88 (brs, 1H), 1.24 (t, J = 7.0, 3H), 1.02 (t, J = 7.2, 3H); 13C NMR (100 
MHz, CDCl3) 168.9, 168.0, 148.3, 146.3, 141.8, 133.5, 129.69, 129.29, 126.4, 123.1, 
122.4, 121.3, 116.2, 105.7, 62.37, 62.31, 61.7, 60.3, 57.7, 37.7, 25.8, 13.9, 13.6; HRMS 
m/z 468.1898 (calcd for C25H28N2O7, 468.1897). 
3.4.4. General Procedure C for the One-pot [2+2]/ [4+2] Synthesis of 
Piperideines 3.68a and 3.68m 
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A solution of cyclobutane was prepared according to General Procedure A (1:1 equiv of 
enol ether and freshly prepared methylidene malonate is employed), and without isolation 
a solution of imine prepared according to General Procedure B was added.  The reaction 
mixture was then concentrated while still cold to a total volume of ca. 2 mL.  The 
reaction was then maintained at –50 °C until complete (tlc, 30 – 60 min), and then 
allowed to warm to rt and processed as described under General Procedure B to afford the 
title compounds.  
 
Diethyl 2-(3-ethoxy-4-methoxyphenyl)-5-(3-hydroxypropyl)-1-phenyl-1,2-
dihydropyridine-3,3(4H)-dicarboxylate (3.68m): 
The synthesis was done at 0.5 mmole scale to yield the tiltled compound as colorless oil 
(84% yield, 0.21 g). Rf 0.11 (30% EtOAc/hexanes); 1H NMR (400 MHz, CDCl3)  7.20 - 
7.15 (m, 2 H), 6.86 - 6.82 (m, 4 H), 6.81 (dd, J = 8.2, 1.8 Hz, 1 H), 6.76 - 6.74 (m, 1 H), 
6.57 (s, 1 H), 5.44 (s, 1 H), 4.14 (dq, J = 11.0, 7.1 Hz, 1 H), 4.10 - 4.02 (m, 5 H), 3.78 (s, 
3 H), 3.68 (t, J = 6.4 Hz, 2 H), 2.61 (d, J = 17.6 Hz, 1 H), 2.56 (d, J = 17.6 Hz, 1 H), 2.20 
(t, J = 7.3 Hz, 2 H), 1.78 - 1.70 (m, 2 H), 1.68 (s, 1 H), 1.43 (t, J = 7.0 Hz, 3 H), 1.19 (t, J 
= 7.3 Hz, 3 H), 1.04 (t, J = 7.0 Hz, 3 H); 13C NMR (100 MHz, CDCl3)  169.3, 168.7, 
149.1, 147.9, 147.1, 132.2, 129.0, 124.3, 120.3, 119.5, 116.0, 112.2, 110.6, 107.8, 77.3, 
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76.7, 64.1, 62.5, 61.7, 57.8, 55.8, 31.3, 31.1, 26.6, 14.8, 13.9, 13.8; HRMS m/z 511.2550 
(calcd for C29H37NO7, 511.2570). 
3.4.5. General Procedure D for the Formal [4+2] Cycloaddition of Imine 
and Cyclobutanes 3.41a: Synthesis of Piperidine 3.74a-f 
The general procedure B was employed, except that after addition of cyclobutane the cold 
bath temperature was set to 0 °C and maintained at this temperature until complete (tlc, 8 
– 12 h).  Workup and purification as described in general procedure B provided the title 
compounds. 
 
Diethyl 6-(4-methoxyphenyl)-1, 2-diphenylpiperidine-3,3-dicarboxylate (3.74a): 
The synthesis was done at 0.3 mmole scale to yield the tiltled compound as colorless oil 
(62% yield, 0.90 g). Rf 0.22 (20% EtOAc/hexanes); 1H NMR (400 MHz, CDCl3)  7.21-
7.19 (m, 2H), 7.13-7.09 (m, 5H), 6.90-6.81 (m, 4H), 6.64-6.61 (m, 3H), 5.66 (s, 1H), 4.73 
(dd, J = 11.5, 3.7,  1H), 4.39 (q, J = 7.1, 2H), 3.87-3.75 (m, 2H), 3.65 (s, 3H), 2.75 (td, J 
= 14.5, 4.1,  1H), 2.56-2.52 (m, 1H), 2.14 (dq, J = 13.9, 3.4,  1H), 1.68-1.57 (m, 1H), 1.37 
(t, J = 7.0, 3H), 0.92 (t, J = 7.0, 3H); 13C NMR (100 MHz, CDCl3)  170.2, 168.9, 157.8, 
149.6, 137.68, 137.07, 129.85, 128.1, 127.65, 127.61, 127.3, 125.1, 121.7, 113.4, 67.7, 
61.81, 61.36, 59.0, 56.6, 54.9, 34.2, 24.5, 14.2, 13.5; HRMS m/z 487.2357 (calcd for 
C30H33NO5, 487.2359). 
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Diethyl 6-(4-methoxyphenyl)-2-(3-nitrophenyl)-1-phenylpiperidine-3,3-
dicarboxylate (3.74b): 
The synthesis was done at 0.3 mmole scale to yield the tiltled compound as colorless oil 
(86% yield, 0.13 g). Rf 0.16 (20% EtOAc/hexanes); 1H NMR (400 MHz, CDCl3)  8.12 
(t, J = 1.9, 1H), 8.0 (dd, J = 8.2, 1.5, 1H), 7.51 (d, J = 7.8, 1H), 7.31 (t, J = 8.2, 1H), 7.09 
(d, J = 8.9, 2H), 6.89 (t, J = 7.4, 2H), 6.81 (d, J = 7.4, 2H), 6.66-6.62 (m, 3H),  5.83 (s, 
1H), 4.71 (dd, J = 11.5, 3.7,  1H), 4.41 (qd, J = 7.1, 2.5, 2H), 3.92-3.79 (m, 2H), 3.66 (s, 
3H), 2.68-2.55 (m, 2H), 2.2 (dq, J = 14.0, 3.5, 1H), 1.70-1.63 (m, 1H), 1.38 (t, J = 7.2, 
3H), 0.98 (t, J = 7.2, 3H); 13C NMR (100 MHz, CDCl3)  169.6, 168.5, 158.0, 148.8, 
147.5, 140.2, 136.2, 135.7, 128.6, 128.0, 124.7, 124.1, 122.4, 122.2, 119.9, 113.5, 67.0, 
62.1, 61.7, 58.8, 56.8, 55.0, 33.9, 24.4, 14.2, 13.6; HRMS m/z 532.2195 (calcd for 
C30H32N2O7, 532.2210). 
 
Diethyl 2,6-bis(4-methoxyphenyl)-1-phenylpiperidine-3,3-dicarboxylate (3.74c): 
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The synthesis was done at 0.3 mmole scale to yield the tiltled compound as colorless oil 
(73% yield, 0.11 g). Rf 0.14 (20% EtOAc/hexanes); 1H NMR (400 MHz, CDCl3)  7.10 
(t, J = 8.9, 4H), 6.88 (t, J = 7.4, 2H), 6.80 (d, J = 7.8, 2H), 6.63 (t, J = 8.6, 5H), 5.60 (s, 
1H), 4.67 (dd, J = 11.5, 3.3,  1H), 4.38 (q, J = 7.0, 2H), 3.89-3.75 (m, 2H), 3.69 (s, 3H), 
3.65 (s, 3H), 2.72 (td, J = 14.6, 3.9, 1H), 2.50 (d, J = 14.8, 1H), 2.12 (dq, J = 13.8, 3.3, 
1H), 1.67-1.59 (m, 1H), 1.37 (t, J = 7.2, 3H), 0.95 (t, J = 7.0, 3H); 13C NMR (100 MHz, 
CDCl3)  170.2, 168.9, 158.6, 157.7, 149.7, 137.1, 130.9, 129.7, 128.1, 127.6, 125.2, 
121.7, 113.3, 112.8, 67.2, 61.7, 61.3, 59.1, 56.4, 54.9, 34.3, 24.4, 14.2, 13.7; HRMS m/z 
517.2452 (calcd for C31H35NO6, 517.2464). 
 
Diethyl 6-(4-methoxyphenyl)-1-phenyl-2-(thiophen-2-yl)piperidine-3,3-dicarboxylate 
(3.74d): 
The synthesis was done at 0.3 mmole scale to yield the tiltled compound as colorless oil 
(59% yield, 0.10 g). Rf 0.25 (20% EtOAc/hexanes); 1H NMR (400 MHz, CDCl3)  7.12 
(d, J = 5.0, 1H), 7.0 (d, J = 8.6, 2H), 6.92 (t, J = 7.4, 2H), 6.81 (d, J = 7.4, 2H), 6.78-
6.69(m, 2H), 6.60 (d, J = 8.6, 2H), 6.53 (d, J = 3.5, 1H), 5.93 (s, 1H), 4.47 (dd, J = 11.3, 
3.1,  1H), 4.40 (q, J = 7.0, 2H), 3.96-3.87 (m, 2H), 3.65 (s, 3H), 3.65 (s, 3H), 2.71-2.56 
(m, 2H), 2.06-2.02 (m, 1H), 1.66-1.55 (m, 1H), 1.39 (t, J = 7.2, 3H), 0.98 (t, J = 7.2, 3H); 
13C NMR (100 MHz, CDCl3)  169.6, 168.5, 157.8, 149.5, 136.9, 136.5, 128.6, 128.3, 
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127.7, 125.5, 125.0, 122.4, 113.4, 65.0, 61.9, 61.5, 59.0, 56.7, 54.9, 34.2, 24.9, 14.3, 
13.6; HRMS m/z 493.1915 (calcd for C28H31NO5S, 493.1923). 
 
Diethyl 6-(4-methoxyphenyl)-2-(naphthalen-1-yl)-1-phenylpiperidine-3,3-
dicarboxylate (3.74e): 
The synthesis was done at 0.3 mmole scale to yield the tiltled compound as colorless oil 
(68% yield, 0.10 g). Rf 0.30 (20% EtOAc/hexanes); 1H NMR (400 MHz, CDCl3)  7.69 
(d, J = 8.9, 1H), 7.64 (d, J = 7.4, 1H), 7.27 (d, J = 8.2, 1H), 7.24 (dd, J = 7.0, 2.3, 1H), 
7.08 (t, J = 7.4, 1H), 6.94-6.88(m, 2H), 6.79 (d, J = 8.6, 2H), 6.57 (s, 1H), 6.52 (d, J = 
7.8, 2H), 6.35 (t, J = 7.8, 2H), 6.27 (d, J = 8.6, 2H), 6.06 (t, J = 7.4, 1H), 4.65 (dd, J = 
11.3, 3.9,  1H), 4.12-4.04(m, 2H), 3.27 (s, 3H), 3.11-3.03 (m, 1H), 2.80-2.72 (m, 1H), 
2.54 (td, J = 14.6, 4.3, 1H), 2.20-2.15(m, 1H), 1.89 (dq, J = 14.0, 3.5, 1H), 1.39-1.28(m, 
1H), 1.03 (t, J = 7.0, 3H), 0.16 (t, J = 7.0, 3H); 13C NMR (100 MHz, CDCl3)  170.6, 
168.7, 157.8, 149.1, 137.2, 135.0, 133.4, 132.6, 128.19, 128.1, 128.06, 127.4, 126.5, 
125.3, 124.8, 124.3, 123.8, 121.5, 113.3, 61.8, 61.0, 59.2, 58.0, 56.7, 54.9, 34.1, 24.2, 
14.2, 12.96; HRMS m/z 537.2510 (calcd for C34H35NO5, 537.2515). 
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Diethyl 2-(2,2-diphenylvinyl)-6-(4-methoxyphenyl)-1-phenylpiperidine-3,3-
dicarboxylate (3.74f): 
The synthesis was done at 0.3 mmole scale to yield the tiltled compound as colorless oil 
(61% yield, 0.10 g). Rf 0.21 (20% EtOAc/hexanes); 1H NMR (400 MHz, CDCl3)  7.25-
7.23(m, 2H), 7.13-7.10(m, 3H), 7.05-6.99(m, 4H), 6.96-6.92(m, 2H), 6.84-6.77(m, 3H), 
6.60 (d, J = 8.6, 2H), 6.43 (d, J = 11.3, 1H), 6.16 (d, J = 7.0, 2H), 4.96 (d, J = 11.3, 1H), 
4.57 (dd, J = 11.3, 3.1,  1H), 4.32 (q, J = 7.0, 2H), 4.25-4.17(m, 1H), 3.94-3.86(m, 1H), 
3.65 (s, 3H), 2.64-2.47 (m, 2H), 1.99 (dd, J = 13.6, 3.1,  1H), 1.65-1.54(m, 1H), 1.32 (t, J 
= 7.2, 3H), 1.11 (t, J = 7.2, 3H); 13C NMR (100 MHz, CDCl3)  169.8, 169.4, 157.7, 
149.6, 146.5, 143.3, 138.5, 136.5, 129.1, 128.3, 128.0, 127.8, 127.47, 127.4, 126.8, 126.6, 
122.6, 120.2, 113.3, 61.7, 61.5, 61.3, 59.0, 56.1,54.9, 34.6, 25.0, 14.2, 13.7; HRMS m/z 
589.2827 (calcd for C38H39NO5, 589.2828). 
3.4.6. General Procedure E for the Annulation Reaction Between Aldehydes 
and Cyclobutane 3.39h:35  
To a solution of Yb(OTf)3  (0.01 equiv, 0.004 mmol ) in CH2Cl2 (2.0 mL) at -50 °C, 
aldehyde (3.0 equiv, 1.2 mmol) and cyclobutane (1.0 equiv, 0.4 mmol) dissolved in 
CH2CL2 (2.0 mL) were added. The reaction mixture then warmed gradually to 0 °C (ca 1-
2 h). After completion, it was filtered through silica gel pad (2 cm). The filtrate was 
concentrated under reduced pressure. Purification by flash column chromatography on 
silica gel using EtOAc-hexanes for elution provided the title compounds. TEA (1%) was 
added to the eluent to buffer silica gel.  
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Diethyl 8a-methoxy-2-(4-methoxyphenyl)hexahydro-2H-chromene-3,3(4H)-
dicarboxylate (3.91v) 
Colourless oil (76% yield, 0.09 g). Rf 0.3 (10% EtOAc/hexanes); 1H NMR (400 MHz, 
CDCl3)  7.38 (d, J = 8.7 Hz, 2 H), 6.78 (m, J = 8.7 Hz, 2 H), 5.25 (s, 1 H), 4.09 (q, J = 
7.3 Hz, 2 H), 4.01 (dq, J = 10.7, 7.2 Hz, 1 H), 3.82-3.78 (m, 1 H), 3.77 (s, 3 H), 3.11 (s, 3 
H), 2.19-2.14 (m, 1 H), 2.11 (t, J = 12.4 Hz, 1 H), 2.08-2.03 (m, 1 H), 2.02 (d, J = 12.8 
Hz, 1 H), 1.71 (d, J = 8.4 Hz, 1 H), 1.61 (d, J = 9.9 Hz, 1 H), 1.44-1.31 (m, 5 H), 1.14 (t, 
J = 7.1 Hz, 3 H), 0.94 ppm (t, J = 7.1 Hz, 3 H); 13C NMR (100 MHz, CDCl3)  170.8, 
169.6, 158.8, 131.8, 129.1, 112.5, 99.0, 72.5, 61.0, 60.4, 58.9, 55.2, 47.1, 39.4, 33.2, 31.2, 
28.6, 25.6, 22.6, 13.9, 13.5; HRMS m/z 420.2159 (calcd for C23H32O7, 420.2148). 
 
Diethyl 2-(4-chlorophenyl)-8a-methoxyhexahydro-2H-chromene-3,3(4H)-
dicarboxylate (3.91w) 
Colourless oil (69% yield, 0.08 g). Rf 0.5 (10% EtOAc/hexanes); 1H NMR (400 MHz, 
CDCl3)  7.39 (d, J = 8.6 Hz, 2 H), 7.21 (d, J = 8.6 Hz, 2 H), 5.29 (s, 1 H), 4.10 (q, J = 
7.0 Hz, 2 H), 3.99 (dq, J = 10.7, 7.1 Hz, 1 H), 3.77 (dq, J = 10.8, 7.1 Hz, 1 H), 3.10 (s, 3 
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H), 2.13-2.09 (m, 2 H), 2.08-2.05 (m, 1 H),  2.04-2.00 (m, 1 H), 1.71-1.70 (m, 1 H), 1.62-
1.60 (m, 1 H), 1.44-1.1.32 (m, 5 H), 1.15 (t, J = 7.0 Hz, 3 H), 0.92 (t, J = 7.2 Hz, 3 H); 
13C NMR (100 MHz, CDCl3)  170.7, 169.3, 138.2, 133.0, 129.3, 127.3, 99.1, 72.2, 61.2, 
60.6, 58.9, 47.1, 39.4, 33.2, 31.2, 28.5, 25.6, 22.6, 13.9, 13.5; HRMS m/z 425.1283 (calcd 
for C22H29ClO6, 424.1653).  
 
Diethyl 8a-methoxy-2-(3-nitrophenyl)hexahydro-2H-chromene-3,3(4H) 
dicarboxylate (3.91x) 
Colourless oil (60% yield, 0.104 g). Rf 0.4 (10% EtOAc/hexanes); 1H NMR (400 MHz, 
CDCl3)  8.32 (s, 1H), 8.09 (d, J = 8.0 Hz, 1H), 7.82 (d, J = 7.7 Hz, 1H), 7.42 (t, J = 8.0 
Hz, 1H), 5.41 (s, 1H), 4.15 (q, J = 7.0 Hz, 2H), 4.02-3.97 (m, 1H), 3.86-3.80 (m, 1H), 
3.11 (s, 3H), 2.21-2.13 (m, 2H), 2.11-2.07 (m, 1H), 2.03 (d, J = 10.6 Hz, 1H), 1.71 (d, J = 
9.1 Hz, 1H), 1.64 (d, J = 8.4 Hz, 1H), 1.46-1.42 (m, 1H), 1.40-1.34(m, 4H), 1.17 (t, J = 
7.1 Hz, 3H), 0.90 (t, J = 7.1 Hz, 3H); 13C NMR (100 MHz, CDCl3)  170.4, 168.8, 147.5, 
141.9, 134.1, 127.9, 123.1, 122.2, 99.5, 71.9, 61.5, 60.7, 59.2, 47.1, 39.6, 33.1, 31.1, 28.4, 
25.5, 22.5, 13.8, 13.5; HRMS m/z 435.1882 (calcd for C22H29NO8, 435.1893).  
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Diethyl 8a-methoxy-2-styrylhexahydro-2H-chromene-3,3(4H)-dicarboxylate (3.91y) 
Colourless oil (71% yield, 0.08 g). Rf 0.25 (10% EtOAc/hexanes); 1H NMR (400 MHz, 
CDCl3)  7.38 (d, J = 7.3 Hz, 2 H), 7.27 (t, J = 7.7 Hz, 2 H), 7.21 - 7.18 (m, 1 H), 6.65 
(dd, J = 16.1, 6.6 Hz, 1 H), 6.58 (d, J = 16.1 Hz, 1 H), 4.74 (d, J = 7.0 Hz, 1 H), 4.19 (q, J 
= 7.0 Hz, 2 H), 4.14 - 4.08 (m, 2 H), 3.17 (s, 3 H), 2.15 - 2.02 (m, 3 H), 1.85 - 1.80 (m, 1 
H), 1.70 (d, J = 12.1 Hz, 1 H), 1.61 (d, J = 12.4 Hz, 1 H), 1.41 - 1.38 (m, 3 H), 1.29-1.24 
(m, 2 H), 1.21 (t, J = 7.1 Hz, 3 H), 1.15 (t, J = 7.1 Hz, 3 H); 13C NMR (100 MHz, CDCl3) 
 170.2, 169.4, 137.0, 131.1, 128.4, 127.4, 127.3, 126.5, 99.0, 77.3, 76.7, 72.9, 61.3, 60.9, 
59.0, 47.0, 40.1, 32.5, 31.3, 28.5, 25.6, 22.5, 14.03, 14.0; HRMS m/z 416.2202 (calcd for 
C24H32O6, 416.2199).  
 
Diethyl 8a-methoxy-2-(thiophen-2-yl)hexahydro-2H-chromene-3,3(4H)-
dicarboxylate (3.91z) 
Colourless oil (56% yield, 0.06 g). Rf 0.3 (10% EtOAc/hexanes); 1H NMR (400 MHz, 
CDCl3)  7.17 (dd, J = 5.1, 1.2 Hz, 1 H), 7.03 (d, J = 3.5 Hz, 1 H), 6.89 (dd, J = 5.1, 3.9 
Hz, 1 H), 5.56 (s, 1 H), 4.20-4.10 (m, 2 H), 4.02 (dq, J = 10.7, 7.1 Hz, 1 H), 3.88 (dq, J = 
10.7, 7.1 Hz, 1 H), 3.15 (s, 3 H), 2.11-2.03 (m, 4 H), 1.70-1.68 (m, 1 H), 1.62-1.60 (m, 1 
H), 1.42-1.33 (m, 5 H), 1.17 (t, J = 7.0 Hz, 3 H), 0.96 (t, J = 7.0 Hz, 3 H); 13C NMR (100 
MHz, CDCl3)  170.5, 169.1, 142.7, 125.7, 125.3, 124.3, 99.4, 70.1, 61.3, 60.8, 59.3, 
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47.2, 39.5, 33.0, 31.1, 28.5, 25.6, 22.6, 13.9, 13.5; HRMS m/z 396.1595 (calcd for 
C20H28O6S, 396.1607).  
3.4.7. General Procedure F for the One-pot [2+2] / [4+2] Synthesis of 
Tetrahydropyran. 
 To a solution of Yb(OTf)3  (0.01 eq) in CH2Cl2 (10.0 mL/ 0.25 mmol) at –78 °C, the 
enol ether (1.1 equiv) was dissolved in CH2Cl2 (10.0 mL/ 5 mmol) and methylidene 
malonate (1.0 equiv) dissolved in CH2Cl2 (10.0 mL/ 5 mmol)  were added by syringe 
pump over 30 minutes. Both solutions were added simultaneously. After 1h, aldehyde 
(3.0 equiv) was added. The reaction mixture warmed gradually to 0 °C. After completion 
(25 min), the reaction was filtered through silica gel pad (2 cm). The filtrate was 
concentrated under reduced pressure. Purification by flash column chromatography on 
silica gel using EtOAc-hexanes for elution provided the title compounds. TEA (1%) was 
added to the eluent to buffer silica gel. 
 
Diethyl 6-ethoxy-2-phenyldihydro-2H-pyran-3,3(4H)-dicarboxylate (3.91t): 
The reaction was done at 45 mmol scale to yield the titled product as colourless oil (54% 
yield, 8.50 g). Rf 0.40 (10% EtOAc/hexanes); 1H NMR (400 MHz, CDCl3)  7.45-7.43 
(m, 2 H), 7.28-7.22 (m, 3 H), 5.08 (s, 1 H), 4.67 (dd, J = 9.4, 2.7 Hz, 1 H), 4.12 (qd,  J = 
7.2, 2.3 Hz, 2 H), 3.05-3.97 (m, 1 H), 3.95-3.84 (m, 2 H), 3.51 (dq, J = 9.6, 7.1 Hz, 1 H), 
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2.63-2.57 (m, 1 H), 2.12 (td, J = 13.3, 4.7 Hz, 1 H), 2.00-1.90 (m, 1 H), 1.87 - 1.81 (m, 1 
H), 1.20 (t, J = 7.0 Hz, 3 H), 1.14 (t, J = 7.2 Hz, 3 H), 0.94 (t, J = 7.0 Hz, 3 H); 13C NMR 
(100 MHz, CDCl3)  171.0, 168.3, 139.2, 127.4, 127.1, 102.5, 79.4, 64.3, 61.4, 60.6, 
58.5, 31.1, 27.8, 15.1, 13.8, 13.5; HRMS m/z 350.1711 (calcd for C19H26O6, 350.1729).  
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Appendix 2 – NMR Spectra for Compounds Presented in Chapter 1 
 
Dimethylbis(phenylethynyl)silane (1.24a) 
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Dihexylbis(phenylethynyl)silane (1.24c) 
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2,5-di(2,2'-terthiophen-5-yl)-1,1-dimethyl-3,4-diphenyl-1H-silole (1.18a) 
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2,5-di(2,2'-terthiophen-5-yl)-1,1-di-tert-butyl-3,4-diphenyl-1H-silole (1.18b) 
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2,5-di(2,2'-terthiophen-5-yl)-1,1-dihexyl-3,4-diphenyl-1H-silole (1.18c) 
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1,1-dihexyl-2,3,4,5-tetraphenyl-1H-silole (1.16a) 
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1,1-dihexyl-3,4-diphenyl-2,5-bis(4-(trifluoromethyl)phenyl)-1H-silole (1.16b) 
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1,1-dihexyl-2,5-bis(4-methoxyphenyl)-3,4-diphenyl-1H-silole (1.16d) 
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4,4'-(1,1-dihexyl-3,4-diphenyl-1H-silole-2,5-diyl)bis(N,N-dimethylaniline) (1.16e) 
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2,2'-(1,1-dihexyl-3,4-diphenyl-1H-silole-2,5-diyl)dipyridine (1.17) 
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2-chloro-1,1-dimethyl-3,4-diphenyl-5-(thiophen-2-yl)-1H-silole (1.36) 
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1,1-dimethyl-2,3,4-triphenyl-5-(thiophen-2-yl)-1H-silole (1.38) 
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1,1-dimethyl-3,4-diphenyl-2-(phenylethynyl)-5-(thiophen-2-yl)-1H-silole (1.39) 
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1-(4-(1,1-dimethyl-3,4-diphenyl-5-(thiophen-2-yl)-1H-silol-2-yl)phenyl)-N-
methylmethanamine (1.41) 
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Appendix 3 – NMR Spectra for Compounds Presented in Chapter 2 
endo- Ethyl-6-methoxy-3-tosyl-3-azabicyclo[4.1.0]heptane-7-carboxylate (endo-2.75) 
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exo-Ethyl 6-methoxy-3-tosyl-3-azabicyclo[4.1.0]heptane-7-carboxylate (exo-2.75) 
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Ethyl 2-methyl-5-tosyl-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridine-3-carboxylate 
(2.76a) 
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Ethyl 2-ethyl-5-tosyl-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridine-3-carboxylate 
(2.76b) 
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Ethyl 2-phenyl-5-tosyl-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridine-3-carboxylate 
(2.76c) 
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Ethyl 2-(4-methoxyphenyl)-5-tosyl-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridine-3-
carboxylate (2.76d) 
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Ethyl 2-styryl-5-tosyl-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridine-3-carboxylate 
(2.76e) 
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Ethyl 2-(thiophen-2-yl)-5-tosyl-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridine-3-
carboxylate (2.76f) 
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Ethyl 8-cyano-2-tosyl-1,2,3,4-tetrahydropyrido[3,4-b]indolizine-10-carboxylate 
(2.80a) 
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Ethyl 6-cyano-2-tosyl-1,2,3,4-tetrahydropyrido[3,4-b]indolizine-10-carboxylate 
(2.80b) 
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10a-Methoxy-5,5a,6,6a,7,8,9,10,10a,10b-decahydrocyclopentadiene[c]pyridine 
[5,6-b]indole-6-carboxylic acid ethyl ester (2.80c) 
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Ethyl 2-methyl-1H-pyrrolo[3,2-c]pyridine-3-carboxylate (2.79a) 
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Ethyl 2-ethyl-1H-pyrrolo[3,2-c]pyridine-3-carboxylate (2.79b) 
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Ethyl 2-phenyl-1H-pyrrolo[3,2-c]pyridine-3-carboxylate (2.79c) 
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Ethyl 2-(4-methoxyphenyl)-1H-pyrrolo[3,2-c]pyridine-3-carboxylate (2.79d) 
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 Ethyl 2-styryl-1H-pyrrolo[3,2-c]pyridine-3-carboxylate (2.79e)
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Ethyl 2-(thiophen-2-yl)-1H-pyrrolo[3,2-c]pyridine-3-carboxylate (2.79f) 
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Ethyl 8-cyanopyrido[3,4-b]indolizine-10-carboxylate (2.81a) 
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Ethyl 6-cyanopyrido[3,4-b]indolizine-10-carboxylate (2.81b) 
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Appendix 4 – NMR Spectra for Compounds Presented in Chapter 3 
Diethyl 2-oxabicyclo[4.2.0]octane-8,8-dicarboxylate (3.39b)  
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Diethyl 2-oxabicyclo[3.2.0]heptane-7,7-dicarboxylate (3.39c) 
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Di-tert-butyl 2-oxabicyclo[3.2.0]heptane-7,7-dicarboxylate (3.39d) 
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Dimethyl 2-ethoxycyclobutane-1,1-dicarboxylate (3.39f) 
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Diethyl 2-ethoxycyclobutane-1,1-dicarboxylate (3.39g) 
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Diethyl 6-methoxybicyclo[4.2.0]octane-7,7-dicarboxylate (3.39h) 
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Diethyl 2-(4-methoxyphenyl)cyclobutane-1,1-dicarboxylate (3.41a) 
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Dimethyl 2-(4-methoxyphenyl)-3-methylcyclobutane-1,1-dicarboxylate (3.41c) 
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Diethyl 2-(4-methoxyphenyl)-3-methylcyclobutane-1,1-dicarboxylate (3.41d) 
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Di-tert-butyl 2-(4-methoxyphenyl)-3-methylcyclobutane-1,1-dicarboxylate(3.41e) 
 
 
 
 
 
 
 
 
 
 
 
 
PROTON_01.esp
9.5 9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5
Chemical Shift (ppm)
9.043.079.181.191.091.061.173.081.951.97
CHLOROFORM-d
1.
02
1.
12
1.
46
1.
64
1.
65
1.
67
2.
682.
70
2.
712.
73
2.
82
2.
83
2.
84
2.
843.
71
3.
74
3.
76
6.
806.
82
7.
21
7.
23
7.
25
1.15 1.10 1.05
Chemical Shift (pp...
9.043.07
1.
11
1.
12
2.9 2.8 2.7
Chemical Shift (ppm)
1.091.06
2.
68
2.
70
2.
712
.7
3
2.
79
2.
802.
812
.8
2
2.
83
2.
84
2.
84
2.
86
2.
88
1.650 1.625
Chemical Shift (pp...
1.19
1.
62
1.
64
1.
65
1.
67
3.725 3.700
Chemical Shift (ppm)
1.173.08
3.
71
3.
74
CARBON_01.esp
190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10
Chemical Shift (ppm)
CHLOROFORM-d
20
.3
3
27
.4
2
27
.9
6
28
.2
7
33
.6
2
51
.3
1
55
.3
3
57
.9
5
68
.1
3
76
.6
9
77
.0
0
77
.3
2
80
.8
9
11
3.
30
12
9.
20
13
0.
86
15
8.
45
16
8.
82
17
1.
24
81 80
Chemical Shift (ppm)
80
.7
3
80
.8
9
29 28 27
Chemical Shift (ppm)
27
.4
2
27
.9
6
28
.2
7
207 
 
 
 
208 
 
 
 
 
 
 
209 
 
Diethyl 7,8-diphenylhexahydro-2H-pyrano[2,3-b]pyridine-6,6(7H)-dicarboxylate 
 (trans-3.67a) 
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Diethyl 7-(3-nitrophenyl)-8 phenylhexahydro-2H-pyrano[2,3-b]pyridine-6,6(7H)-
dicarboxylate (trans-3.67b)2 
 
 
 
 
 
 
 
 
                                                 
2 Product contaminated with 20% 3-nitrobenzaldehyde arising from aldimine hydrolysis during flash chromatography. 
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Diethyl 7-(3-nitrophenyl)-8 phenylhexahydro-2H-pyrano[2,3-b]pyridine-6,6(7H)-
dicarboxylate (cis-3.67b) 
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Diethyl 5-(3-hydroxypropyl)-1,2-diphenyl-1,2-dihydropyridine-3,3(4H)-
dicarboxylate (3.68a) 
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Diethyl 5-(3-hydroxypropyl)-2-(3-nitrophenyl)-1-phenyl-1,2-dihydropyridine-
3,3(4H)-dicarboxylate (3.68b): 
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Diethyl 5-(3-hydroxypropyl)-2-(4-methoxyphenyl)-1-phenyl-1,2-dihydropyridine-
3,3(4H)-dicarboxylate (3.68c) 
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Diethyl 5-(3-hydroxypropyl)-1-phenyl-2-(thiophen-2-yl)-1,2-dihydropyridine-
3,3(4H)-dicarboxylate (3.68d): 
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 Diethyl 5-(3-hydroxypropyl)-2-(naphthalen-1-yl)-1-phenyl-1,2-dihydropyridine-
3,3(4H)-dicarboxylate (3.68e): 
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Diethyl 5-(2-hydroxyethyl)-1,2-diphenyl-1,2-dihydropyridine-3,3(4H)-dicarboxylate 
(3.68f) 
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Diethyl 5-(2-hydroxyethyl)-2-(3-nitrophenyl)-1-phenyl-1,2-dihydropyridine-3,3(4H)-
dicarboxylate (3.68g): 
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Diethyl 2-(3-ethoxy-4-methoxyphenyl)-5-(3-hydroxypropyl)-1-phenyl-1,2-
dihydropyridine-3,3(4H)-dicarboxylate (3.68m) 
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Diethyl 6-(4-methoxyphenyl)-1,2-diphenylpiperidine-3,3-dicarboxylate (3.74a) 
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Diethyl 6-(4-methoxyphenyl)-2-(3-nitrophenyl)-1-phenylpiperidine-3,3-
dicarboxylate (3.74b): 
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Diethyl 2,6-bis(4-methoxyphenyl)-1-phenylpiperidine-3,3-dicarboxylate (3.74c): 
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Diethyl 6-(4-methoxyphenyl)-1-phenyl-2-(thiophen-2-yl)piperidine-3,3-dicarboxylate 
(3.74d): 
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Diethyl 6-(4-methoxyphenyl)-2-(naphthalen-1-yl)-1-phenylpiperidine-3,3-
dicarboxylate (3.74e): 
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Diethyl 2-(2,2-diphenylvinyl)-6-(4-methoxyphenyl)-1-phenylpiperidine-3,3-
dicarboxylate (3.74f): 
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Diethyl 8a-methoxy-2-(4-methoxyphenyl)hexahydro-2H-chromene-3,3(4H)-
dicarboxylate (3.91v) 
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Diethyl 2-(4-chlorophenyl)-8a-methoxyhexahydro-2H-chromene-3,3(4H)-
dicarboxylate (3.91w) 
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Diethyl 8a-methoxy-2-(3-nitrophenyl)hexahydro-2H-chromene-3,3(4H)-
dicarboxylate (3.91x) 
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Diethyl 8a-methoxy-2-styrylhexahydro-2H-chromene-3,3(4H)-dicarboxylate (3.91y) 
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Diethyl 8a-methoxy-2-(thiophen-2-yl)hexahydro-2H-chromene-3,3(4H)-
dicarboxylate (3.91z) 
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Diethyl 6-ethoxy-2-phenyldihydro-2H-pyran-3,3(4H)-dicarboxylate (3.91t) 
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